Colgate-Palmolive (CL) 10-K 19 Feb 15 2014 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information Document (USD $)	12 Months Ended
In Billions, except Share data, unless otherwise specified	Dec. 31, 2014	Jan. 31, 2015	Jun. 30, 2014
Entity Information [Line Items]
Entity Registrant Name	COLGATE PALMOLIVE CO
Entity Central Index Key	21665
Current Fiscal Year End Date	-19
Entity Filer Category	Large Accelerated Filer
Document Type	10-K
Document Period End Date	31-Dec-14
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	FY
Amendment Flag	FALSE
Trading Symbol	CL
Entity Common Stock, Shares Outstanding		907,081,762
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Public Float			$62.10

Consolidated_Statements_of_Inc

Consolidated Statements of Income (USD $)	12 Months Ended
In Millions, except Per Share data, unless otherwise specified	Dec. 31, 2014		Dec. 31, 2013		Dec. 31, 2012
Net sales	$17,277		$17,420		$17,085
Cost of sales	7,168		7,219		7,153
Gross profit	10,109	[1]	10,201	[2]	9,932
Selling, general and administrative expenses	5,982		6,223		5,930
Other (income) expense, net	570		422		113
Operating profit	3,557		3,556		3,889
Interest (income) expense, net	24		-9		15
Income before income taxes	3,533		3,565		3,874
Provision for income taxes	1,194		1,155		1,243
Net income including noncontrolling interests	2,339	[3]	2,410	[4]	2,631
Net Income (Loss) Attributable to Noncontrolling Interest	159		169		159
Net income attributable to Colgate-Palmolive Company	$2,180	[3]	$2,241	[4]	$2,472
Earnings per common share, basic	$2.38	[3]	$2.41	[4]	$2.60
Earnings per common share, diluted	$2.36	[3]	$2.38	[4]	$2.57
[1]	Gross profit for the full year of 2014 includes $29 of charges related to the 2012 Restructuring Program and $4 of costs related to the sale of land in Mexico.
[2]	Gross profit for the full year of 2013 includes $32 of charges related to the 2012 Restructuring Program and $15 of costs related to the sale of land in Mexico.
[3]	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the full year of 2014 include $208 of aftertax charges related to the 2012 Restructuring Program, $214 of aftertax charges related to the 2014 Venezuela Remeasurements, $41 of charges for European competition law matters, $3 of aftertax costs related to the sale of land in Mexico and a $66 charge for a foreign tax matter.
[4]	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the full year of 2013 include $278 of aftertax charges related to the 2012 Restructuring Program, a $111 aftertax charge related to the 2013 Venezuela Remeasurement, a $23 charge for a European competition law matter and $12 of aftertax costs related to the sale of land in Mexico.

Consolidated_Statements_of_Com

Consolidated Statements of Comprehensive Income (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014		Dec. 31, 2013		Dec. 31, 2012
Statement of Comprehensive Income [Abstract]
Net income including noncontrolling interests	$2,339	[1]	$2,410	[2]	$2,631
Other comprehensive income (loss), net of tax:
Cumulative translation adjustments	-685		-166		-18
Retirement Plan and other retiree benefit adjustments	-329		318		-145
Gains (losses) on available-for-sale securities	-48		13		18
Gains (losses) on cash flow hedges	2		2		1
Total Other comprehensive income (loss), net of tax	-1,060		167		-144
Total Comprehensive income including noncontrolling interests	1,279		2,577		2,487
Less: Net income attributable to noncontrolling interests	159		169		159
Less: Cumulative translation adjustments attributable to noncontrolling interests	-4		-3		2
Total Comprehensive income attributable to noncontrolling interests	155		166		161
Total Comprehensive income attributable to Colgate-Palmolive Company	$1,124		$2,411		$2,326
[1]	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the full year of 2014 include $208 of aftertax charges related to the 2012 Restructuring Program, $214 of aftertax charges related to the 2014 Venezuela Remeasurements, $41 of charges for European competition law matters, $3 of aftertax costs related to the sale of land in Mexico and a $66 charge for a foreign tax matter.
[2]	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the full year of 2013 include $278 of aftertax charges related to the 2012 Restructuring Program, a $111 aftertax charge related to the 2013 Venezuela Remeasurement, a $23 charge for a European competition law matter and $12 of aftertax costs related to the sale of land in Mexico.

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Dec. 31, 2014		Dec. 31, 2013
In Millions, unless otherwise specified
Current Assets
Cash and cash equivalents	$1,089		$962
Receivables (net of allowances of $54 and $67, respectively)	1,552		1,636
Inventories	1,382		1,425
Other current assets	840		908
Total current assets	4,863		4,931
Property, plant and equipment, net	4,080		4,083
Goodwill	2,307		2,474
Other intangible assets, net	1,413		1,496
Deferred income taxes	76		77
Other assets	720		924
Total assets	13,459	[1]	13,985	[1]
Current Liabilities
Notes and loans payable	16		13
Current portion of long-term debt	488		895
Accounts payable	1,231		1,343
Accrued income taxes	294		239
Other accruals	1,917		2,089
Total current liabilities	3,946		4,579
Long-term debt	5,644		4,749
Deferred income taxes	261		444
Other liabilities	2,223		1,677
Total liabilities	12,074		11,449
Commitments and contingent liabilities	0		0
Shareholders’ Equity
Common stock, $1 par value (2,000,000,000 shares authorized, 1,465,706,360 shares issued)	1,466		1,466
Additional paid-in capital	1,236		1,004
Retained earnings	18,832		17,952
Accumulated other comprehensive income (loss)	-3,507		-2,451
Unearned compensation	-20		-33
Treasury stock, at cost	-16,862		-15,633
Total Colgate-Palmolive Company shareholders’ equity	1,145		2,305
Noncontrolling interests	240		231
Total shareholders’ equity	1,385		2,536
Total liabilities and shareholders’ equity	$13,459		$13,985
[1]	Long-lived assets in the U.S., primarily property, plant and equipment and goodwill and other intangibles represented approximately one-third of total long-lived assets of $8,086, $8,248 and $8,066 in 2014, 2013 and 2012, respectively.

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Millions, except Share data, unless otherwise specified
Current Assets
Allowance for Doubtful Accounts Receivable, Current	$54	$67
Shareholders’ Equity
Common Stock, Par or Stated Value Per Share	$1	$1
Common Stock, Shares Authorized (in shares)	2,000,000,000	2,000,000,000
Common Stock, Shares Issued (in shares)	1,465,706,360	1,465,706,360

Consolidated_Statements_of_Cha

Consolidated Statements of Changes in Shareholders' Equity (USD $)	Total		Common Stock [Member]	Additional Paid-In Capital [Member]	Unearned Compensation [Member]	Treasury Stock [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Noncontrolling Interest [Member]
In Millions, unless otherwise specified
Beginning Balance at Dec. 31, 2011			$1,466	$603	($60)	($12,808)	$15,649	($2,475)	$166
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income	2,631						2,472		159
Other comprehensive income (loss), net of tax	-144							-146	2
Dividends declared:
Common stock							-1,168		-109
Stock-based compensation expense				120
Shares issued for stock options				99		297
Shares issued for restricted stock awards				-70		70
Treasury stock acquired						-1,943
Other				66	19	-2			-17
Ending Balance at Dec. 31, 2012			1,466	818	-41	-14,386	16,953	-2,621	201
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income	2,410	[1]					2,241		169
Other comprehensive income (loss), net of tax	167							170	-3
Dividends declared:
Common stock							-1,242		-140
Stock-based compensation expense				128
Shares issued for stock options				82		201
Shares issued for restricted stock awards				-75		75
Treasury stock acquired						-1,521
Other				51	8	-2			4
Ending Balance at Dec. 31, 2013	2,536		1,466	1,004	-33	-15,633	17,952	-2,451	231
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income	2,339	[2]					2,180		159
Other comprehensive income (loss), net of tax	-1,060							-1,056	-4
Dividends declared:
Common stock							-1,300		-146
Stock-based compensation expense				131
Shares issued for stock options				100		225
Shares issued for restricted stock awards				77		77
Treasury stock acquired						-1,530
Other				78	13	-1
Ending Balance at Dec. 31, 2014	$1,385		$1,466	$1,236	($20)	($16,862)	$18,832	($3,507)	$240
[1]	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the full year of 2013 include $278 of aftertax charges related to the 2012 Restructuring Program, a $111 aftertax charge related to the 2013 Venezuela Remeasurement, a $23 charge for a European competition law matter and $12 of aftertax costs related to the sale of land in Mexico.
[2]	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the full year of 2014 include $208 of aftertax charges related to the 2012 Restructuring Program, $214 of aftertax charges related to the 2014 Venezuela Remeasurements, $41 of charges for European competition law matters, $3 of aftertax costs related to the sale of land in Mexico and a $66 charge for a foreign tax matter.

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014		Dec. 31, 2013		Dec. 31, 2012
Operating Activities
Net income including noncontrolling interests	$2,339	[1]	$2,410	[2]	$2,631
Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations:
Depreciation and amortization	442		439		425
Restructuring and termination benefits, net of cash	64		182		35
Venezuela remeasurement charges	327		172		0
Voluntary benefit plan contributions	-2		-101		-101
Charge For Foreign Tax Matter	66		0		0
Stock-based compensation expense	131		128		120
Deferred income taxes	18		71		63
Cash effects of changes in:
Receivables	-109		-37		19
Inventories	-60		-97		-21
Accounts payable and other accruals	57		24		-5
Other non-current assets and liabilities	25		13		30
Net cash provided by operations	3,298		3,204		3,196
Investing Activities
Capital expenditures	-757		-670		-565
Sale of property and non-core product lines	24		15		72
Purchases of marketable securities and investments	-340		-505		-545
Proceeds from sale of marketable securities and investments	283		267		147
Payment for acquisitions, net of cash acquired	-87		-3		-29
Other	18		6		55
Net cash used in investing activities	-859		-890		-865
Financing Activities
Principal payments on debt	-8,525		-7,554		-5,011
Proceeds from issuance of debt	8,960		7,976		5,452
Dividends paid	-1,446		-1,382		-1,277
Purchases of treasury shares	-1,530		-1,521		-1,943
Proceeds from exercise of stock options and excess tax benefits	371		339		478
Net cash used in financing activities	-2,170		-2,142		-2,301
Effect of exchange rate changes on Cash and cash equivalents	-142		-94		-24
Net increase (decrease) in Cash and cash equivalents	127		78		6
Cash and cash equivalents at beginning of year	962		884		878
Cash and cash equivalents at end of year	1,089		962		884
Supplemental Cash Flow Information
Income taxes paid	1,009		1,087		1,280
Interest paid	$133		$118		$77
[1]	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the full year of 2014 include $208 of aftertax charges related to the 2012 Restructuring Program, $214 of aftertax charges related to the 2014 Venezuela Remeasurements, $41 of charges for European competition law matters, $3 of aftertax costs related to the sale of land in Mexico and a $66 charge for a foreign tax matter.
[2]	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the full year of 2013 include $278 of aftertax charges related to the 2012 Restructuring Program, a $111 aftertax charge related to the 2013 Venezuela Remeasurement, a $23 charge for a European competition law matter and $12 of aftertax costs related to the sale of land in Mexico.

Nature_of_Operations

Nature of Operations	12 Months Ended
	Dec. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Operations	Nature of Operations
	The Company manufactures and markets a wide variety of products in the U.S. and around the world in two product segments: Oral, Personal and Home Care; and Pet Nutrition. Oral, Personal and Home Care products include toothpaste, toothbrushes and mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, laundry and dishwashing detergents, fabric conditioners, household cleaners, bleaches and other similar items. These products are sold primarily to retail trade customers and wholesale distributors worldwide. Pet Nutrition products include specialty pet nutrition products manufactured and marketed by Hill’s Pet Nutrition. The principal customers for Pet Nutrition products are authorized pet supply retailers and veterinarians. Principal global and regional trademarks include Colgate, Palmolive, Speed Stick, Lady Speed Stick, Softsoap, Irish Spring, Protex, Sorriso, Kolynos, elmex, Tom’s of Maine, Sanex, Ajax, Axion, Fabuloso, Soupline and Suavitel, as well as Hill’s Science Diet, Hill’s Prescription Diet and Hill’s Ideal Balance.
	The Company’s principal classes of products accounted for the following percentages of worldwide Net sales for the past three years:
		2014		2013		2012
	Oral Care	46	%	46	%	44	%
	Personal Care	21	%	21	%	22	%
	Home Care	20	%	20	%	21	%
	Pet Nutrition	13	%	13	%	13	%
	Total	100	%	100	%	100	%

Summary_of_Significant_Account

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies
	Principles of Consolidation
	The Consolidated Financial Statements include the accounts of Colgate-Palmolive Company and its majority-owned or controlled subsidiaries. Intercompany transactions and balances have been eliminated. The Company’s investments in consumer products companies with interests ranging between 20% and 50%, where the Company has significant influence over the investee, are accounted for using the equity method. Net income (loss) from such investments is recorded in Other (income) expense, net in the Consolidated Statements of Income. As of December 31, 2014 and 2013, equity method investments included in Other assets in the Consolidated Balance Sheets were $31 and $27, respectively. Unrelated third parties hold the remaining ownership interests in these investments. Investments with less than a 20% interest are accounted for using the cost method.
	Use of Estimates
	The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to use judgment and make estimates that affect the reported amounts of assets and liabilities and disclosure of contingent gains and losses at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The level of uncertainty in estimates and assumptions increases with the length of time until the underlying transactions are completed. As such, the most significant uncertainty in the Company’s assumptions and estimates involved in preparing the financial statements includes pension and other retiree benefit cost assumptions, stock-based compensation, asset impairments, uncertain tax positions, tax valuation allowances and legal and other contingency reserves. Additionally, the Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments and retirement plan assets. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. Actual results could ultimately differ from those estimates.
	Revenue Recognition
	Sales are recorded at the time products are shipped to trade customers and when risk of ownership transfers. Net sales reflect units shipped at selling list prices reduced by sales returns and the cost of current and continuing promotional programs. Current promotional programs, such as product listing allowances and co-operative advertising arrangements, are recorded in the period incurred. Continuing promotional programs are predominantly consumer coupons and volume-based sales incentive arrangements with trade customers. The redemption cost of consumer coupons is based on historical redemption experience and is recorded when coupons are distributed. Volume-based incentives offered to trade customers are based on the estimated cost of the program and are recorded as products are sold.
	Shipping and Handling Costs
	Shipping and handling costs are classified as Selling, general and administrative expenses and were $1,326, $1,304 and $1,262 for the years ended December 31, 2014, 2013 and 2012, respectively.
	Marketing Costs
	The Company markets its products through advertising and other promotional activities. Advertising costs are included in Selling, general and administrative expenses and are expensed as incurred. Certain consumer and trade promotional programs, such as consumer coupons, are recorded as a reduction of sales.
	Cash and Cash Equivalents
	The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents.
	Inventories
	Inventories are stated at the lower of cost or market. The cost of approximately 80% of inventories is determined using the first-in, first-out (“FIFO”) method. The cost of all other inventories, in the U.S. and Mexico, is determined using the last-in, first-out (“LIFO”) method.
	Property, Plant and Equipment
	Land, buildings and machinery and equipment are stated at cost. Depreciation is provided, primarily using the straight-line method, over estimated useful lives ranging from 3 to 15 years for machinery and equipment and up to 40 years for buildings. Depreciation attributable to manufacturing operations is included in Cost of sales. The remaining component of depreciation is included in Selling, general and administrative expenses.
	Goodwill and Other Intangibles
	Goodwill and indefinite life intangible assets, such as the Company’s global brands, are subject to impairment tests at least annually. These tests were performed and did not result in an impairment charge. Other intangible assets with finite lives, such as local brands and trademarks, customer relationships and non-compete agreements, are amortized over their estimated useful lives, generally ranging from 5 to 40 years. Amortization expense related to intangible assets is included in Other (income) expense, net, which is included in Operating profit.
	Income Taxes
	The provision for income taxes is determined using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized based upon the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates that will be in effect at the time such differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Provision is made currently for taxes payable on remittances of overseas earnings; no provision is made for taxes on overseas retained earnings that are deemed to be indefinitely reinvested.
	The Company uses a comprehensive model to recognize, measure, present and disclose in its financial statements uncertain tax positions that the Company has taken or expects to take on an income tax return.  The Company recognizes interest expense and penalties related to unrecognized tax benefits within income tax expense.
	Financial Instruments
	Derivative instruments are recorded as assets and liabilities at estimated fair value based on available market information. The Company’s derivative instruments that qualify for hedge accounting are designated as either fair value hedges, cash flow hedges or net investment hedges. For fair value hedges, changes in the fair value of the derivative, as well as the offsetting changes in the fair value of the hedged item, are recognized in earnings each period. For cash flow hedges, changes in the fair value of the derivative are recorded in Other comprehensive income (loss) and are recognized in earnings when the offsetting effect of the hedged item is also recognized in earnings. For hedges of the net investment in foreign subsidiaries, changes in the fair value of the derivative are recorded in Other comprehensive income (loss) to offset the change in the value of the net investment being hedged.  Cash flows related to hedges are classified in the same category as the cash flows from the hedged item in the Consolidated Statements of Cash Flows.
	The Company may also enter into certain foreign currency and interest rate instruments that economically hedge certain of its risks but do not qualify for hedge accounting. Changes in fair value of these derivative instruments, based on quoted market prices, are recognized in earnings each period. The Company’s derivative instruments and other financial instruments are more fully described in Note 7, Fair Value Measurements and Financial Instruments along with the related fair value measurement considerations.
	Stock-Based Compensation
	The Company recognizes the cost of employee services received in exchange for awards of equity instruments, such as stock options and restricted stock units, based on the fair value of those awards at the date of grant over the requisite service period.  The Company uses the Black-Scholes-Merton (“Black-Scholes”) option pricing model to determine the fair value of stock option awards.  Stock-based compensation plans, related expenses and assumptions used in the Black-Scholes option pricing model are more fully described in Note 8, Capital Stock and Stock-Based Compensation Plans.
	Currency Translation
	The assets and liabilities of foreign subsidiaries, other than those operating in highly inflationary environments, are translated into U.S. dollars at year-end exchange rates with resulting translation gains and losses accumulated in a separate component of shareholders’ equity. Income and expense items are translated into U.S. dollars at average rates of exchange prevailing during the year.
	For subsidiaries operating in highly inflationary environments (currently, Venezuela), local currency-denominated non-monetary assets, including inventories, goodwill and property, plant and equipment, are remeasured at their historical exchange rates, while local currency-denominated monetary assets and liabilities are remeasured at year-end exchange rates. Remeasurement adjustments for these operations are included in Net income attributable to Colgate-Palmolive Company.
	Recent Accounting Pronouncements
	On May 28, 2014, the Financial Accounting Standards Board (“FASB”) and the International Accounting Standards Board (“IASB”) issued their final converged standard on revenue recognition. The standard, issued as Accounting Standards Update (“ASU”) No. 2014-09 “Revenue from Contracts with Customers” by the FASB, provides a single, comprehensive revenue recognition model for all contracts with customers and supersedes current revenue recognition guidance. The revenue standard contains principles that an entity will apply to determine the measurement of revenue and timing of when it is recognized. The underlying principle is that an entity will recognize revenue to depict the transfer of goods or services to customers at an amount that the entity expects to be entitled to in exchange for those goods or services. The new standard also includes enhanced disclosures which are significantly more comprehensive than those in existing revenue standards. This new guidance is effective for the Company beginning January 1, 2017, with no early adoption permitted. The standard allows for either “full retrospective” adoption, meaning the standard is applied to all of the periods presented, or “modified retrospective” adoption, meaning the standard is applied only to the most current period presented in the financial statements. While the Company is currently assessing the impact of the new standard, it does not expect this new guidance to have a material impact on its Consolidated Financial Statements.
	On April 10, 2014, the FASB issued ASU No. 2014-08 “Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity.” ASU No. 2014-08 changes the criteria for reporting discontinued operations and modifies related disclosure requirements. The new guidance is effective for the Company on a prospective basis beginning January 1, 2015. This new guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements.
	Reclassifications
	Certain prior year amounts have been reclassified to conform to the current year presentation. Additionally, Other current assets in the December 31, 2013 Consolidated Balance Sheet were adjusted to include certain non-income tax receivables which were previously included in Other accruals.

Acquisitions_and_Divestitures

Acquisitions and Divestitures	12 Months Ended
	Dec. 31, 2014
Business Combinations [Abstract]
Acquisitions And Divestitures	Acquisitions and Divestitures
	Acquisition
	On October 3, 2014, the Company acquired an oral care business in Myanmar for $62 in cash plus additional consideration contingent upon achievement of performance targets under a distribution services agreement.
	Sale of Land in Mexico
	On September 13, 2011, the Company’s Mexican subsidiary entered into an agreement to sell to the United States of America (the “Purchaser”) the Mexico City site on which its commercial operations, technology center and soap production facility were located. The sale price is payable in three installments. During the third quarter of 2011, the Company received the first installment of $24 upon signing the agreement. During the third quarter of 2012, the Company received the second installment of $36. The final installment is due upon the transfer of the property, which is subject to the Company’s satisfaction of certain closing conditions relating to site preparation by March 20, 2015. While these conditions are not expected to be fully satisfied by March 20, 2015, in which case the Purchaser has several options under the agreement (including termination and the return to it of the first two installment payments), based on the transaction to date, the Company believes that the transfer of the property is likely to occur in 2015. The Company has reinvested the first two installments to relocate its soap production to a new state-of-the-art facility at its Mission Hills, Mexico site, to relocate its commercial and technology operations within Mexico City and to prepare the existing site for transfer. Exit costs incurred during the project primarily relate to staff leaving indemnities, accelerated depreciation and demolition to make the site building-ready. In 2014, 2013 and 2012 the Company recorded $4, $18 and $24 of pretax costs ($3, $12 and $18 of aftertax costs), respectively, related to the sale.

Restructuring_and_Related_Impl

Restructuring and Related Implementation Charges	12 Months Ended
	Dec. 31, 2014
Restructuring and Related Activities [Abstract]
Restructuring and Related Implementation Charges	Restructuring and Related Implementation Charges
	In the fourth quarter of 2012, the Company commenced a four-year Global Growth and Efficiency Program for sustained growth. The program’s initiatives are expected to help Colgate ensure continued solid worldwide growth in unit volume, organic sales and earnings per share and enhance its global leadership positions in its core businesses.
	On October 23, 2014, the Company’s Board of Directors approved an expansion of the Global Growth and Efficiency Program (as expanded the “2012 Restructuring Program”) to take advantage of additional savings opportunities.
	Cumulative pretax charges related to the 2012 Restructuring Program, once all phases are approved and implemented, are estimated to be $1,285 to $1,435 ($950 to $1,050 aftertax). Implementation of the 2012 Restructuring Program is expected to be substantially completed by December 31, 2016. These pretax charges are currently estimated to be comprised of the following categories: Employee-Related Costs, including severance, pension and other termination benefits (50%); asset-related costs, primarily Incremental Depreciation and Asset Impairments (10%); and Other charges, which include contract termination costs, consisting primarily of implementation-related charges resulting directly from exit activities (20%) and the implementation of new strategies (20%). Anticipated pretax charges for 2015 are expected to amount to approximately $330 to $385 ($245 to $285 aftertax). Over the course of the 2012 Restructuring Program, it is currently estimated that approximately 75% of the charges will result in cash expenditures.
	It is expected that the cumulative pretax charges, once all projects are approved and implemented, will relate to initiatives undertaken in North America (15%), Europe/South Pacific (20%), Latin America (5%), Asia (5%), Africa/Eurasia (5%), Hill’s Pet Nutrition (10%) and Corporate (40%), which includes substantially all of the costs related to the implementation of new strategies, noted above, on a global basis. It is expected that, by the end of 2016, the 2012 Restructuring Program will contribute a net reduction of approximately 2,000-2,500 positions from the Company’s global employee workforce.
	For the years ended December 31, 2014, 2013 and 2012, restructuring and implementation-related charges are reflected in the Consolidated Statements of Income as follows:
		2014				2013				2012
	Cost of sales	$	29			$	32			$	2
	Selling, general and administrative expenses	62				137				6
	Other (income) expense, net	195				202				81
	Total 2012 Restructuring Program charges, pretax	$	286			$	371			$	89
	Total 2012 Restructuring Program charges, aftertax	$	208			$	278			$	70
	Restructuring and related implementation charges in the preceding table are recorded in the Corporate segment as these initiatives are predominantly centrally directed and controlled and are not included in internal measures of segment operating performance.
	Total charges incurred for the 2012 Restructuring Program relate to initiatives undertaken by the following reportable operating segments:
											Program-to-date
		2014			2013			2012			Accumulated Charges
	North America	11	%		11	%		2	%		10	%
	Latin America	4	%		4	%		—	%		4	%
	Europe/South Pacific	20	%		28	%		55	%		28	%
	Asia	3	%		—	%		—	%		1	%
	Africa/Eurasia	3	%		7	%		2	%		5	%
	Hill’s Pet Nutrition	10	%		8	%		3	%		8	%
	Corporate	49	%		42	%		38	%		44	%
	Since the inception of the 2012 Restructuring Program in the fourth quarter of 2012, the Company has incurred pretax cumulative charges of $746 ($556 aftertax) in connection with the implementation of various projects as follows:
		Cumulative Charges
		as of December 31, 2014
	Employee-Related Costs	$	295
	Incremental Depreciation	51
	Asset Impairments	2
	Other	398
	Total	$	746
	The majority of costs incurred since inception relate to the following projects: the implementation of the Company’s overall hubbing strategy; the consolidation of facilities; the simplification and streamlining of the Company’s research and development capabilities and oral care supply chain, both in Europe; restructuring how the Company will provide future retirement benefits to substantially all of its U.S.-based employees participating in the Company’s defined benefit retirement plan by shifting them to the Company’s defined contribution plan; the extension of shared business services and streamlining of global functions; and the closing of the Morristown, New Jersey personal care facility.
	The following table summarizes the activity for the restructuring and implementation-related charges discussed above and the related accruals:
			Employee-Related				Incremental				Asset			Other			Total
			Costs				Depreciation				Impairments
	Balance at January 1, 2012		$	—			$	—			$	—		$	—		$	—
	Charges		78				—				—			11			89
	Cash payments		(1		)		—				—			(4		)	(5		)
	Charges against assets		—				—				—			—			—
	Foreign exchange		7				—				—			(2		)	5
	Balance at December 31, 2012		$	84			$	—			$	—		$	5		$	89
	Charges		144				26				1			200			371
	Cash payments		(97		)		—				—			(72		)	(169		)
	Charges against assets		(17		)		(26		)		(1		)	—			(44		)
	Foreign exchange		2				—				—			—			2
	Other		—				—				—			(91		)	(91		)
	Balance at December 31, 2013		$	116			$	—			$	—		$	42		$	158
	Charges		73				25				1			187			286
	Cash payments		(95		)		—				—			(117		)	(212		)
	Charges against assets		(5		)		(25		)		(1		)	—			(31		)
	Foreign exchange		(4		)		—				—			(5		)	(9		)
	Other		—				—				—			—			—
	Balance at December 31, 2014		$	85			$	—			$	—		$	107		$	192
	Employee-Related Costs primarily include severance and other termination benefits and are calculated based on long-standing benefit practices, local statutory requirements and, in certain cases, voluntary termination arrangements. Employee-Related Costs also include pension and other retiree benefit enhancements amounting to $5, $17 and $0 for the years ended December 31, 2014, 2013 and 2012, respectively, which are reflected as Charges against assets within Employee-Related Costs in the preceding tables, as the corresponding balance sheet amounts are reflected as a reduction of pension assets or an increase in pension and other retiree benefit liabilities (see Note 10, Retirement Plans and Other Retiree Benefits).
	Incremental Depreciation is recorded to reflect changes in useful lives and estimated residual values for long-lived assets that will be taken out of service prior to the end of their normal service period. Asset Impairments are recorded to write down assets held for sale or disposal to their fair value based on amounts expected to be realized. Charges against assets within Asset Impairments are net of cash proceeds pertaining to the sale of certain assets.
	Other charges consist primarily of charges resulting directly from exit activities and the implementation of new strategies as a result of the 2012 Restructuring Program. These charges for the years ended December 31, 2014, 2013 and 2012 included third-party incremental costs related to the development and implementation of new business and strategic initiatives of $65, $50 and $8, respectively, and contract termination costs and charges resulting directly from exit activities of $40, $34 and $3, respectively, directly related to the 2012 Restructuring Program. These charges were expensed as incurred. Also included in Other charges for the years ended December 31, 2014 and 2013 are other exit costs of $82 and $25, respectively, related to the consolidation of facilities. Other charges for the year ended December 31, 2013 also included a curtailment charge of $91 related to changes to the Company’s U.S. defined benefit retirement plans (see Note 10, Retirement Plans and Other Retiree Benefits).

Goodwill_and_Other_Intangible_

Goodwill and Other Intangible Assets	12 Months Ended
	Dec. 31, 2014
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Other Intangible Assets	Goodwill and Other Intangible Assets
	The net carrying value of Goodwill as of December 31, 2014 and 2013, by segment is as follows:
		2014		2013
	Oral, Personal and Home Care
	North America	$	352	$	362
	Latin America	320		353
	Europe/South Pacific	1,374		1,525
	Asia	160		126
	Africa/Eurasia	86		93
	Total Oral, Personal and Home Care	2,292		2,459
	Pet Nutrition	15		15
	Total Goodwill	$	2,307	$	2,474
	The change in the amount of Goodwill in each year is primarily due to the impact of foreign currency translation.
	Other intangible assets as of December 31, 2014 and 2013 are comprised of the following:
		2014							2013
		Gross Carrying Amount		Accumulated Amortization			Net		Gross Carrying Amount		Accumulated Amortization			Net
	Trademarks	$	552	$	(285	)	$	267	$	551	$	(275	)	$	276
	Other finite life intangible assets	213		(54		)	159		219		(45		)	174
	Indefinite life intangible assets	987		—			987		1,046		—			1,046
	Total Other intangible assets	$	1,752	$	(339	)	$	1,413	$	1,816	$	(320	)	$	1,496
	The changes in the net carrying amounts of Other intangible assets during 2014, 2013 and 2012 were primarily due to amortization expense of $32, $32 and $31, respectively, as well as the impact of foreign currency translation. Annual estimated amortization expense for each of the next five years is expected to be approximately $30.

LongTerm_Debt_and_Credit_Facil

Long-Term Debt and Credit Facilities	12 Months Ended
	Dec. 31, 2014
Debt Disclosure [Abstract]
Long-Term Debt and Credit Facilities	Long-Term Debt and Credit Facilities
	Long-term debt consists of the following at December 31:
			Weighted Average Interest Rate	Maturities			2014		2013
	Notes		1.90%	2015	-	2078	$	5,877	$	5,644
	Commercial paper		—%	2015			255		—
							6,132		5,644
	Less: Current portion of long-term debt						488		895
	Total						$	5,644	$	4,749
	The weighted-average interest rate on short-term borrowings of $16 in 2014 and $13 in 2013 included in Notes and loans payable in the Consolidated Balance Sheets as of December 31, 2014 and 2013 was 1.9% and 2.2%, respectively.
	The Company classifies commercial paper as long-term debt when it has the intent and ability to refinance such obligations on a long-term basis. Excluding commercial paper reclassified as long-term debt, scheduled maturities of long-term debt and capitalized leases outstanding as of December 31, 2014, are as follows:
	Years Ended December 31,
	2015	$	488
	2016	263
	2017	660
	2018	697
	2019	498
	Thereafter	3,271
	The Company has entered into interest rate swap agreements and foreign exchange contracts related to certain of these debt instruments. See Note 7, Fair Value Measurements and Financial Instruments for further information about the Company’s financial instruments.
	During the fourth quarter of 2014, the Company issued $134 of forty-year notes at a variable rate. During the first quarter of 2014, the Company issued $500 of five-year notes at a fixed rate of 1.75% and $500 of ten-year notes at a fixed-rate of 3.25%. During the fourth quarter of 2013, the Company issued $300 of five-year notes at a fixed rate of 1.50% and $82 of forty-year notes at a variable rate. During the second quarter of 2013, the Company issued $400 of five-year notes at a fixed rate of 0.90% and $400 of ten-year notes at a fixed rate of 2.10%.
	The debt issuances in 2014 and 2013 were U.S. dollar denominated and were under the Company’s shelf registration statement. Proceeds from the debt issuances in the first and fourth quarter of 2014 were used for general corporate purposes which included the retirement of commercial paper borrowings. Proceeds from the debt issuances in the first quarter of 2014 were also used to repay and retire $250 of U.S. dollar denominated notes and €250 of euro denominated notes, both of which became due in the second quarter of 2014. Proceeds from the debt issuances in the second and fourth quarters of 2013 were used for general corporate purposes which included the retirement of commercial paper borrowings. In addition, proceeds from the debt issuance in the second quarter of 2013 were used to repay and retire $250 of notes due in 2013.
	At December 31, 2014, the Company had access to unused domestic and foreign lines of credit of $3,001 (including under the facilities discussed below) and could also issue medium-term notes pursuant to an effective shelf registration statement. In November 2011, the Company entered into a five-year revolving credit facility with a capacity of $1,850 with a syndicate of banks. This facility was extended for an additional year in 2012 and again in 2013. In 2014, the Company entered into an amendment of this facility whereby the facility was extended for an additional year to November 2019 and the capacity of the facility was increased to $2,370. The Company also has the ability to draw $165 from a revolving credit facility that expires in November 2015. In addition, the Company has the ability to draw $20 from a new credit facility entered into during 2014, which expires in December 2015. Commitment fees related to the credit facilities are not material.
	Certain agreements with respect to the Company’s bank borrowings contain financial and other covenants as well as cross-default provisions. Noncompliance with these requirements could ultimately result in the acceleration of amounts owed. The Company is in full compliance with all such requirements and believes the likelihood of noncompliance is remote.

Fair_Value_Measurements_and_Fi

Fair Value Measurements and Financial Instruments	12 Months Ended
	Dec. 31, 2014
Financial Instruments and Fair Value Measurements [Abstract]
Financial Instruments and Fair Value Measurements	Fair Value Measurements and Financial Instruments
	The Company is exposed to market risk from foreign currency exchange rates, interest rates and commodity price fluctuations. Volatility relating to these exposures is managed on a global basis by utilizing a number of techniques, including working capital management, sourcing strategies, selling price increases, selective borrowings in local currencies and entering into selective derivative instrument transactions, issued with standard features, in accordance with the Company’s treasury and risk management policies, which prohibit the use of derivatives for speculative purposes and leveraged derivatives for any purpose. It is the Company’s policy to enter into derivative instrument contracts with terms that match the underlying exposure being hedged. Hedge ineffectiveness, if any, is not material for any period presented. Provided below are details of the Company’s exposures by type of risk and derivative instruments by type of hedge designation.
	Valuation Considerations
	Assets and liabilities carried at fair value are classified as follows:
	Level 1: Based upon quoted market prices in active markets for identical assets or liabilities.
	Level 2: Based upon observable market-based inputs or unobservable inputs that are corroborated by market data.
	Level 3: Based upon unobservable inputs reflecting the reporting entity’s own assumptions.
	Foreign Exchange Risk
	As the Company markets its products in over 200 countries and territories, it is exposed to currency fluctuations related to manufacturing and selling its products in currencies other than the U.S. dollar. The Company manages its foreign currency exposures through a combination of cost-containment measures, sourcing strategies, selling price increases and the hedging of certain costs in an effort to minimize the impact on earnings of foreign currency rate movements.
	The Company utilizes foreign currency contracts, including forward and swap contracts, local currency deposits and local currency borrowings to hedge portions of its foreign currency purchases, assets and liabilities arising in the normal course of business and the net investment in certain foreign subsidiaries. The duration of foreign currency contracts generally does not exceed 12 months and the contracts are valued using observable market rates (Level 2 valuation).
	Interest Rate Risk
	The Company manages its targeted mix of fixed and floating rate debt with debt issuances and by entering into interest rate swaps in order to mitigate fluctuations in earnings and cash flows that may result from interest rate volatility. The notional amount, interest payment and maturity date of the swaps generally match the principal, interest payment and maturity date of the related debt, and the swaps are valued using observable benchmark rates (Level 2 valuation).
	Commodity Price Risk
	The Company is exposed to price volatility related to raw materials used in production, such as resins, pulp, essential oils, tropical oils, tallow, poultry, corn and soybeans. The Company manages its raw material exposures through a combination of cost containment measures, sourcing strategies, ongoing productivity initiatives and the limited use of commodity hedging contracts.  Futures contracts are used on a limited basis, primarily in the Hill’s Pet Nutrition segment, to manage volatility related to raw material inventory purchases of certain traded commodities, and these contracts are measured using quoted commodity exchange prices (Level 1 valuation). The duration of the commodity contracts generally does not exceed 12 months.
	Credit Risk
	The Company is exposed to the risk of credit loss in the event of nonperformance by counterparties to financial instrument contracts; however, nonperformance is considered unlikely and any nonperformance is unlikely to be material as it is the Company’s policy to contract with diverse, credit-worthy counterparties based upon both strong credit ratings and other credit considerations.
	The following summarizes the fair value of the Company’s derivative instruments and other financial instruments at December 31, 2014 and December 31, 2013:
		Assets										Liabilities
		Account		Fair Value								Account	Fair Value
	Designated derivative instruments			12/31/14				12/31/13					12/31/14			12/31/13
	Interest rate swap contracts	Other current assets		$	1			$	1			Other accruals	$	—		$	—
	Interest rate swap contracts	Other assets		12				20				Other liabilities	2			1
	Foreign currency contracts	Other current assets		21				14				Other accruals	4			8
	Foreign currency contracts	Other assets		60				—				Other liabilities	—			10
	Commodity contracts	Other current assets		—				—				Other accruals	1			—
	Total designated			$	94			$	35				$	7		$	19
	Derivatives not designated
	Foreign currency contracts	Other current assets		$	—			$	—			Other accruals	$	—		$	3
	Foreign currency contracts	Other assets		8				—				Other liabilities	—			—
	Total not designated			$	8			$	—				$	—		$	3
	Total derivative instruments			$	102			$	35				$	7		$	22
	Other financial instruments
	Marketable securities	Other current assets		$	200			$	173
	Available-for-sale securities	Other assets		322				685
	Note receivable	Other current assets		42				—
	Total other financial			$	564			$	858
	instruments
	The carrying amount of cash, cash equivalents, accounts receivable, a note receivable and short-term debt approximated fair value as of December 31, 2014 and 2013. The estimated fair value of the Company’s long-term debt, including the current portion, as of December 31, 2014 and 2013, was $6,346 and $5,690, respectively, and the related carrying value was $6,132 and $5,644, respectively. The estimated fair value of long-term debt was derived principally from quoted prices on the Company’s outstanding fixed-term notes (Level 2 valuation).
	Fair Value Hedges
	The Company has designated all interest rate swap contracts and certain foreign currency forward and option contracts as fair value hedges, for which the gain or loss on the derivative and the offsetting gain or loss on the hedged item are recognized in current earnings. The impact of foreign currency contracts is primarily recognized in Selling, general and administrative expenses and the impact of interest rate swap contracts is recognized in Interest (income) expense, net.
	Activity related to fair value hedges recorded during each period presented was as follows:
		2014											2013
		Foreign				Interest							Foreign			Interest
		Currency				Rate				Total			Currency			Rate			Total
		Contracts				Swaps							Contracts			Swaps
	Notional Value at December 31,	$	1,163			$	1,438			$	2,601		$	1,320		$	1,188		$	2,508
	Gain (loss) on derivative	3				(8		)		(5		)	24			(22		)	2
	Gain (loss) on hedged items	(3		)		8				5			(24		)	22			(2		)
	Cash Flow Hedges
	All of the Company’s commodity contracts and certain foreign currency forward contracts have been designated as cash flow hedges, for which the effective portion of the gain or loss is reported as a component of Other comprehensive income (“OCI”) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings.
	Activity related to cash flow hedges recorded during each period presented was as follows:
		2014											2013
		Foreign				Commodity							Foreign			Commodity
		Currency				Contracts				Total			Currency			Contracts			Total
		Contracts											Contracts
	Notional Value at December 31,	$	511			$	14			$	525		$	386		$	14		$	400
	Gain (loss) recognized in OCI	9				—				9			20			—			20
	Gain (loss) reclassified into Cost of sales	5				—				5			16			1			17
	The net gain (loss) recognized in OCI for both foreign currency contracts and commodity contracts is expected to be recognized in Cost of sales within the next twelve months.
	Net Investment Hedges
	The Company has designated certain foreign currency forward and option contracts and certain foreign currency-denominated debt as net investment hedges, for which the gain or loss on the instrument is reported as a component of Currency translation adjustments within OCI, along with the offsetting gain or loss on the hedged items.
	Activity related to net investment hedges recorded during each period presented was as follows:
		2014											2013
		Foreign				Foreign							Foreign			Foreign
Currency			Currency			Total				Currency			Currency			Total
Contracts			Debt							Contracts			Debt
Notional Value at December 31,	$	567			$	297			$	864		$	529		$	256		$	785
Gain (loss) on instruments	73				11				84			(24		)	(4		)	(28		)
Gain (loss) on hedged items	(73		)		(11		)		(84		)	23			4			27
Derivatives Not Designated as Hedging Instruments
Derivatives not designated as hedging instruments for each period consist of a cross-currency swap that serves as an economic hedge of a foreign currency deposit, for which the gain or loss on the instrument and the offsetting gain or loss on the hedged item are recognized in Other (income) expense, net for each period.
Activity related to these contracts during each period presented was as follows:
	2014				2013
	Cross-currency				Cross-currency
	Swap				Swap
Notional Value at December 31,	$	102			$	96
Gain (loss) on instrument	5				(2		)
Gain (loss) on hedged item	(5		)		2
Other Financial Instruments
Other financial instruments are classified as Other current assets or Other assets.
Other financial instruments classified as Other current assets include marketable securities and a fixed interest rate note receivable. Marketable securities consist of bank deposits of $123 with original maturities greater than 90 days (Level 1 valuation) and the current portion of bonds issued by the Venezuelan government (Level 2 valuation) in the amount of $77. The long-term portion of these bonds in the amount of $322 is included in Other assets.
Through its subsidiary in Venezuela, the Company is invested in U.S. dollar-linked devaluation-protected bonds and bolivar denominated fixed interest rate bonds, both of which are issued by the Venezuelan government. These bonds are actively traded and, therefore, are considered Level 2 investments as their values are determined based upon observable market-based inputs or unobservable inputs that are corroborated by market data. As of December 31, 2014, the fair market value of U.S. dollar-linked devaluation-protected bonds and bolivar denominated fixed interest rate bonds was $114 and $285, respectively. These bonds are considered available-for-sale securities and, as noted above, the long-term portion in the amount of $322 is included in Other assets.
The following table presents a reconciliation of the Venezuelan bonds at fair value for the twelve months ended December 31:
	2014				2013
Beginning balance as of January 1	$	685			$	642
Unrealized gain (loss) on investment	(341		)		(113		)
Purchases and sales during the period	55				156
Ending balance as of December 31	$	399			$	685
Unrealized loss on investment for the year ended December 31, 2014 included a net loss of $324 primarily related to the remeasurement of the bolivar denominated fixed interest rate bonds and the devaluation-protected bonds in Venezuela as a result of the effective devaluations in the first and third quarters of 2014.
Unrealized loss on investment for the year ended December 31, 2013 consisted primarily of a charge of $133 related only to the remeasurement of the bolivar denominated fixed interest rate bonds in Venezuela as a result of the devaluation in the first quarter of 2013. No remeasurement charge was required on the devaluation-protected bonds in the first quarter of 2013 since the official exchange rate changed from 4.30 to 6.30 bolivares per dollar and the devaluation-protected bonds revalued to the official exchange rate. For further information regarding Venezuela, refer to Note 14, Venezuela.

Capital_Stock_and_StockBased_C

Capital Stock and Stock-Based Compensation Plans	12 Months Ended
	Dec. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Capital Stock and Stock-Based Compensation Plans	Capital Stock and Stock-Based Compensation Plans
	Preference Stock
	The Company has the authority to issue 50,262,150 shares of preference stock.
	Stock Repurchases
	The Company repurchased its common stock at a cost of $1,530 during 2014 under a share repurchase program that was approved by the Board of Directors and publicly announced in September 2011 (the “2011 Program”). The 2011 Program authorized the Company to repurchase up to 50 million shares of its common stock. The Board authorized that the number of shares remaining under the 2011 Program as of May 15, 2013 be increased by 100% as a result of the two-for-one stock split of the Company’s common stock in 2013. The Board also has authorized share repurchases on an ongoing basis to fulfill certain requirements of the Company’s compensation and benefit programs. The shares may be repurchased from time to time in open market or privately negotiated transactions at the Company’s discretion, subject to market conditions, customary blackout periods and other factors.
	On February 19, 2015, the Board authorized the repurchase of shares of the Company’s common stock having an aggregate purchase price of up to $5,000 under a new share repurchase program (the “2015 Program”), which replaced the 2011 Program. The Company will commence repurchase of shares of the Company’s common stock under the 2015 Program after February 19, 2015.
	The Company may use either authorized and unissued shares or treasury shares to meet share requirements resulting from the exercise of stock options and the vesting of restricted stock unit awards.
	A summary of common stock and treasury stock activity for the three years ended December 31, is as follows:
		Common Stock Outstanding		Treasury Stock
	Balance, January 1, 2012	960,036,150		505,670,210
	Common stock acquired	(38,730,602	)	38,730,602
	Shares issued for stock options	12,217,230		(12,217,230	)
	Shares issued for restricted stock units and other	2,205,898		(2,205,898	)
	Balance, December 31, 2012	935,728,676		529,977,684
	Common stock acquired	(25,573,317	)	25,573,317
	Shares issued for stock options	7,883,834		(7,883,834	)
	Shares issued for restricted stock units and other	1,907,382		(1,907,382	)
	Balance, December 31, 2013	919,946,575		545,759,785
	Common stock acquired	(23,131,081	)	23,131,081
	Shares issued for stock options	7,977,124		(7,977,124	)
	Shares issued for restricted stock units and other	1,919,527		(1,919,527	)
	Balance, December 31, 2014	906,712,145		558,994,215
	Stock-Based Compensation
	The Company recognizes the cost of employee services received in exchange for awards of equity instruments, such as stock options and restricted stock units, based on the fair value of those awards at the date of grant. The value of restricted stock units, based on market prices, is amortized on a straight-line basis over the requisite service period. The estimated fair value of stock options on the date of grant is amortized on a straight-line basis over the requisite service period for each separately vesting portion of the award. Awards to employees eligible for retirement prior to the award becoming fully vested are recognized as compensation cost from the grant date through the date that the employee first becomes eligible to retire and is no longer required to provide service to earn the award.
	The Company has one incentive compensation plan, which was approved by the Company’s stockholders on May 10, 2013, pursuant to which it issues restricted stock units and stock options to employees and shares of common stock and stock options to non-employee directors. The Personnel and Organization Committee of the Board of Directors, which is comprised entirely of independent directors, administers the incentive compensation plan. Previously, the Company issued these awards pursuant to four different stockholder-approved plans. The total stock-based compensation expense charged against pretax income for these plans was $131, $128 and $120 for the years ended December 31, 2014, 2013 and 2012, respectively. The total income tax benefit recognized on stock-based compensation was approximately $42, $39 and $37 for the years ended December 31, 2014, 2013 and 2012, respectively.
	Stock-based compensation expense is recorded within Selling, general and administrative expenses in the Corporate segment as these amounts are not included in internal measures of segment operating performance.
	The Company uses the Black-Scholes option pricing model to determine the fair value of stock option awards. The weighted-average estimated fair value of stock options granted in the years ended December 31, 2014, 2013 and 2012 was $7.60, $7.41 and $6.73, respectively. Fair value is estimated using the Black-Scholes option pricing model with the assumptions summarized in the following table:
		2014		2013		2012
	Expected Term of Options	4.5 years		4.5 years		4.5 years
	Expected Volatility Rate	17.1	%	18.4	%	20.8	%
	Risk-Free Interest Rate	1.6	%	1.5	%	0.6	%
	Expected Dividend Yield	2.3	%	2.3	%	2.4	%
	The weighted-average expected term of options granted each year was determined with reference to historical exercise and post-vesting cancellation experience, the vesting period of the awards and contractual term of the awards, among other factors. Expected volatility incorporates implied share-price volatility derived from exchange traded options on the Company’s common stock. The risk-free interest rate for the expected term of the option is based on the yield of a zero-coupon U.S. Treasury bond with a maturity period equal to the option’s expected term.
	Restricted Stock Units
	The Company grants restricted stock unit awards to officers and other employees. Awards vest at the end of the restriction period, which is generally three years.  As of December 31, 2014, approximately 12,414,000 shares of common stock were available for future restricted stock unit awards.
	A summary of restricted stock unit activity during 2014 is presented below:
		Shares		Weighted Average Grant Date Fair Value Per Award
		(in thousands)
	Restricted stock units as of January 1, 2014	4,539		$	48
	Activity:
	Granted	1,092		64
	Vested	(1,867	)	42
	Forfeited	(70	)	52
	Restricted stock units as of December 31, 2014	3,694		$	56
	As of December 31, 2014, there was $63 of total unrecognized compensation expense related to nonvested restricted stock unit awards, which will be recognized over a weighted-average period of 2.1 years. The total fair value of shares vested during the years ended December 31, 2014, 2013 and 2012 was $71, $69 and $63, respectively.
	Stock Options
	The Company issues non-qualified stock options to non-employee directors, officers and other employees. Stock options generally have a contractual term of six years and vest over three years. As of December 31, 2014, 46,062,000 shares of common stock were available for future stock option grants.
	A summary of stock option activity during 2014 is presented below:
		Shares		Weighted Average Exercise Price			Weighted Average Remaining Contractual Life	Intrinsic Value of Unexercised
		(in thousands)					(in years)	In-the-Money Options
	Options outstanding, January 1, 2014	42,832		$	47
	Granted	9,036		64
	Exercised	(8,526	)	41
	Forfeited or expired	(440	)	57
	Options outstanding, December 31, 2014	42,902		52			4	$	746
	Options exercisable, December 31, 2014	24,946		$	46		3	$	582
	As of December 31, 2014, there was $46 of total unrecognized compensation expense related to options, which will be recognized over a weighted-average period of 1.5 years. The total intrinsic value of options exercised during the years ended December 31, 2014, 2013 and 2012 was $211, $180 and $210, respectively.
	The benefits of tax deductions in excess of grant date fair value resulting from the exercise of stock options and vesting of restricted stock unit awards for the years ended December 31, 2014, 2013 and 2012 was $63, $51 and $60, respectively, and was reported as a financing cash flow. Cash proceeds received from options exercised for the years ended December 31, 2014, 2013 and 2012 were $314, $289 and $409, respectively.

Employee_Stock_Ownership_Plan

Employee Stock Ownership Plan	12 Months Ended
	Dec. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Employee Stock Ownership Plan	Employee Stock Ownership Plan
	In 1989, the Company expanded its Employee Stock Ownership Plan (“ESOP”) through the introduction of a leveraged ESOP that funds certain benefits for employees who have met eligibility requirements. The ESOP issued $410 of long-term notes due through July 2009 bearing an average interest rate of 8.7%. The notes, which were guaranteed by the Company, were repaid in July 2009. The ESOP used the proceeds from the notes issuance to purchase 6,315,149 shares of Series B Convertible Preference stock (the “Series B Preference stock”) from the Company. As a result of rules issued by the Internal Revenue Service (“IRS”) related to employer stock held in defined contribution plans, the Company issued a notice of redemption with respect to the remaining shares of Series B Preference stock outstanding on December 29, 2010. At the direction of the Company’s ESOP trustee, these shares of Series B Preference stock were converted into 38,483,072 shares of common stock, adjusted for the two-for-one stock split of the Company’s common stock in 2013. As of December 31, 2014 and 2013, there were 26,137,798 and 29,119,135 shares of common stock, respectively, outstanding and issued to the Company’s ESOP. The common stock for the conversion was issued from treasury shares.
	During 2000, the ESOP entered into a loan agreement with the Company under which the benefits of the ESOP may be extended through 2035. As of December 31, 2014, the ESOP had outstanding borrowings from the Company of $20, which represents unearned compensation shown as a reduction in Shareholders’ equity.
	Dividends on stock held by the ESOP are paid to the ESOP trust and, together with cash contributions from the Company, are (a) used by the ESOP to repay principal and interest, (b) credited to participant accounts, or (c) used for contributions to the Company’s defined contribution plans. Stock is allocated to participants based upon the ratio of the current year’s debt service to the sum of total outstanding principal and interest payments over the life of the debt. As of December 31, 2014, 18,489,250 shares of common stock were released and allocated to participant accounts and 7,648,548 shares of common stock were available for future allocation to participant accounts.
	Dividends on the stock used to repay principal and interest or credited to participant accounts are deductible for income tax purposes and, accordingly, are reflected net of their tax benefit in the Consolidated Statements of Changes in Shareholders’ Equity.
	Annual expense related to the ESOP was $2, $0, and $0 in 2014, 2013 and 2012, respectively.
	The Company paid dividends on the shares held by the ESOP of $40 in 2014, $41 in 2013 and $40 in 2012. The Company contributed $2 to the ESOP in 2014. The Company did not make any contributions to the ESOP in 2013 or 2012.

Retirement_Plans_and_Other_Ret

Retirement Plans and Other Retiree Benefits	12 Months Ended
	Dec. 31, 2014
Compensation and Retirement Disclosure [Abstract]
Retirement Plans and Other Retiree Benefits	Retirement Plans and Other Retiree Benefits
	Retirement Plans
	The Company and certain of its U.S. and overseas subsidiaries maintain defined benefit retirement plans. Benefits under these plans are based primarily on years of service and employees’ career earnings.
	Effective January 1, 2014, the Company changed the way it provides retirement benefits to substantially all of its U.S.-based employees participating in its defined benefit retirement plan. For these employees, the Company now provides all future retirement benefits through the Company’s defined contribution plan. As a result, no future service is considered for these employees for future accruals in the U.S. defined benefit retirement plans. Participants in the Company’s U.S. defined benefit retirement plan whose retirement benefit was determined under the cash balance formula continue to earn interest on their vested balances as of December 31, 2013. Participants whose retirement benefit was determined under the final average earnings formula continue to have their final average earnings adjusted for pay increases until termination of employment. These changes resulted in a curtailment charge of $91 as all of the previously unamortized prior service costs recorded in Accumulated other comprehensive income (loss) was recognized in 2013.
	In the Company’s principal U.S. plans and certain funded overseas plans, funds are contributed to trusts in accordance with regulatory limits to provide for current service and for any unfunded projected benefit obligation over a reasonable period. The target asset allocation for the Company’s defined benefit plans are as follows:
			United States			International
	Asset Category
	Equity securities		27	%		39	%
	Fixed income securities		53			47
	Real estate and other investments		20			14
	Total		100	%		100	%
	At December 31, 2014 the allocation of the Company’s plan assets and the level of valuation input for each major asset category was as follows:
			Level of Valuation		Pension Plans
			Input		United States				International				Other Retiree
													Benefit Plans
	Investments:
	Cash & cash equivalents		Level 1		$	48			$	10			$	1
	U.S. common stocks		Level 1		130				3				3
	International common stocks		Level 1		—				2				—
	Fixed income securities(a)		Level 2		625				—				13
	Common/collective trust funds(b):		Level 2
	Developed market equity index funds				352				193				9
	Emerging market equity index funds				32				8				1
	Other common stock funds				118				27				3
	Fixed income funds: U.S. or foreign government and agency securities				115				107				3
	Fixed income funds: investment grade corporate bonds				168				75				4
	Fixed income funds: high yield corporate bonds and other				136				54				3
	Guaranteed investment contracts(c)		Level 2		1				54				—
	Real estate funds(d)		Level 3		46				19				1
	Total Investments at fair value				$	1,771			$	552			$	41
	At December 31, 2013 the allocation of the Company’s plan assets and the level of valuation input for each major asset category was as follows:
			Level of Valuation		Pension Plans
			Input		United States				International				Other Retiree
													Benefit Plans
	Investments:
	Cash & cash equivalents		Level 1		$	97			$	23			$	3
	U.S. common stocks		Level 1		127				—				3
	International common stocks		Level 1		51				—				1
	Fixed income securities(a)		Level 2		433				—				8
	Common/collective trust funds(b):		Level 2
	Developed market equity index funds				359				229				9
	Emerging market equity index funds				33				9				1
	Other common stock funds				123				41				3
	Fixed income funds: U.S. or foreign government and agency securities				149				73				3
	Fixed income funds: investment grade corporate bonds				203				71				5
	Fixed income funds: high yield corporate bonds and other				119				35				4
	Guaranteed investment contracts(c)		Level 2		2				56				—
	Real estate funds(d)		Level 3		40				21				1
	Total Investments at fair value				$	1,736			$	558			$	41
	_______
	(a)	The fixed income securities are traded over the counter and certain of these securities lack daily pricing or liquidity and as such are classified as Level 2. As of December 31, 2014 and 2013, approximately 50% of the fixed income portfolio was invested in U.S. treasury or agency securities, with the remainder invested in other government bonds and corporate bonds.
	(b)	Interests in common/collective trust funds are valued using the net asset value (“NAV”) per unit in each fund. The NAV is based on the value of the underlying investments owned by each trust, minus its liabilities, divided by the number of shares outstanding.
	(c)	The guaranteed investment contracts (“GICs”) represent contracts with insurance companies measured at the cash surrender value of each contract. The Level 2 valuation reflects that the cash surrender value is based principally on a referenced pool of investment funds with active redemption.
	(d)	Real estate is valued using the NAV per unit of funds that are invested in real estate property. The investment value of the real estate property is determined quarterly using independent market appraisals as determined by the investment manager. Since the appraisals include unobservable inputs, these investments are classified as Level 3. These unobservable inputs may include items such as annual gross rents, projected vacancy rates, collection losses and recovery rates, yield rates, growth assumptions and risk adjusted discount rates.
	The following table presents a reconciliation of Level 3 plan assets measured at fair value for the year ended December 31:
			2014								2013
			United States Real Estate Fund				International Real Estate Fund				United States Real Estate Fund				International Real Estate Fund
	Beginning balance as of January 1		$	41			$	21			$	72			$	20
	Earned income, net of management expenses		2				—				2				—
	Unrealized gain (loss) on investment		4				(1		)		9				—
	Purchases, sales, issuances and settlements, net		—				(1		)		(42		)		1
	Ending balance as of December 31		$	47			$	19			$	41			$	21
	Equity securities in the U.S. plans include investments in the Company’s common stock representing 7% of U.S. plan assets at December 31, 2014 and 6% of U.S. plan assets at December 31, 2013. No shares of the Company’s common stock were purchased or sold by the U.S. plans in 2014. In 2013, the U.S. plans sold 1,540,215 shares of the Company’s common stock to the Company. The plans received dividends on the Company’s common stock of $2 in 2014 and $3 in 2013.
	Other Retiree Benefits
The Company and certain of its subsidiaries provide health care and life insurance benefits for retired employees to the extent not provided by government-sponsored plans.
The Company uses a December 31 measurement date for its defined benefit and other retiree benefit plans. Summarized information for the Company’s defined benefit and other retiree benefit plans are as follows:
		Pension Plans																Other Retiree Benefit Plans
		2014				2013				2014				2013				2014			2013
		United States								International
Change in Benefit Obligations
Benefit obligations at beginning of year		$	2,102			$	2,227			$	894			$	888			$	792		$	875
Service cost		1				24				17				19				10			11
Interest cost		102				90				35				34				42			38
Participants’ contributions		—				1				4				3				—			—
Acquisitions/plan amendments		—				40				—				2				—			—
Actuarial loss (gain)		362				(148		)		123				(1		)		203			(101		)
Foreign exchange impact		—				—				(88		)		12				(3		)	(5		)
Termination benefits (1)		5				11				—				—				—			6
Curtailments and settlements		—				(12		)		(28		)		(21		)		—			—
Benefit payments		(154		)		(131		)		(40		)		(41		)		(33		)	(32		)
Other		(12		)		—				(1		)		(1		)		—			—
Benefit obligations at end of year		$	2,406			$	2,102			$	916			$	894			$	1,011		$	792
Change in Plan Assets
Fair value of plan assets at beginning of year		$	1,736			$	1,597			$	558			$	486			$	41		$	37
Actual return on plan assets		178				148				65				59				4			4
Company contributions		23				121				36				61				29			32
Participants’ contributions		—				1				4				3				—			—
Foreign exchange impact		—				—				(43		)		2				—			—
Settlements		—				—				(27		)		(11		)		—			—
Benefit payments		(154		)		(131		)		(40		)		(41		)		(33		)	(32		)
Other		(12		)		—				(1		)		(1		)		—			—
Fair value of plan assets at end of year		$	1,771			$	1,736			$	552			$	558			$	41		$	41
Funded Status
Benefit obligations at end of year		$	2,406			$	2,102			$	916			$	894			$	1,011		$	792
Fair value of plan assets at end of year		1,771				1,736				552				558				41			41
Net amount recognized		$	(635	)		$	(366	)		$	(364	)		$	(336	)		$	(970	)	$	(751	)
Amounts Recognized in Balance Sheet
Noncurrent assets		$	—			$	16			$	6			$	12			$	—		$	—
Current liabilities		(20		)		(19		)		(28		)		(36		)		(41		)	(39		)
Noncurrent liabilities		(615		)		(363		)		(342		)		(312		)		(929		)	(712		)
Net amount recognized		$	(635	)		$	(366	)		$	(364	)		$	(336	)		$	(970	)	$	(751	)
Amounts Recognized in Accumulated Other Comprehensive Income (Loss)
Actuarial loss		$	933			$	674			$	259			$	181			$	481		$	296
Transition/prior service cost		2				3				19				23				(3		)	1
		$	935			$	677			$	278			$	204			$	478		$	297
Accumulated benefit obligation		$	2,283			$	1,995			$	817			$	802			$	—		$	—
		Pension Plans												Other Retiree Benefit Plans
		2014			2013			2014			2013			2014			2013
		United States						International
Weighted-Average Assumptions Used to Determine Benefit Obligations
Discount rate		4.24	%		4.96	%		3.06	%		3.99	%		4.36	%		5.24	%
Long-term rate of return on plan assets		6.8	%		6.8	%		5.05	%		5.5	%		6.8	%		6.8	%
Long-term rate of compensation increase		3.5	%		3.5	%		2.83	%		3.02	%		—	%		—	%
ESOP growth rate		—	%		—	%		—	%		—	%		10	%		10	%
Medical cost trend rate of increase		—	%		—	%		—	%		—	%		7	%		7	%
_________
(1)	Represents pension and other retiree benefit enhancements incurred in 2014 and 2013 pursuant to the 2012 Restructuring Program.
The overall investment objective of the plans is to balance risk and return so that obligations to employees are met. The Company evaluates its long-term rate of return on plan assets on an annual basis. In determining the long-term rate of return, the Company considers the nature of the plans’ investments and the historical rates of return. The assumed rate of return as of December 31, 2014 for the U.S. plans was 6.80%. Average annual rates of return for the U.S. plans for the most recent 1-year, 5-year, 10-year, 15-year and 25-year periods were 11%, 10%, 7%, 5%, and 8%, respectively.  Similar assessments were performed in determining rates of return on international pension plan assets to arrive at the Company’s 2014 weighted-average rate of return of 5.05%.
The medical cost trend rate of increase assumed in measuring the expected cost of benefits is projected to decrease from 7.0% in 2015 to 5.0% by 2021, remaining at 5.0% for the years thereafter. Changes in the assumed rate can have a significant effect on amounts reported. A 1% change in the assumed medical cost trend rate would have the following approximate effect:
		One percentage point
		Increase				Decrease
Accumulated postretirement benefit obligation		$	150			$	(119	)
Total of service and interest cost components		11				(9		)
Expected mortality is a key assumption in the measurement for pension and other postretirement benefit obligations. For the Company’s U.S. plans, this assumption was updated as of December 31, 2014 in order to reflect the Society of Actuaries’ Retirement Plan Experience Committee’s updated mortality tables and mortality improvement scale published in October 2014. This resulted in an increase of 6% and 9% to the benefit obligations for the Company’s U.S. pension plans and other postretirement benefits, respectively.
Plans with projected benefit obligations in excess of plan assets and plans with accumulated benefit obligations in excess of plan assets as of December 31 consist of the following:
		Years Ended December 31,
		2014				2013
Benefit Obligation Exceeds Fair Value of Plan Assets
Projected benefit obligation		$	2,958			$	1,130
Fair value of plan assets		1,955				402
Accumulated benefit obligation		2,725				700
Fair value of plan assets		1,922				66
Summarized information regarding the net periodic benefit costs for the Company’s defined benefit and other retiree benefit plans is as follows:
		Pension Plans																						Other Retiree Benefit Plans
		2014				2013				2012				2014				2013			2012			2014			2013			2012
		United States												International
Components of Net Periodic Benefit Cost
Service cost		$	1			$	24			$	24			$	17			$	19		$	12		$	11		$	13		$	11
Interest cost		102				90				97				35				34			35			42			38			40
Annual ESOP allocation		—				—				—				—				—			—			(1		)	(2		)	(2		)
Expected return on plan assets		(112		)		(118		)		(112		)		(29		)		(26		)	(26		)	(3		)	(3		)	(3		)
Amortization of transition & prior service costs (credits)		1				9				9				4				2			2			3			1			3
Amortization of actuarial loss		37				68				62				6				10			9			16			21			18
Net periodic benefit cost		$	29			$	73			$	80			$	33			$	39		$	32		$	68		$	68		$	67
Other postretirement charges		5				102				—				(8		)		3			9			—			6			1
Total pension cost		$	34			$	175			$	80			$	25			$	42		$	41		$	68		$	74		$	68
Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost
Discount rate		4.96		%		4.14		%		4.9		%		3.99		%		3.57		%	4.59		%	5.24		%	4.32		%	5.26		%
Long-term rate of return on plan assets		6.8		%		7.3		%		7.75		%		5.5		%		5.39		%	5.91		%	6.8		%	7.3		%	7.75		%
Long-term rate of compensation increase		3.5		%		3.5		%		4		%		3.02		%		2.8		%	2.87		%	—		%	—		%	—		%
ESOP growth rate		—		%		—		%		—		%		—		%		—		%	—		%	10		%	10		%	10		%
Medical cost trend rate of increase		—		%		—		%		—		%		—		%		—		%	—		%	7		%	7.5		%	8		%
Other postretirement charges in 2014 include pension and other benefit enhancements amounting to $5 incurred pursuant to the 2012 Restructuring Program.
Other postretirement charges in 2013 primarily relate to a curtailment charge of $91 resulting from changes to the Company’s defined benefit retirement plans in the U.S. and certain other one-time pension and other retiree benefit enhancements incurred pursuant to the 2012 Restructuring Program.
Other postretirement charges in 2012 primarily relate to the sale of land in Mexico.
The Company made voluntary contributions of $2, $101 and $101 in 2014, 2013 and 2012, respectively, to its U.S. retirement plans.
The estimated actuarial loss and the estimated transition/prior service cost for defined benefit and other retiree benefit plans that will be amortized from Accumulated other comprehensive income (loss) into net periodic benefit cost over the next fiscal year is as follows:
		Pension Plans				Other Retiree Benefit Plans
Net actuarial loss		$	48			$	27
Net transition & prior service cost		11				3
Expected Contributions & Benefit Payments
Management does not expect to make a voluntary contribution to U.S. pension plans for the year ending December 31, 2015. Actual funding may differ from current estimates depending on the variability of the market value of the assets as compared to the obligation and other market or regulatory conditions.
Total benefit payments to be paid to participants for the year ending December 31, 2015 from the Company’s assets are estimated to be approximately $69. Total benefit payments expected to be paid to participants from plan assets, or directly from the Company’s assets to participants in unfunded plans, are as follows:
		Pension Plans
Years Ended December 31,		United States				International				Other Retiree Benefit Plans				Total
2015		$	139			$	63			$	42			$	244
2016		139				45				43				227
2017		139				55				44				238
2018		139				54				45				238
2019		140				64				46				250
2020-2024		721				646				247				1,614

Income_Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes
	The components of income before income taxes are as follows for the three years ended December 31:
			2014				2013				2012
	United States		$	1,094			$	1,018			$	1,155
	International		2,439				2,547				2,719
	Total Income before income taxes		$	3,533			$	3,565			$	3,874
	The provision for income taxes consists of the following for the three years ended December 31:
			2014				2013				2012
	United States		$	348			$	314			$	395
	International		846				841				848
	Total Provision for income taxes		$	1,194			$	1,155			$	1,243
	Temporary differences between accounting for financial statement purposes and accounting for tax purposes result in the current provision for taxes being higher (lower) than the total provision for income taxes as follows:
			2014				2013				2012
	Goodwill and intangible assets		$	(40	)		$	(14	)		$	(7	)
	Property, plant and equipment		(13		)		—				(13		)
	Pension and other retiree benefits		19				85				(14		)
	Stock-based compensation		11				10				5
	Tax loss and tax credit carryforwards		5				(30		)		(39		)
	Other, net		(19		)		(33		)		32
	Total deferred tax provision		$	(37	)		$	18			$	(36	)
	The difference between the statutory U.S. federal income tax rate and the Company’s global effective tax rate as reflected in the Consolidated Statements of Income is as follows:
	Percentage of Income before income taxes		2014			2013			2012
	Tax at United States statutory rate		35	%		35	%		35	%
	State income taxes, net of federal benefit		0.7			0.4			0.7
	Earnings taxed at other than United States statutory rate		(2.3	)		(1.4	)		(2.6	)
	Charge for a foreign tax matter (1)		1.9			—			—
	Other, net		(1.5	)		(1.6	)		(1.0	)
	Effective tax rate		33.8	%		32.4	%		32.1	%
	_________
	(1)	The charge for a foreign tax matter relates to a notice of an adverse decision in a foreign court regarding a tax position taken in prior years received by the Company in the second quarter of 2014.
	The components of deferred tax assets (liabilities) are as follows at December 31:
			2014				2013
	Deferred tax liabilities:
	Goodwill and intangible assets		$	(497	)		$	(475	)
	Property, plant and equipment		(380		)		(375		)
	Other		(266		)		(237		)
			(1,143		)		(1,087		)
	Deferred tax assets:
	Pension and other retiree benefits		638				448
	Tax loss and tax credit carryforwards		33				28
	Accrued liabilities		276				317
	Stock-based compensation		119				116
	Other		148				95
			1,214				1,004
	Net deferred income taxes		$	71			$	(83	)
			2014				2013
	Deferred taxes included within:
	Assets:
	Other current assets		$	256			$	284
	Deferred income taxes		76				77
	Liabilities:
	Deferred income taxes		(261		)		(444		)
	Net deferred income taxes		$	71			$	(83	)
	Applicable U.S. income and foreign withholding taxes have not been provided on approximately $4,900 of undistributed earnings of foreign subsidiaries at December 31, 2014. These earnings have been and currently are considered to be indefinitely reinvested outside of the U.S. and currently are not subject to such taxes. As the Company operates in over 200 countries and territories throughout the world and due to the complexities in the tax laws and the assumptions that would have to be made, it is not practicable to determine the tax liability that would arise if these earnings were repatriated.
	In addition, net tax expense of $251 in 2014, net tax expense of $116 in 2013, and net tax benefits of $80 in 2012 recorded directly through equity predominantly include current and future tax impacts related to employee equity compensation and benefit plans.
	The Company uses a comprehensive model to recognize, measure, present and disclose in its financial statements uncertain tax positions that the Company has taken or expects to take on an income tax return.
	Unrecognized tax benefits activity for the years ended December 31, 2014, 2013 and 2012 is summarized below:
			2014				2013				2012
	Unrecognized tax benefits:
	Balance, January 1		$	199			$	212			$	176
	Increases as a result of tax positions taken during the current year		23				23				34
	Decreases of tax positions taken during prior years		(11		)		(52		)		(6		)
	Increases of tax positions taken during prior years		32				37				10
	Decreases as a result of settlements with taxing authorities and the expiration of statutes of limitations		(10		)		(22		)		(3		)
Effect of foreign currency rate movements		(15		)		1				1
Balance, December 31		$	218			$	199			$	212
If all of the unrecognized tax benefits for 2014 above were recognized, approximately $195 would impact the effective tax rate. Although it is possible that the amount of unrecognized benefits with respect to our uncertain tax positions will increase or decrease in the next 12 months, the Company does not expect material changes.
The Company recognized approximately $4, $5 and $5 of interest expense related to the above unrecognized tax benefits within income tax expense in 2014, 2013 and 2012, respectively. The Company had accrued interest of approximately $24, $24 and $19 as of December 31, 2014, 2013 and 2012, respectively.
The Company and its subsidiaries file U.S. federal income tax returns as well as income tax returns in many state and foreign jurisdictions. All U.S. federal income tax returns through December 31, 2009 have been audited by, and settled with, the IRS. With a few exceptions, the Company is no longer subject to U.S. state and local income tax examinations for income tax returns through December 31, 2009. In addition, the Company has subsidiaries in various foreign jurisdictions that have statutes of limitations for tax audits generally ranging from three to six years.

Earnings_Per_Share

Earnings Per Share	12 Months Ended
	Dec. 31, 2014
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share
		For the Year Ended 2014					For the Year Ended 2013					For the Year Ended 2012
		Net income attributable to Colgate-Palmolive Company		Shares	Per		Net income attributable to Colgate-Palmolive Company		Shares	Per		Net income attributable to Colgate-Palmolive Company		Shares	Per
				(millions)	Share				(millions)	Share				(millions)	Share
	Basic EPS	2,180		915.1	$	2.38	2,241		930.8	$	2.41	2,472		952.1	$	2.6
	Stock options and restricted stock units			9.2					9.1					8.1
	Diluted EPS	$	2,180	924.3	$	2.36	$	2,241	939.9	$	2.38	$	2,472	960.2	$	2.57
	Basic earnings per common share is computed by dividing net income available for common stockholders by the weighted-average number of shares of common stock outstanding for the period.
	Diluted earnings per common share is computed using the treasury stock method on the basis of the weighted-average number of shares of common stock plus the dilutive effect of potential common shares outstanding during the period. Dilutive potential common shares include outstanding stock options and restricted stock units.
	As of December 31, 2014, 2013 and 2012, the average number of stock options that were anti-dilutive and not included in diluted earnings per share calculations were 1,729,511, 1,785,032 and 3,504,608, respectively. As of December 31, 2014, 2013 and 2012, the average number of restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 2,311, 3,709, and 2,252, respectively.

Commitments_and_Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2014
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies
	Minimum rental commitments under noncancellable operating leases, primarily for office and warehouse facilities, are $201 in 2015, $170 in 2016, $148 in 2017, $138 in 2018, $126 in 2019 and $280 thereafter. Rental expense amounted to $234 in 2014, $232 in 2013 and $228 in 2012. Capital leases included in fixed assets, contingent rentals and sublease income are not significant. The Company has various contractual commitments to purchase raw, packaging and other materials totaling approximately $774 at December 31, 2014.
	As a global company serving consumers in more than 200 countries and territories, the Company is routinely subject to a wide variety of legal proceedings. These include disputes relating to intellectual property, contracts, product liability, marketing, advertising, foreign exchange controls, antitrust and trade regulation, as well as labor and employment, environmental and tax matters and consumer class actions. Management proactively reviews and monitors the Company’s exposure to, and the impact of, environmental matters. The Company is party to various environmental matters and, as such, may be responsible for all or a portion of the cleanup, restoration and post-closure monitoring of several sites.
	The Company establishes accruals for loss contingencies when it has determined that a loss is probable and that the amount of loss, or range of loss, can be reasonably estimated. Any such accruals are adjusted thereafter as appropriate to reflect changes in circumstances.
	The Company also determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that a loss is reasonably possible and it is able to determine such estimates. For those matters disclosed below, the Company currently estimates that the aggregate range of reasonably possible losses in excess of any accrued liabilities is $0 to approximately $200 (based on current exchange rates). The estimates included in this amount are based on the Company’s analysis of currently available information and, as new information is obtained, these estimates may change. Due to the inherent subjectivity of the assessments and the unpredictability of outcomes of legal proceedings, any amounts accrued or included in this aggregate amount may not represent the ultimate loss to the Company from the matters in question. Thus, the Company’s exposure and ultimate losses may be higher or lower, and possibly significantly so, than the amounts accrued or the range disclosed above.
	Based on current knowledge, management does not believe that the ultimate resolution of loss contingencies arising from the matters discussed herein will have a material effect on the Company’s consolidated financial position or its ongoing results of operations or cash flows. However, in light of the inherent uncertainties noted above, an adverse outcome in one or more of these matters could be material to the Company’s results of operations or cash flows for any particular quarter or year.
	Brazilian Matters
	There are certain tax and civil proceedings outstanding, as described below, related to the Company’s 1995 acquisition of the Kolynos oral care business from Wyeth (the “Seller”).
	The Brazilian internal revenue authority has disallowed interest deductions and foreign exchange losses taken by the Company’s Brazilian subsidiary for certain years in connection with the financing of the Kolynos acquisition. The tax assessments with interest, at the current exchange rate, are approximately $107. The Company has been disputing the disallowances by appealing the assessments within the internal revenue authority’s appellate process since October 2001. Numerous appeals are currently pending at the administrative level. In the event the Company is ultimately unsuccessful, further appeals are available within the Brazilian federal courts. The Company intends to challenge these assessments vigorously. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel and other advisors, that the disallowances are without merit and that the Company should ultimately prevail on appeal, if necessary, in the Brazilian federal courts.
	In July 2002, the Brazilian Federal Public Attorney filed a civil action against the federal government of Brazil, Laboratorios Wyeth-Whitehall Ltda. (the Brazilian subsidiary of the Seller) and the Company, as represented by its Brazilian subsidiary, in the 6th. Lower Federal Court in the City of São Paulo, seeking to annul an April 2000 decision by the Brazilian Board of Tax Appeals that found in favor of the Seller’s Brazilian subsidiary on the issue of whether it had incurred taxable capital gains as a result of the divestiture of Kolynos. The action seeks to make the Company’s Brazilian subsidiary jointly and severally liable for any tax due from the Seller’s Brazilian subsidiary. The case has been pending since 2002, and the Lower Federal Court has not issued a decision. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the Company should ultimately prevail in this action. The Company intends to challenge this action vigorously.
	In December 2005, the Brazilian internal revenue authority issued to the Company’s Brazilian subsidiary a tax assessment with interest and penalties of approximately $66, at the current exchange rate, based on a claim that certain purchases of U.S. Treasury bills by the subsidiary and their subsequent disposition during the period 2000 to 2001 were subject to a tax on foreign exchange transactions. The Company has been disputing the assessment within the internal revenue authority’s administrative appeals process. In November 2014, the Superior Chamber of Administrative Tax Appeals denied the Company’s most recent appeal. Further appeals are available both at the administrative level and within the Brazilian federal courts. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the tax assessment is without merit and that the Company should ultimately prevail on appeal, if not at the administrative level, in the Brazilian federal courts. The Company intends to challenge this assessment vigorously.
	Competition Matters
	European Competition Matters
	Certain of the Company’s subsidiaries in Europe are subject to investigations, and in some cases, fines by governmental authorities in a number of European countries related to potential competition law violations. The Company understands that substantially all of these matters also involve other consumer goods companies and/or retail customers. The status of the various pending matters is discussed below.
	Fines have been imposed on the Company in the following matters, although, as noted below, the Company has appealed each of these fines:
	▪	In December 2009, the Swiss competition law authority imposed a fine of $6 on the Company’s GABA subsidiary for alleged violations of restrictions on parallel imports into Switzerland, which the Company appealed. In January 2014, this appeal was denied. The Company is appealing before the Swiss Supreme Court.
	▪	In January 2010, the Company’s Spanish subsidiary was fined $3 by the Spanish competition law authority on the basis that it had entered an agreement with other shower gel manufacturers regarding product downsizing, which the Company contested. The fine was annulled by the Court of Appeal in July 2013. The Spanish competition law authority is appealing this judgment before the Spanish Supreme Court.
	▪	In December 2010, the Italian competition law authority found that 16 consumer goods companies, including the Company’s Italian subsidiary, exchanged competitively sensitive information in the cosmetics sector, for which the Company’s Italian subsidiary was fined $3. The Company is appealing the fine in the Italian courts.
	▪	In March 2012, the French competition law authority found that three pet food producers, including the Company’s Hill’s French subsidiary, had violated competition law, for which it imposed a fine of $7 on the Company’s Hill’s French subsidiary for alleged restrictions on exports from France, which the Company contested. In October 2013, the Company’s appeal was denied. The Company is appealing before the French Supreme Court.
	▪	In December 2014, the French competition law authority found that 13 consumer goods companies, including the Company’s French subsidiary, exchanged competitively sensitive information related to the French home care and personal care sectors, for which the Company’s French subsidiary was fined $57. In addition, as a result of the Company’s acquisition of the Sanex personal care business in 2011 from Unilever N.V. and Unilever PLC (together with Unilever N.V., “Unilever”) pursuant to a Business and Share Sale and Purchase Agreement (the “Sanex Purchase Agreement”), the French competition law authority found that the Company’s French subsidiary, along with another consumer goods company, are jointly and severally liable for fines of $25 assessed against Sara Lee’s French subsidiary. The Company is seeking indemnification for the $25 fine from Unilever under the Sanex Purchase Agreement. The Company is appealing both fines in the French courts.
	Currently, formal claims of violations or statements of objections are pending against the Company as follows:
	▪	In October 2012, the Belgian competition law authority alleged that 11 branded goods companies, including the Company’s Belgian subsidiary, assisted retailers to coordinate their retail prices on the Belgian market. The defendants have initiated preliminary talks with the authority regarding a possible settlement.
	▪	In July 2014, the Greek competition law authority issued a statement of objections alleging the Company and its Greek subsidiary restricted parallel imports into Greece. The Company has responded to this statement of objections.
	Australian Competition Matter
	In December 2013, the Australian competition law authority instituted civil proceedings in the Sydney registry of the Federal Court of Australia alleging that three consumer goods companies, including the Company’s Australian subsidiary, a retailer and a former employee of the Company’s Australian subsidiary violated the Australian competition law by coordinating the launching and pricing of ultra-concentrated laundry detergents. The Company is defending these proceedings. Since the amount of any potential losses from these proceedings currently cannot be estimated, the range of reasonably possible losses in excess of accrued liabilities disclosed above does not include any amount relating to these proceedings.
	The Company’s policy is to comply with antitrust and competition laws and, if a violation of any such laws is found, to take appropriate remedial action and to cooperate fully with any related governmental inquiry. Competition and antitrust law investigations often continue for several years and can result in substantial fines for violations that are found. While the Company cannot predict the final financial impact of these competition law issues, as these matters may change, the Company evaluates developments in these matters quarterly and accrues liabilities as and when appropriate.
	Talcum Powder Matters
	The Company is a defendant in a number of civil actions alleging that certain talc products it sold prior to 1996 were contaminated with asbestos. Since 2008, the Company has challenged and intends to continue to challenge these cases vigorously, and although there can be no assurances, it believes, based on the advice of its legal counsel, that they are without merit and the Company should ultimately prevail. Currently, there are 13 single plaintiff cases pending against the Company in state courts in California, Delaware, Illinois, Maryland, New Jersey and New York and one case pending in federal court in North Carolina. 19 similar cases previously filed against the Company have been dismissed and final judgment entered in favor of the Company. To date, there have been no findings of liability against the Company in any of these cases. Since the amount of any potential losses from these cases currently cannot be estimated, the range of reasonably possible losses in excess of accrued liabilities disclosed above does not include any amount relating to these cases.
	Some of these cases are currently expected to go to trial in 2015, although the Company may succeed in dismissing or otherwise resolving some or all of them prior to trial. As stated above, while the Company believes, based on the advice of its legal counsel, that it should ultimately prevail, there can be no assurances of the outcome at trial.
	ERISA Matters
	In July 2014, the Colgate-Palmolive Company Employees’ Retirement Income Plan (the “Plan”) settled a putative class action alleging improper calculation of lump sum distributions and failure to satisfy minimum accrual requirements under the Plan. Under the settlement agreement, the Plan agreed to pay approximately $40 after application of certain offsets to resolve the litigation.

Venezuela

Venezuela	12 Months Ended
	Dec. 31, 2014
Foreign Currency [Abstract]
Venezuela	Venezuela
	Venezuela has been designated hyper-inflationary and, therefore, the functional currency for the Company’s Venezuelan subsidiary (“CP Venezuela”) is the U.S. dollar and Venezuelan currency fluctuations are reported in income.
	During the first quarter of 2014, the Venezuelan government enacted several changes to Venezuela’s foreign exchange regime, introducing a multi-tier foreign exchange system creating three exchange rate mechanisms available to convert Venezuelan bolivares to U.S. dollars. Although the official exchange rate, as determined by the National Center for Foreign Commerce (“CENCOEX”), remained at 6.30 bolivares per dollar, the exchange rate for foreign investments moved to the rate available on the SICAD I (Supplementary System for the Administration of Foreign Currency) currency market. The Venezuelan government also introduced an alternative currency market known as SICAD II. The Company remeasures the financial statements of CP Venezuela at the end of each month at the rate at which it expects to remit future dividends which, based on the advice of legal counsel, is the SICAD I rate.
	During the year ended December 31, 2014, the Company incurred net pretax losses of $327 ($214 aftertax losses or $0.23 per diluted common share) related to the remeasurement of CP Venezuela’s local currency-denominated net monetary assets at the quarter-end SICAD I rate for each of the first three quarters of 2014. The SICAD I rate did not revalue during the fourth quarter of 2014 and remained at 12.00 bolivares per dollar as of December 31, 2014. Included in the net remeasurement losses during 2014 were charges related to the devaluation-protected bonds issued by the Venezuelan government and held by CP Venezuela. Because the official exchange rate remained at 6.30 bolivares per dollar, the devaluation-protected bonds did not revalue at the rate available on the SICAD I currency market but remained at the official exchange rate which resulted in an impairment in the fair value of the bonds.
	CP Venezuela continues to be able to settle certain of its U.S. dollar obligations for imported materials at the official rate of 6.30 bolivares per dollar and records the gains related to such transactions when the funds are authorized by CENCOEX and the liabilities are paid.
	During the year ended December 31, 2013, the Company incurred a pretax loss of $172 ($111 aftertax loss or $0.12 per diluted common share) related to the remeasurement of CP Venezuela’s local currency-denominated net monetary assets at the date of the devaluation that changed the official exchange rate from 4.30 to 6.30 bolivares per dollar.
	For the year ended December 31, 2014, CP Venezuela represented approximately 3% of the Company’s consolidated Net sales. At December 31, 2014, CP Venezuela’s local currency-denominated net monetary asset position, which would be subject to remeasurement in the event of further changes in the SICAD I rate, was $549. This amount includes the devaluation-protected bonds issued by the Venezuelan government. CP Venezuela’s local currency-denominated non-monetary assets were $310 at December 31, 2014 and included $235 of fixed assets that could be subject to impairment if CP Venezuela is not able to implement further price increases to offset the impacts of continued high inflation or further devaluations, or if it does not have sufficient access to U.S. dollars to fund imports.
	Additional devaluations or the imposition of additional or more stringent controls on foreign currency exchange, pricing, payments, profits or imports or other governmental actions or continued or increased labor unrest would further negatively affect the Company’s business in Venezuela and the Company’s ability to effectively make key operational decisions in regard to its Venezuelan operations, both of which could result in an impairment of the Company’s investment in CP Venezuela. At December 31, 2014, the Company’s total investment in CP Venezuela was $955, which included intercompany payables of CP Venezuela.

Segment_Information

Segment Information	12 Months Ended
	Dec. 31, 2014
Segment Reporting [Abstract]
Segment Information	Segment Information
	The Company operates in two product segments: Oral, Personal and Home Care; and Pet Nutrition. The operations of the Oral, Personal and Home Care product segment are managed geographically in five reportable operating segments: North America, Latin America, Europe/South Pacific, Asia and Africa/Eurasia.
	The Company evaluates segment performance based on several factors, including Operating profit. The Company uses Operating profit as a measure of the operating segment performance because it excludes the impact of corporate-driven decisions related to interest expense and income taxes.
	The accounting policies of the operating segments are generally the same as those described in Note 2, Summary of Significant Accounting Policies. Intercompany sales have been eliminated. Corporate operations include costs related to stock options and restricted stock unit awards, research and development costs, Corporate overhead costs, restructuring and related implementation costs, and gains and losses on sales of non-core product lines and assets. The Company reports these items within Corporate operations as they relate to Corporate-based responsibilities and decisions and are not included in the internal measures of segment operating performance used by the Company to measure the underlying performance of the operating segments.
	Approximately 80% of the Company’s Net sales are generated from markets outside the U.S., with over 50% of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe).
	In 2014, Corporate Operating profit (loss) includes charges of $286 related to the 2012 Restructuring Program, charges of $327 related to the 2014 Venezuela Remeasurements, charges of $41 for European competition law matters and costs of $4 related to the sale of land in Mexico. In 2013, Corporate Operating profit (loss) included charges of $371 related to the 2012 Restructuring Program, a charge of $172 related to the 2013 Venezuela Remeasurement, a charge of $23 for a European competition law matter and costs of $18 related to the sale of land in Mexico. In 2012, Corporate Operating profit (loss) included charges of $89 related to the 2012 Restructuring Program, costs of $24 related to the sale of land in Mexico and costs of $21 associated with various business realignment and other cost-saving initiatives. The various business realignment and other cost-saving initiatives included the integration of Sanex, the right-sizing of the Colombia business and the closing of an oral care facility in Mississauga, Canada and a Hill’s facility in Los Angeles, California. For further information regarding the 2012 Restructuring Program, refer to Note 4, Restructuring and Related Implementation Charges. For further information regarding Venezuela, refer to Note 14, Venezuela. For further information regarding the European competition law matters, refer to Note 13, Commitments and Contingencies. For further information regarding the sale of land in Mexico, refer to Note 3, Acquisitions and Divestitures.
			2014			2013			2012
	Net sales
	Oral, Personal and Home Care
	North America(1)		$	3,124		$	3,072		$	2,971
	Latin America		4,769			5,012			5,032
	Europe/South Pacific		3,406			3,396			3,417
	Asia		2,515			2,472			2,264
	Africa/Eurasia		1,208			1,257			1,241
	Total Oral, Personal and Home Care		15,022			15,209			14,925
	Pet Nutrition(2)		2,255			2,211			2,160
	Total Net sales		$	17,277		$	17,420		$	17,085
	_________
	(1)	Net sales in the U.S. for Oral, Personal and Home Care were $2,835, $2,771 and $2,669 in 2014, 2013 and 2012, respectively.
	(2)	Net sales in the U.S. for Pet Nutrition were $1,149, $1,116 and $1,052 in 2014, 2013 and 2012, respectively.
			2014			2013			2012
	Operating profit
	Oral, Personal and Home Care
	North America		$	926		$	927		$	810
	Latin America		1,279			1,385			1,454
	Europe/South Pacific		877			805			747
	Asia		736			698			619
	Africa/Eurasia		235			268			267
	Total Oral, Personal and Home Care		4,053			4,083			3,897
	Pet Nutrition		592			563			589
	Corporate		(1,088		)	(1,090		)	(597		)
	Total Operating profit		$	3,557		$	3,556		$	3,889
			2014			2013			2012
	Capital expenditures
	Oral, Personal and Home Care
	North America		$	136		$	54		$	43
	Latin America		205			235			237
	Europe/South Pacific		78			74			71
	Asia		147			123			88
	Africa/Eurasia		14			11			16
	Total Oral, Personal and Home Care		580			497			455
	Pet Nutrition		40			45			37
	Corporate		137			128			73
	Total Capital expenditures		$	757		$	670		$	565
			2014			2013			2012
	Depreciation and amortization
	Oral, Personal and Home Care
	North America		$	43		$	51		$	50
	Latin America		93			93			91
	Europe/South Pacific		84			85			85
	Asia		78			72			70
	Africa/Eurasia		10			11			11
	Total Oral, Personal and Home Care		308			312			307
	Pet Nutrition		52			51			50
	Corporate		82			76			68
	Total Depreciation and amortization		$	442		$	439		$	425
			2014			2013			2012
	Identifiable assets
	Oral, Personal and Home Care
	North America		$	2,326		$	2,301		$	2,157
	Latin America		3,693			4,202			4,288
	Europe/South Pacific		3,836			3,978			3,649
	Asia		1,903			1,794			1,608
	Africa/Eurasia		510			557			561
Total Oral, Personal and Home Care		12,268			12,832			12,263
Pet Nutrition		1,051			1,087			1,045
Corporate(3)		140			66			86
Total Identifiable assets(4)		$	13,459		$	13,985		$	13,394
____________
(3)	In 2014, Corporate identifiable assets primarily consist of derivative instruments (62%) and investments in equity securities (22%).  In 2013, Corporate identifiable assets primarily consist of derivative instruments (32%) and investments in equity securities (41%).  In 2012, Corporate identifiable assets primarily consist of derivative instruments (67%) and investments in equity securities (28%).
(4)	Long-lived assets in the U.S., primarily property, plant and equipment and goodwill and other intangibles represented approximately one-third of total long-lived assets of $8,086, $8,248 and $8,066 in 2014, 2013 and 2012, respectively.

Supplemental_Income_Statement_

Supplemental Income Statement Information	12 Months Ended
	Dec. 31, 2014
Supplemental Income Statement Elements [Abstract]
Supplemental Income Statement Information	Supplemental Income Statement Information
	Other (income) expense, net	2014			2013			2012
	Amortization of intangible assets	$	32		$	32		$	31
	2012 Restructuring Program	195			202			81
	Venezuela remeasurement charges	327			172			—
	Charges for European competition law matters	41			23			—
	Costs related to the sale of land in Mexico	—			3			—
	Business realignment and other cost-saving initiatives	—			—			2
	Equity (income)	(7		)	(5		)	(7		)
	Other, net	(18		)	(5		)	6
	Total Other (income) expense, net	$	570		$	422		$	113
	Interest (income) expense, net	2014			2013			2012
	Interest incurred	$	134		$	119		$	81
	Interest capitalized	(4		)	(3		)	(1		)
	Interest income	(106		)	(125		)	(65		)
	Total Interest (income) expense, net	$	24		$	(9	)	$	15
		2014			2013			2012
	Research and development	$	277		$	267		$	259
	Advertising	$	1,784		$	1,891		$	1,792

Supplemental_Balance_Sheet_Inf

Supplemental Balance Sheet Information	12 Months Ended
	Dec. 31, 2014
Balance Sheet Related Disclosures [Abstract]
Supplemental Balance Sheet Information	Supplemental Balance Sheet Information
	Inventories by major class are as follows:
	Inventories	2014			2013
	Raw materials and supplies	$	349		$	340
	Work-in-process	55			60
	Finished goods	978			1,025
	Total Inventories	$	1,382		$	1,425
	Inventories valued under LIFO amounted to $287 and $289 at December 31, 2014 and 2013, respectively. The excess of current cost over LIFO cost at the end of each year was $18 and $37, respectively. The liquidations of LIFO inventory quantities had no material effect on income in 2014, 2013 and 2012.
	Property, plant and equipment, net	2014			2013
	Land	$	250		$	254
	Buildings	1,660			1,625
	Manufacturing machinery and equipment	5,220			5,220
	Other equipment	1,255			1,231
		8,385			8,330
	Accumulated depreciation	(4,305		)	(4,247		)
	Total Property, plant and equipment, net	$	4,080		$	4,083
	Other accruals	2014			2013
	Accrued advertising and coupon redemption	$	550		$	676
	Accrued payroll and employee benefits	332			361
	Accrued taxes other than income taxes	122			131
	Restructuring accrual	114			142
	Pension and other retiree benefits	89			94
	Accrued interest	28			27
	Derivatives	5			11
	Other	677			647
	Total Other accruals	$	1,917		$	2,089
	Other liabilities	2014			2013
	Pension and other retiree benefits	$	1,886		$	1,387
	Restructuring accrual	78			16
	Other	259			274
	Total Other liabilities	$	2,223		$	1,677

Supplemental_Comprehensive_Inc

Supplemental Comprehensive Income (Loss) Information	12 Months Ended
	Dec. 31, 2014
Other Comprehensive Income (Loss), Net of Tax [Abstract]
Supplemental Comprehensive Income (Loss) Information	Supplemental Other Comprehensive Income (Loss) Information
	Other Comprehensive Income (Loss) components attributable to Colgate-Palmolive Company before tax and net of tax during the years ended December 31 were as follows:
			2014						2013						2012
			Pre-tax			Net of Tax			Pre-tax			Net of Tax			Pre-tax			Net of Tax
	Cumulative translation adjustments		$	(663	)	$	(681	)	$	(188	)	$	(163	)	$	18		$	(20	)
	Pension and other benefits:
	Net actuarial gain (loss) and prior		(580		)	(374		)	295			189			(317		)	(207		)
	service costs arising during the
	period
	Amortization of net actuarial loss,		67			45			111			70			101			62
	transition and prior service costs(1)
	Curtailment loss - unamortized		—			—			91			59			—			—
	prior service costs(1)
	Retirement Plan and other retiree benefit		(513		)	(329		)	497			318			(216		)	(145		)
	adjustments
	Available-for-sale securities:
	Unrealized gains (losses) on available-		(341		)	(222		)	(113		)	(73		)	28			18
	for-sale securities(2)
	Reclassification of (gains) losses		267			174			133			86			—			—
	into net earnings on available-
	for-sale securities(3)
	Gains (losses) on available-for-sale		(74		)	(48		)	20			13			28			18
	securities
	Cash flow hedges:
	Unrealized gains (losses) on cash flow		9			6			20			13			13			8
	hedges
	Reclassification of (gains) losses		(5		)	(4		)	(17		)	(11		)	(11		)	(7		)
	into net earnings on cash flow
	hedges(4)
	Gains (losses) on cash flow hedges		4			2			3			2			2			1
	Total Other comprehensive income (loss)		$	(1,246	)	$	(1,056	)	$	332		$	170		$	(168	)	$	(146	)
	_________
	(1)	These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 10, Retirement Plans and Other Retiree Benefits for additional details.
	(2)	For the year ended December 31, 2014, these amounts included pretax net losses of $324 related to the remeasurement of the bolivar denominated fixed interest rate bonds and the devaluation-protected bonds in Venezuela.
	For the year ended December 31, 2013, these amounts included pretax losses of $133 related only to the remeasurement of the bolivar denominated fixed interest rate bonds in Venezuela as a result of the devaluation in the first quarter of 2013. No remeasurement charge was required on the devaluation-protected bonds in the first quarter of 2013 since the official exchange rate changed from 4.30 to 6.30 bolivares per dollar and the devaluation-protected bonds revalued to the official exchange rate. See Note 7, Fair Value Measurements and Financial Instruments for additional details.
	(3)	Represents reclassification of losses on the Venezuela bonds into Other (income) expense, net due to an impairment in the fair value of the bonds as a result of the effective devaluations in the first and third quarters of 2014 and the devaluation in 2013. See Note 7, Fair Value Measurements and Financial Instruments for additional details.
	(4)	These (gains) losses are reclassified into Cost of sales. See Note 7, Fair Value Measurements and Financial Instruments for additional details.
	There were no tax impacts on Other comprehensive income (loss) attributable to Noncontrolling interests.
	Accumulated Other Comprehensive Income (Loss)
	Accumulated other comprehensive income (loss) is comprised of cumulative foreign currency translation gains and losses, unrecognized pension and other retiree benefit costs, unrealized gains and losses from derivative instruments designated as cash flow hedges and unrealized gains and losses on available-for-sale securities. At December 31, 2014 and 2013, Accumulated other comprehensive income (loss) consisted primarily of aftertax unrecognized pension and other retiree benefit costs of $1,064 and $735, respectively, and cumulative foreign currency translation adjustments of $2,453 and $1,772, respectively. Foreign currency translation adjustments in 2014 primarily reflect losses from the Euro, the Brazilian real, the Mexican peso, and the Swiss franc. In 2013, foreign currency translation adjustments primarily reflect gains from the Mexican peso, the Euro and the Swiss franc, which were offset by losses from the Brazilian real, the Australian dollar and the Argentine peso.

Quarterly_Financial_Data_Unaud

Quarterly Financial Data (Unaudited)	12 Months Ended
	Dec. 31, 2014
Quarterly Financial Data [Abstract]
Quarterly Financial Data (Unaudited)	Quarterly Financial Data (Unaudited)
		Total			First			Second			Third			Fourth
					Quarter			Quarter			Quarter			Quarter
	2014
	Net sales	$	17,277		$	4,325		$	4,352		$	4,379		$	4,221
	Gross profit	10,109		(1)	2,524		(3)	2,552		(5)	2,558		(7)	2,475		(9)
	Net income including noncontrolling interests	2,339		(2)	432		(4)	661		(6)	580		(8)	666		(10)
	Net income attributable to Colgate-Palmolive Company	2,180		(2)	388		(4)	622		(6)	542		(8)	628		(10)
	Earnings per common share:
	Basic	2.38		(2)	0.42		(4)	0.68		(6)	0.59		(8)	0.69		(10)
	Diluted	2.36		(2)	0.42		(4)	0.67		(6)	0.59		(8)	0.68		(10)
	2013
	Net sales	$	17,420		$	4,315		$	4,346		$	4,398		$	4,361
	Gross profit	10,201		(11)	2,515		(13)	2,534		(15)	2,585		(17)	2,567		(19)
	Net income including noncontrolling interests	2,410		(12)	506		(14)	604		(16)	699		(18)	601		(20)
	Net income attributable to Colgate-Palmolive Company	2,241		(12)	460		(14)	561		(16)	656		(18)	564		(20)
	Earnings per common share:
	Basic	2.41		(12)	0.49		(14)	0.6		(16)	0.71		(18)	0.61		(20)
	Diluted	2.38		(12)	0.48		(14)	0.6		(16)	0.7		(18)	0.6		(20)
	____________
	Note:	Basic and diluted earnings per share are computed independently for each quarter and the year-to-date period presented. Accordingly, the sum of the quarterly earnings per common share may not necessarily equal the earnings per share for the year-to-date period.
	(1)	Gross profit for the full year of 2014 includes $29 of charges related to the 2012 Restructuring Program and $4 of costs related to the sale of land in Mexico.
	(2)	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the full year of 2014 include $208 of aftertax charges related to the 2012 Restructuring Program, $214 of aftertax charges related to the 2014 Venezuela Remeasurements, $41 of charges for European competition law matters, $3 of aftertax costs related to the sale of land in Mexico and a $66 charge for a foreign tax matter.
	(3)	Gross profit for the first quarter of 2014 includes $10 of charges related to the 2012 Restructuring Program and $1 of costs related to the sale of land in Mexico.
	(4)	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the first quarter of 2014 include $73 of aftertax charges related to the 2012 Restructuring Program, a $174 aftertax charge related to the 2014 Venezuela Remeasurements and $1 of aftertax costs related to the sale of land in Mexico.
	(5)	Gross profit for the second quarter of 2014 includes $6 of charges related to the 2012 Restructuring Program and $2 of costs related to the sale of land in Mexico.
	(6)	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the second quarter of 2014 include $53 of aftertax charges related to the 2012 Restructuring Program and $1 of aftertax costs related to the sale of land in Mexico.
	(7)	Gross profit for the third quarter of 2014 includes $7 of charges related to the 2012 Restructuring Program and $1 of costs related to the sale of land in Mexico.
	(8)	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the third quarter of 2014 include $41 of aftertax charges related to the 2012 Restructuring Program, a $40 aftertax charge related to the 2014 Venezuela Remeasurements, an $11 charge for a European competition law matter, $1 of aftertax costs related to the sale of land in Mexico and a $66 charge for a foreign tax matter.
	(9)	Gross profit for the fourth quarter of 2014 includes $6 of charges related to the 2012 Restructuring Program.
	(10)	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the fourth quarter of 2014 include $41 of aftertax charges related to the 2012 Restructuring Program and a $30 charge for a European competition law matter.
	(11)	Gross profit for the full year of 2013 includes $32 of charges related to the 2012 Restructuring Program and $15 of costs related to the sale of land in Mexico.
	(12)	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the full year of 2013 include $278 of aftertax charges related to the 2012 Restructuring Program, a $111 aftertax charge related to the 2013 Venezuela Remeasurement, a $23 charge for a European competition law matter and $12 of aftertax costs related to the sale of land in Mexico.
	(13)	Gross profit for the first quarter of 2013 includes $8 of charges related to the 2012 Restructuring Program and $4 of costs related to the sale of land in Mexico.
	(14)	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the first quarter of 2013 include $52 of aftertax charges related to the 2012 Restructuring Program, a $111 aftertax charge related to the 2013 Venezuela Remeasurement and $3 of aftertax costs related to the sale of land in Mexico.
	(15)	Gross profit for the second quarter of 2013 includes $10 of charges related to the 2012 Restructuring Program and $4 of costs related to the sale of land in Mexico.
	(16)	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the second quarter of 2013 include $79 of aftertax charges related to the 2012 Restructuring Program, an $18 charge for a European competition law matter and $4 of aftertax costs related to the sale of land in Mexico.
	(17)	Gross profit for the third quarter of 2013 includes $8 of charges related to the 2012 Restructuring Program and $3 of costs related to the sale of land in Mexico.
	(18)	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the third quarter of 2013 include $22 of aftertax charges related to the 2012 Restructuring Program and $2 of aftertax costs related to the sale of land in Mexico.
	(19)	Gross profit for the fourth quarter of 2013 includes $6 of charges related to the 2012 Restructuring Program and $4 of costs related to the sale of land in Mexico.
	(20)	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the fourth quarter of 2013 include $125 of aftertax charges related to the 2012 Restructuring Program, a $5 charge for a European competition law matter and $3 of aftertax costs related to the sale of land in Mexico.

Schedule_II_Valuation_and_Qual

Schedule II - Valuation and Qualifying Accounts	12 Months Ended
	Dec. 31, 2014
Valuation and Qualifying Accounts [Abstract]
SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS
				Additions
		Balance at Beginning of Period		Charged to Costs and Expenses		Other		Deductions		Balance at End of Period
	Year Ended December 31, 2014
	Allowance for doubtful accounts and estimated returns	$	67	$	—	$	—	$	13	$	54
	Valuation allowance for deferred tax assets	$	6	$	—	$	—	$	6	$	—
	Year Ended December 31, 2013
	Allowance for doubtful accounts and estimated returns	$	61	$	15	$	—	$	9	$	67
	Valuation allowance for deferred tax assets	$	1	$	6	$	—	$	1	$	6
	Year Ended December 31, 2012
	Allowance for doubtful accounts and estimated returns	$	49	$	18	$	—	$	6	$	61
	Valuation allowance for deferred tax assets	$	1	$	—	$	—	$	—	$	1

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation
	The Consolidated Financial Statements include the accounts of Colgate-Palmolive Company and its majority-owned or controlled subsidiaries. Intercompany transactions and balances have been eliminated. The Company’s investments in consumer products companies with interests ranging between 20% and 50%, where the Company has significant influence over the investee, are accounted for using the equity method. Net income (loss) from such investments is recorded in Other (income) expense, net in the Consolidated Statements of Income. As of December 31, 2014 and 2013, equity method investments included in Other assets in the Consolidated Balance Sheets were $31 and $27, respectively. Unrelated third parties hold the remaining ownership interests in these investments. Investments with less than a 20% interest are accounted for using the cost method.
Use of Estimates	Use of Estimates
	The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to use judgment and make estimates that affect the reported amounts of assets and liabilities and disclosure of contingent gains and losses at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The level of uncertainty in estimates and assumptions increases with the length of time until the underlying transactions are completed. As such, the most significant uncertainty in the Company’s assumptions and estimates involved in preparing the financial statements includes pension and other retiree benefit cost assumptions, stock-based compensation, asset impairments, uncertain tax positions, tax valuation allowances and legal and other contingency reserves. Additionally, the Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments and retirement plan assets. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. Actual results could ultimately differ from those estimates.
Revenue Recognition	Revenue Recognition
	Sales are recorded at the time products are shipped to trade customers and when risk of ownership transfers. Net sales reflect units shipped at selling list prices reduced by sales returns and the cost of current and continuing promotional programs. Current promotional programs, such as product listing allowances and co-operative advertising arrangements, are recorded in the period incurred. Continuing promotional programs are predominantly consumer coupons and volume-based sales incentive arrangements with trade customers. The redemption cost of consumer coupons is based on historical redemption experience and is recorded when coupons are distributed. Volume-based incentives offered to trade customers are based on the estimated cost of the program and are recorded as products are sold.
Shipping and Handling Costs	Shipping and Handling Costs
	Shipping and handling costs are classified as Selling, general and administrative expenses and were $1,326, $1,304 and $1,262 for the years ended December 31, 2014, 2013 and 2012, respectively.
Marketing Costs	Marketing Costs
	The Company markets its products through advertising and other promotional activities. Advertising costs are included in Selling, general and administrative expenses and are expensed as incurred. Certain consumer and trade promotional programs, such as consumer coupons, are recorded as a reduction of sales.
Cash and Cash equivalents	Cash and Cash Equivalents
	The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents.
Inventories	Inventories
	Inventories are stated at the lower of cost or market. The cost of approximately 80% of inventories is determined using the first-in, first-out (“FIFO”) method. The cost of all other inventories, in the U.S. and Mexico, is determined using the last-in, first-out (“LIFO”) method.
Property, Plant and Equipment	Property, Plant and Equipment
	Land, buildings and machinery and equipment are stated at cost. Depreciation is provided, primarily using the straight-line method, over estimated useful lives ranging from 3 to 15 years for machinery and equipment and up to 40 years for buildings. Depreciation attributable to manufacturing operations is included in Cost of sales. The remaining component of depreciation is included in Selling, general and administrative expenses.
Goodwill and Other Intangibles	Goodwill and Other Intangibles
	Goodwill and indefinite life intangible assets, such as the Company’s global brands, are subject to impairment tests at least annually. These tests were performed and did not result in an impairment charge. Other intangible assets with finite lives, such as local brands and trademarks, customer relationships and non-compete agreements, are amortized over their estimated useful lives, generally ranging from 5 to 40 years. Amortization expense related to intangible assets is included in Other (income) expense, net, which is included in Operating profit.
Income Taxes	Income Taxes
	The provision for income taxes is determined using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized based upon the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates that will be in effect at the time such differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Provision is made currently for taxes payable on remittances of overseas earnings; no provision is made for taxes on overseas retained earnings that are deemed to be indefinitely reinvested.
	The Company uses a comprehensive model to recognize, measure, present and disclose in its financial statements uncertain tax positions that the Company has taken or expects to take on an income tax return.  The Company recognizes interest expense and penalties related to unrecognized tax benefits within income tax expense.
Financial Instruments	Financial Instruments
	Derivative instruments are recorded as assets and liabilities at estimated fair value based on available market information. The Company’s derivative instruments that qualify for hedge accounting are designated as either fair value hedges, cash flow hedges or net investment hedges. For fair value hedges, changes in the fair value of the derivative, as well as the offsetting changes in the fair value of the hedged item, are recognized in earnings each period. For cash flow hedges, changes in the fair value of the derivative are recorded in Other comprehensive income (loss) and are recognized in earnings when the offsetting effect of the hedged item is also recognized in earnings. For hedges of the net investment in foreign subsidiaries, changes in the fair value of the derivative are recorded in Other comprehensive income (loss) to offset the change in the value of the net investment being hedged.  Cash flows related to hedges are classified in the same category as the cash flows from the hedged item in the Consolidated Statements of Cash Flows.
	The Company may also enter into certain foreign currency and interest rate instruments that economically hedge certain of its risks but do not qualify for hedge accounting. Changes in fair value of these derivative instruments, based on quoted market prices, are recognized in earnings each period. The Company’s derivative instruments and other financial instruments are more fully described in Note 7, Fair Value Measurements and Financial Instruments along with the related fair value measurement considerations.
Stock-Based Compensation	Stock-Based Compensation
	The Company recognizes the cost of employee services received in exchange for awards of equity instruments, such as stock options and restricted stock units, based on the fair value of those awards at the date of grant over the requisite service period.  The Company uses the Black-Scholes-Merton (“Black-Scholes”) option pricing model to determine the fair value of stock option awards.  Stock-based compensation plans, related expenses and assumptions used in the Black-Scholes option pricing model are more fully described in Note 8, Capital Stock and Stock-Based Compensation Plans.
Currency Translation	Currency Translation
	The assets and liabilities of foreign subsidiaries, other than those operating in highly inflationary environments, are translated into U.S. dollars at year-end exchange rates with resulting translation gains and losses accumulated in a separate component of shareholders’ equity. Income and expense items are translated into U.S. dollars at average rates of exchange prevailing during the year.
	For subsidiaries operating in highly inflationary environments (currently, Venezuela), local currency-denominated non-monetary assets, including inventories, goodwill and property, plant and equipment, are remeasured at their historical exchange rates, while local currency-denominated monetary assets and liabilities are remeasured at year-end exchange rates. Remeasurement adjustments for these operations are included in Net income attributable to Colgate-Palmolive Company.
Recent Accounting Pronouncements	Recent Accounting Pronouncements
	On May 28, 2014, the Financial Accounting Standards Board (“FASB”) and the International Accounting Standards Board (“IASB”) issued their final converged standard on revenue recognition. The standard, issued as Accounting Standards Update (“ASU”) No. 2014-09 “Revenue from Contracts with Customers” by the FASB, provides a single, comprehensive revenue recognition model for all contracts with customers and supersedes current revenue recognition guidance. The revenue standard contains principles that an entity will apply to determine the measurement of revenue and timing of when it is recognized. The underlying principle is that an entity will recognize revenue to depict the transfer of goods or services to customers at an amount that the entity expects to be entitled to in exchange for those goods or services. The new standard also includes enhanced disclosures which are significantly more comprehensive than those in existing revenue standards. This new guidance is effective for the Company beginning January 1, 2017, with no early adoption permitted. The standard allows for either “full retrospective” adoption, meaning the standard is applied to all of the periods presented, or “modified retrospective” adoption, meaning the standard is applied only to the most current period presented in the financial statements. While the Company is currently assessing the impact of the new standard, it does not expect this new guidance to have a material impact on its Consolidated Financial Statements.
	On April 10, 2014, the FASB issued ASU No. 2014-08 “Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity.” ASU No. 2014-08 changes the criteria for reporting discontinued operations and modifies related disclosure requirements. The new guidance is effective for the Company on a prospective basis beginning January 1, 2015. This new guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements.
Reclassifications	Reclassifications
	Certain prior year amounts have been reclassified to conform to the current year presentation. Additionally, Other current assets in the December 31, 2013 Consolidated Balance Sheet were adjusted to include certain non-income tax receivables which were previously included in Other accruals.

Nature_of_Operations_Tables

Nature of Operations (Tables)	12 Months Ended
	Dec. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Percentage of worldwide sales	The Company’s principal classes of products accounted for the following percentages of worldwide Net sales for the past three years:
		2014		2013		2012
	Oral Care	46	%	46	%	44	%
	Personal Care	21	%	21	%	22	%
	Home Care	20	%	20	%	21	%
	Pet Nutrition	13	%	13	%	13	%
	Total	100	%	100	%	100	%

Restructuring_and_Related_Impl1

Restructuring and Related Implementation Charges (Tables)	12 Months Ended
	Dec. 31, 2014
Restructuring and Related Activities [Abstract]
Schedule of Restructuring and Related Costs	For the years ended December 31, 2014, 2013 and 2012, restructuring and implementation-related charges are reflected in the Consolidated Statements of Income as follows:
		2014				2013				2012
	Cost of sales	$	29			$	32			$	2
	Selling, general and administrative expenses	62				137				6
	Other (income) expense, net	195				202				81
	Total 2012 Restructuring Program charges, pretax	$	286			$	371			$	89
	Total 2012 Restructuring Program charges, aftertax	$	208			$	278			$	70
Schedule of Percent Of Total Restructuring Charges Related To Segment for the period	Total charges incurred for the 2012 Restructuring Program relate to initiatives undertaken by the following reportable operating segments:
											Program-to-date
		2014			2013			2012			Accumulated Charges
	North America	11	%		11	%		2	%		10	%
	Latin America	4	%		4	%		—	%		4	%
	Europe/South Pacific	20	%		28	%		55	%		28	%
	Asia	3	%		—	%		—	%		1	%
	Africa/Eurasia	3	%		7	%		2	%		5	%
	Hill’s Pet Nutrition	10	%		8	%		3	%		8	%
	Corporate	49	%		42	%		38	%		44	%
Schedule of Restructuring and Related Costs Incurred to Date	Since the inception of the 2012 Restructuring Program in the fourth quarter of 2012, the Company has incurred pretax cumulative charges of $746 ($556 aftertax) in connection with the implementation of various projects as follows:
		Cumulative Charges
		as of December 31, 2014
	Employee-Related Costs	$	295
	Incremental Depreciation	51
	Asset Impairments	2
	Other	398
	Total	$	746
Schedule of Restructuring Reserve by Type of Cost	The following table summarizes the activity for the restructuring and implementation-related charges discussed above and the related accruals:
			Employee-Related				Incremental				Asset			Other			Total
			Costs				Depreciation				Impairments
	Balance at January 1, 2012		$	—			$	—			$	—		$	—		$	—
	Charges		78				—				—			11			89
	Cash payments		(1		)		—				—			(4		)	(5		)
	Charges against assets		—				—				—			—			—
	Foreign exchange		7				—				—			(2		)	5
	Balance at December 31, 2012		$	84			$	—			$	—		$	5		$	89
	Charges		144				26				1			200			371
	Cash payments		(97		)		—				—			(72		)	(169		)
	Charges against assets		(17		)		(26		)		(1		)	—			(44		)
	Foreign exchange		2				—				—			—			2
	Other		—				—				—			(91		)	(91		)
	Balance at December 31, 2013		$	116			$	—			$	—		$	42		$	158
	Charges		73				25				1			187			286
	Cash payments		(95		)		—				—			(117		)	(212		)
	Charges against assets		(5		)		(25		)		(1		)	—			(31		)
	Foreign exchange		(4		)		—				—			(5		)	(9		)
	Other		—				—				—			—			—
	Balance at December 31, 2014		$	85			$	—			$	—		$	107		$	192

Goodwill_and_Other_Intangible_1

Goodwill and Other Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2014
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The net carrying value of Goodwill as of December 31, 2014 and 2013, by segment is as follows:
		2014		2013
	Oral, Personal and Home Care
	North America	$	352	$	362
	Latin America	320		353
	Europe/South Pacific	1,374		1,525
	Asia	160		126
	Africa/Eurasia	86		93
	Total Oral, Personal and Home Care	2,292		2,459
	Pet Nutrition	15		15
	Total Goodwill	$	2,307	$	2,474
Schedule Of Finite And Indefinite Lived Intangible Assets By Major Class	Other intangible assets as of December 31, 2014 and 2013 are comprised of the following:
		2014							2013
		Gross Carrying Amount		Accumulated Amortization			Net		Gross Carrying Amount		Accumulated Amortization			Net
	Trademarks	$	552	$	(285	)	$	267	$	551	$	(275	)	$	276
	Other finite life intangible assets	213		(54		)	159		219		(45		)	174
	Indefinite life intangible assets	987		—			987		1,046		—			1,046
	Total Other intangible assets	$	1,752	$	(339	)	$	1,413	$	1,816	$	(320	)	$	1,496

LongTerm_Debt_and_Credit_Facil1

Long-Term Debt and Credit Facilities (Tables)	12 Months Ended
	Dec. 31, 2014
Debt Disclosure [Abstract]
Schedule of Long-term Debt Instruments	Long-term debt consists of the following at December 31:
			Weighted Average Interest Rate	Maturities			2014		2013
	Notes		1.90%	2015	-	2078	$	5,877	$	5,644
	Commercial paper		—%	2015			255		—
							6,132		5,644
	Less: Current portion of long-term debt						488		895
	Total						$	5,644	$	4,749
Schedule of Maturities of Long-term Debt	Excluding commercial paper reclassified as long-term debt, scheduled maturities of long-term debt and capitalized leases outstanding as of December 31, 2014, are as follows:
	Years Ended December 31,
	2015	$	488
	2016	263
	2017	660
	2018	697
	2019	498
	Thereafter	3,271

Fair_Value_Measurements_and_Fi1

Fair Value Measurements and Financial Instruments (Tables)	12 Months Ended
	Dec. 31, 2014
Financial Instruments and Fair Value Measurements [Abstract]
Schedule of Derivative Instruments	The following summarizes the fair value of the Company’s derivative instruments and other financial instruments at December 31, 2014 and December 31, 2013:
		Assets										Liabilities
		Account		Fair Value								Account	Fair Value
	Designated derivative instruments			12/31/14				12/31/13					12/31/14			12/31/13
	Interest rate swap contracts	Other current assets		$	1			$	1			Other accruals	$	—		$	—
	Interest rate swap contracts	Other assets		12				20				Other liabilities	2			1
	Foreign currency contracts	Other current assets		21				14				Other accruals	4			8
	Foreign currency contracts	Other assets		60				—				Other liabilities	—			10
	Commodity contracts	Other current assets		—				—				Other accruals	1			—
	Total designated			$	94			$	35				$	7		$	19
	Derivatives not designated
	Foreign currency contracts	Other current assets		$	—			$	—			Other accruals	$	—		$	3
	Foreign currency contracts	Other assets		8				—				Other liabilities	—			—
	Total not designated			$	8			$	—				$	—		$	3
	Total derivative instruments			$	102			$	35				$	7		$	22
	Other financial instruments
	Marketable securities	Other current assets		$	200			$	173
	Available-for-sale securities	Other assets		322				685
	Note receivable	Other current assets		42				—
	Total other financial			$	564			$	858
	instruments
Activity related to fair value hedges	Activity related to fair value hedges recorded during each period presented was as follows:
		2014											2013
		Foreign				Interest							Foreign			Interest
		Currency				Rate				Total			Currency			Rate			Total
		Contracts				Swaps							Contracts			Swaps
	Notional Value at December 31,	$	1,163			$	1,438			$	2,601		$	1,320		$	1,188		$	2,508
	Gain (loss) on derivative	3				(8		)		(5		)	24			(22		)	2
	Gain (loss) on hedged items	(3		)		8				5			(24		)	22			(2		)
Activity related to cash flow hedges	Activity related to cash flow hedges recorded during each period presented was as follows:
		2014											2013
		Foreign				Commodity							Foreign			Commodity
		Currency				Contracts				Total			Currency			Contracts			Total
		Contracts											Contracts
	Notional Value at December 31,	$	511			$	14			$	525		$	386		$	14		$	400
	Gain (loss) recognized in OCI	9				—				9			20			—			20
	Gain (loss) reclassified into Cost of sales	5				—				5			16			1			17
Activity related to net investment hedges	Activity related to net investment hedges recorded during each period presented was as follows:
		2014											2013
		Foreign				Foreign							Foreign			Foreign
		Currency				Currency				Total			Currency			Currency			Total
		Contracts				Debt							Contracts			Debt
	Notional Value at December 31,	$	567			$	297			$	864		$	529		$	256		$	785
	Gain (loss) on instruments	73				11				84			(24		)	(4		)	(28		)
	Gain (loss) on hedged items	(73		)		(11		)		(84		)	23			4			27
Activity related to derivatives not designated as hedging instruments	Activity related to these contracts during each period presented was as follows:
		2014				2013
		Cross-currency				Cross-currency
		Swap				Swap
	Notional Value at December 31,	$	102			$	96
	Gain (loss) on instrument	5				(2		)
	Gain (loss) on hedged item	(5		)		2
Reconciliation of the Venezuelan investments at fair value	The following table presents a reconciliation of the Venezuelan bonds at fair value for the twelve months ended December 31:
		2014				2013
	Beginning balance as of January 1	$	685			$	642
	Unrealized gain (loss) on investment	(341		)		(113		)
	Purchases and sales during the period	55				156
	Ending balance as of December 31	$	399			$	685

Capital_Stock_and_StockBased_C1

Capital Stock and Stock-Based Compensation Plans (Tables)	12 Months Ended
	Dec. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule Of Common And Treasury Stock Activity	A summary of common stock and treasury stock activity for the three years ended December 31, is as follows:
		Common Stock Outstanding		Treasury Stock
	Balance, January 1, 2012	960,036,150		505,670,210
	Common stock acquired	(38,730,602	)	38,730,602
	Shares issued for stock options	12,217,230		(12,217,230	)
	Shares issued for restricted stock units and other	2,205,898		(2,205,898	)
	Balance, December 31, 2012	935,728,676		529,977,684
	Common stock acquired	(25,573,317	)	25,573,317
	Shares issued for stock options	7,883,834		(7,883,834	)
	Shares issued for restricted stock units and other	1,907,382		(1,907,382	)
	Balance, December 31, 2013	919,946,575		545,759,785
	Common stock acquired	(23,131,081	)	23,131,081
	Shares issued for stock options	7,977,124		(7,977,124	)
	Shares issued for restricted stock units and other	1,919,527		(1,919,527	)
	Balance, December 31, 2014	906,712,145		558,994,215
Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions	Fair value is estimated using the Black-Scholes option pricing model with the assumptions summarized in the following table:
		2014		2013		2012
	Expected Term of Options	4.5 years		4.5 years		4.5 years
	Expected Volatility Rate	17.1	%	18.4	%	20.8	%
	Risk-Free Interest Rate	1.6	%	1.5	%	0.6	%
	Expected Dividend Yield	2.3	%	2.3	%	2.4	%
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity	A summary of restricted stock unit activity during 2014 is presented below:
		Shares		Weighted Average Grant Date Fair Value Per Award
		(in thousands)
	Restricted stock units as of January 1, 2014	4,539		$	48
	Activity:
	Granted	1,092		64
	Vested	(1,867	)	42
	Forfeited	(70	)	52
	Restricted stock units as of December 31, 2014	3,694		$	56
Schedule of Share-based Compensation, Stock Options, Activity	A summary of stock option activity during 2014 is presented below:
		Shares		Weighted Average Exercise Price			Weighted Average Remaining Contractual Life	Intrinsic Value of Unexercised
		(in thousands)					(in years)	In-the-Money Options
	Options outstanding, January 1, 2014	42,832		$	47
	Granted	9,036		64
	Exercised	(8,526	)	41
	Forfeited or expired	(440	)	57
	Options outstanding, December 31, 2014	42,902		52			4	$	746
	Options exercisable, December 31, 2014	24,946		$	46		3	$	582

Retirement_Plans_and_Other_Ret1

Retirement Plans and Other Retiree Benefits (Tables)	12 Months Ended
	Dec. 31, 2014
Compensation and Retirement Disclosure [Abstract]
Schedule of Allocation of Plan Assets	The target asset allocation for the Company’s defined benefit plans are as follows:
			United States			International
	Asset Category
	Equity securities		27	%		39	%
	Fixed income securities		53			47
	Real estate and other investments		20			14
	Total		100	%		100	%
	At December 31, 2014 the allocation of the Company’s plan assets and the level of valuation input for each major asset category was as follows:
			Level of Valuation		Pension Plans
			Input		United States				International				Other Retiree
													Benefit Plans
	Investments:
	Cash & cash equivalents		Level 1		$	48			$	10			$	1
	U.S. common stocks		Level 1		130				3				3
	International common stocks		Level 1		—				2				—
	Fixed income securities(a)		Level 2		625				—				13
	Common/collective trust funds(b):		Level 2
	Developed market equity index funds				352				193				9
	Emerging market equity index funds				32				8				1
	Other common stock funds				118				27				3
	Fixed income funds: U.S. or foreign government and agency securities				115				107				3
	Fixed income funds: investment grade corporate bonds				168				75				4
	Fixed income funds: high yield corporate bonds and other				136				54				3
	Guaranteed investment contracts(c)		Level 2		1				54				—
	Real estate funds(d)		Level 3		46				19				1
	Total Investments at fair value				$	1,771			$	552			$	41
	At December 31, 2013 the allocation of the Company’s plan assets and the level of valuation input for each major asset category was as follows:
			Level of Valuation		Pension Plans
			Input		United States				International				Other Retiree
													Benefit Plans
	Investments:
	Cash & cash equivalents		Level 1		$	97			$	23			$	3
	U.S. common stocks		Level 1		127				—				3
	International common stocks		Level 1		51				—				1
	Fixed income securities(a)		Level 2		433				—				8
	Common/collective trust funds(b):		Level 2
	Developed market equity index funds				359				229				9
	Emerging market equity index funds				33				9				1
	Other common stock funds				123				41				3
	Fixed income funds: U.S. or foreign government and agency securities				149				73				3
	Fixed income funds: investment grade corporate bonds				203				71				5
	Fixed income funds: high yield corporate bonds and other				119				35				4
	Guaranteed investment contracts(c)		Level 2		2				56				—
	Real estate funds(d)		Level 3		40				21				1
	Total Investments at fair value				$	1,736			$	558			$	41
	_______
	(a)	The fixed income securities are traded over the counter and certain of these securities lack daily pricing or liquidity and as such are classified as Level 2. As of December 31, 2014 and 2013, approximately 50% of the fixed income portfolio was invested in U.S. treasury or agency securities, with the remainder invested in other government bonds and corporate bonds.
	(b)	Interests in common/collective trust funds are valued using the net asset value (“NAV”) per unit in each fund. The NAV is based on the value of the underlying investments owned by each trust, minus its liabilities, divided by the number of shares outstanding.
	(c)	The guaranteed investment contracts (“GICs”) represent contracts with insurance companies measured at the cash surrender value of each contract. The Level 2 valuation reflects that the cash surrender value is based principally on a referenced pool of investment funds with active redemption.
	(d)	Real estate is valued using the NAV per unit of funds that are invested in real estate property. The investment value of the real estate property is determined quarterly using independent market appraisals as determined by the investment manager. Since the appraisals include unobservable inputs, these investments are classified as Level 3. These unobservable inputs may include items such as annual gross rents, projected vacancy rates, collection losses and recovery rates, yield rates, growth assumptions and risk adjusted discount rates.
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	The following table presents a reconciliation of Level 3 plan assets measured at fair value for the year ended December 31:
			2014								2013
			United States Real Estate Fund				International Real Estate Fund				United States Real Estate Fund				International Real Estate Fund
	Beginning balance as of January 1		$	41			$	21			$	72			$	20
	Earned income, net of management expenses		2				—				2				—
	Unrealized gain (loss) on investment		4				(1		)		9				—
	Purchases, sales, issuances and settlements, net		—				(1		)		(42		)		1
	Ending balance as of December 31		$	47			$	19			$	41			$	21
Defined benefit plans disclosures	The Company uses a December 31 measurement date for its defined benefit and other retiree benefit plans. Summarized information for the Company’s defined benefit and other retiree benefit plans are as follows:
			Pension Plans																Other Retiree Benefit Plans
			2014				2013				2014				2013				2014			2013
			United States								International
	Change in Benefit Obligations
	Benefit obligations at beginning of year		$	2,102			$	2,227			$	894			$	888			$	792		$	875
	Service cost		1				24				17				19				10			11
	Interest cost		102				90				35				34				42			38
	Participants’ contributions		—				1				4				3				—			—
	Acquisitions/plan amendments		—				40				—				2				—			—
	Actuarial loss (gain)		362				(148		)		123				(1		)		203			(101		)
	Foreign exchange impact		—				—				(88		)		12				(3		)	(5		)
	Termination benefits (1)		5				11				—				—				—			6
	Curtailments and settlements		—				(12		)		(28		)		(21		)		—			—
	Benefit payments		(154		)		(131		)		(40		)		(41		)		(33		)	(32		)
	Other		(12		)		—				(1		)		(1		)		—			—
	Benefit obligations at end of year		$	2,406			$	2,102			$	916			$	894			$	1,011		$	792
	Change in Plan Assets
	Fair value of plan assets at beginning of year		$	1,736			$	1,597			$	558			$	486			$	41		$	37
	Actual return on plan assets		178				148				65				59				4			4
	Company contributions		23				121				36				61				29			32
	Participants’ contributions		—				1				4				3				—			—
	Foreign exchange impact		—				—				(43		)		2				—			—
	Settlements		—				—				(27		)		(11		)		—			—
	Benefit payments		(154		)		(131		)		(40		)		(41		)		(33		)	(32		)
	Other		(12		)		—				(1		)		(1		)		—			—
	Fair value of plan assets at end of year		$	1,771			$	1,736			$	552			$	558			$	41		$	41
	Funded Status
	Benefit obligations at end of year		$	2,406			$	2,102			$	916			$	894			$	1,011		$	792
	Fair value of plan assets at end of year		1,771				1,736				552				558				41			41
	Net amount recognized		$	(635	)		$	(366	)		$	(364	)		$	(336	)		$	(970	)	$	(751	)
	Amounts Recognized in Balance Sheet
	Noncurrent assets		$	—			$	16			$	6			$	12			$	—		$	—
	Current liabilities		(20		)		(19		)		(28		)		(36		)		(41		)	(39		)
	Noncurrent liabilities		(615		)		(363		)		(342		)		(312		)		(929		)	(712		)
	Net amount recognized		$	(635	)		$	(366	)		$	(364	)		$	(336	)		$	(970	)	$	(751	)
	Amounts Recognized in Accumulated Other Comprehensive Income (Loss)
	Actuarial loss		$	933			$	674			$	259			$	181			$	481		$	296
	Transition/prior service cost		2				3				19				23				(3		)	1
			$	935			$	677			$	278			$	204			$	478		$	297
	Accumulated benefit obligation		$	2,283			$	1,995			$	817			$	802			$	—		$	—
			Pension Plans												Other Retiree Benefit Plans
			2014			2013			2014			2013			2014			2013
			United States						International
	Weighted-Average Assumptions Used to Determine Benefit Obligations
	Discount rate		4.24	%		4.96	%		3.06	%		3.99	%		4.36	%		5.24	%
	Long-term rate of return on plan assets		6.8	%		6.8	%		5.05	%		5.5	%		6.8	%		6.8	%
	Long-term rate of compensation increase		3.5	%		3.5	%		2.83	%		3.02	%		—	%		—	%
	ESOP growth rate		—	%		—	%		—	%		—	%		10	%		10	%
	Medical cost trend rate of increase		—	%		—	%		—	%		—	%		7	%		7	%
	_________
	(1)	Represents pension and other retiree benefit enhancements incurred in 2014 and 2013 pursuant to the 2012 Restructuring Program.
Schedule of Effect of One-Percentage-Point Change in Assumed Health Care Cost Trend Rates	A 1% change in the assumed medical cost trend rate would have the following approximate effect:
			One percentage point
			Increase				Decrease
	Accumulated postretirement benefit obligation		$	150			$	(119	)
	Total of service and interest cost components		11				(9		)
Schedule of Accumulated Benefit Obligations in Excess of Fair Value of Plan Assets	Plans with projected benefit obligations in excess of plan assets and plans with accumulated benefit obligations in excess of plan assets as of December 31 consist of the following:
			Years Ended December 31,
			2014				2013
	Benefit Obligation Exceeds Fair Value of Plan Assets
	Projected benefit obligation		$	2,958			$	1,130
	Fair value of plan assets		1,955				402
	Accumulated benefit obligation		2,725				700
	Fair value of plan assets		1,922				66
Schedule of Net Benefit Costs	Summarized information regarding the net periodic benefit costs for the Company’s defined benefit and other retiree benefit plans is as follows:
			Pension Plans																						Other Retiree Benefit Plans
			2014				2013				2012				2014				2013			2012			2014			2013			2012
			United States												International
	Components of Net Periodic Benefit Cost
	Service cost		$	1			$	24			$	24			$	17			$	19		$	12		$	11		$	13		$	11
	Interest cost		102				90				97				35				34			35			42			38			40
	Annual ESOP allocation		—				—				—				—				—			—			(1		)	(2		)	(2		)
	Expected return on plan assets		(112		)		(118		)		(112		)		(29		)		(26		)	(26		)	(3		)	(3		)	(3		)
	Amortization of transition & prior service costs (credits)		1				9				9				4				2			2			3			1			3
	Amortization of actuarial loss		37				68				62				6				10			9			16			21			18
	Net periodic benefit cost		$	29			$	73			$	80			$	33			$	39		$	32		$	68		$	68		$	67
	Other postretirement charges		5				102				—				(8		)		3			9			—			6			1
	Total pension cost		$	34			$	175			$	80			$	25			$	42		$	41		$	68		$	74		$	68
	Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost
	Discount rate		4.96		%		4.14		%		4.9		%		3.99		%		3.57		%	4.59		%	5.24		%	4.32		%	5.26		%
	Long-term rate of return on plan assets		6.8		%		7.3		%		7.75		%		5.5		%		5.39		%	5.91		%	6.8		%	7.3		%	7.75		%
	Long-term rate of compensation increase		3.5		%		3.5		%		4		%		3.02		%		2.8		%	2.87		%	—		%	—		%	—		%
	ESOP growth rate		—		%		—		%		—		%		—		%		—		%	—		%	10		%	10		%	10		%
	Medical cost trend rate of increase		—		%		—		%		—		%		—		%		—		%	—		%	7		%	7.5		%	8		%
Schedule of Amounts in Accumulated Other Comprehensive Income (Loss) to be Recognized over Next Fiscal Year	The estimated actuarial loss and the estimated transition/prior service cost for defined benefit and other retiree benefit plans that will be amortized from Accumulated other comprehensive income (loss) into net periodic benefit cost over the next fiscal year is as follows:
			Pension Plans				Other Retiree Benefit Plans
	Net actuarial loss		$	48			$	27
	Net transition & prior service cost		11				3
Schedule of Expected Benefit Payments	Total benefit payments expected to be paid to participants from plan assets, or directly from the Company’s assets to participants in unfunded plans, are as follows:
			Pension Plans
	Years Ended December 31,		United States				International				Other Retiree Benefit Plans				Total
	2015		$	139			$	63			$	42			$	244
	2016		139				45				43				227
	2017		139				55				44				238
	2018		139				54				45				238
	2019		140				64				46				250
	2020-2024		721				646				247				1,614

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Components of income before income taxes	The components of income before income taxes are as follows for the three years ended December 31:
			2014				2013				2012
	United States		$	1,094			$	1,018			$	1,155
	International		2,439				2,547				2,719
	Total Income before income taxes		$	3,533			$	3,565			$	3,874
Provision for Income Taxes	The provision for income taxes consists of the following for the three years ended December 31:
			2014				2013				2012
	United States		$	348			$	314			$	395
	International		846				841				848
	Total Provision for income taxes		$	1,194			$	1,155			$	1,243
Schedule of Components of Income Tax Expense (Benefit)	Temporary differences between accounting for financial statement purposes and accounting for tax purposes result in the current provision for taxes being higher (lower) than the total provision for income taxes as follows:
			2014				2013				2012
	Goodwill and intangible assets		$	(40	)		$	(14	)		$	(7	)
	Property, plant and equipment		(13		)		—				(13		)
	Pension and other retiree benefits		19				85				(14		)
	Stock-based compensation		11				10				5
	Tax loss and tax credit carryforwards		5				(30		)		(39		)
	Other, net		(19		)		(33		)		32
	Total deferred tax provision		$	(37	)		$	18			$	(36	)
Effective tax rate reconciliation	The difference between the statutory U.S. federal income tax rate and the Company’s global effective tax rate as reflected in the Consolidated Statements of Income is as follows:
	Percentage of Income before income taxes		2014			2013			2012
	Tax at United States statutory rate		35	%		35	%		35	%
	State income taxes, net of federal benefit		0.7			0.4			0.7
	Earnings taxed at other than United States statutory rate		(2.3	)		(1.4	)		(2.6	)
	Charge for a foreign tax matter (1)		1.9			—			—
	Other, net		(1.5	)		(1.6	)		(1.0	)
	Effective tax rate		33.8	%		32.4	%		32.1	%
	_________
	(1)	The charge for a foreign tax matter relates to a notice of an adverse decision in a foreign court regarding a tax position taken in prior years received by the Company in the second quarter of 2014.
Components of deferred tax assets (liabilities)	The components of deferred tax assets (liabilities) are as follows at December 31:
			2014				2013
	Deferred tax liabilities:
	Goodwill and intangible assets		$	(497	)		$	(475	)
	Property, plant and equipment		(380		)		(375		)
	Other		(266		)		(237		)
			(1,143		)		(1,087		)
	Deferred tax assets:
	Pension and other retiree benefits		638				448
	Tax loss and tax credit carryforwards		33				28
	Accrued liabilities		276				317
	Stock-based compensation		119				116
	Other		148				95
			1,214				1,004
	Net deferred income taxes		$	71			$	(83	)
			2014				2013
	Deferred taxes included within:
	Assets:
	Other current assets		$	256			$	284
	Deferred income taxes		76				77
	Liabilities:
	Deferred income taxes		(261		)		(444		)
	Net deferred income taxes		$	71			$	(83	)
Unrecognized tax benefits activity	Unrecognized tax benefits activity for the years ended December 31, 2014, 2013 and 2012 is summarized below:
			2014				2013				2012
	Unrecognized tax benefits:
	Balance, January 1		$	199			$	212			$	176
	Increases as a result of tax positions taken during the current year		23				23				34
	Decreases of tax positions taken during prior years		(11		)		(52		)		(6		)
	Increases of tax positions taken during prior years		32				37				10
	Decreases as a result of settlements with taxing authorities and the expiration of statutes of limitations		(10		)		(22		)		(3		)
	Effect of foreign currency rate movements		(15		)		1				1
	Balance, December 31		$	218			$	199			$	212

Earnings_Per_Share_Tables

Earnings Per Share (Tables)	12 Months Ended
	Dec. 31, 2014
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted
		For the Year Ended 2014					For the Year Ended 2013					For the Year Ended 2012
		Net income attributable to Colgate-Palmolive Company		Shares	Per		Net income attributable to Colgate-Palmolive Company		Shares	Per		Net income attributable to Colgate-Palmolive Company		Shares	Per
				(millions)	Share				(millions)	Share				(millions)	Share
	Basic EPS	2,180		915.1	$	2.38	2,241		930.8	$	2.41	2,472		952.1	$	2.6
	Stock options and restricted stock units			9.2					9.1					8.1
	Diluted EPS	$	2,180	924.3	$	2.36	$	2,241	939.9	$	2.38	$	2,472	960.2	$	2.57

Segment_Information_Tables

Segment Information (Tables)	12 Months Ended
	Dec. 31, 2014
Segment Reporting [Abstract]
Schedule of Segment Reporting Information, by Segment
			2014			2013			2012
	Net sales
	Oral, Personal and Home Care
	North America(1)		$	3,124		$	3,072		$	2,971
	Latin America		4,769			5,012			5,032
	Europe/South Pacific		3,406			3,396			3,417
	Asia		2,515			2,472			2,264
	Africa/Eurasia		1,208			1,257			1,241
	Total Oral, Personal and Home Care		15,022			15,209			14,925
	Pet Nutrition(2)		2,255			2,211			2,160
	Total Net sales		$	17,277		$	17,420		$	17,085
	_________
	(1)	Net sales in the U.S. for Oral, Personal and Home Care were $2,835, $2,771 and $2,669 in 2014, 2013 and 2012, respectively.
	(2)	Net sales in the U.S. for Pet Nutrition were $1,149, $1,116 and $1,052 in 2014, 2013 and 2012, respectively.
			2014			2013			2012
	Operating profit
	Oral, Personal and Home Care
	North America		$	926		$	927		$	810
	Latin America		1,279			1,385			1,454
	Europe/South Pacific		877			805			747
	Asia		736			698			619
	Africa/Eurasia		235			268			267
	Total Oral, Personal and Home Care		4,053			4,083			3,897
	Pet Nutrition		592			563			589
	Corporate		(1,088		)	(1,090		)	(597		)
	Total Operating profit		$	3,557		$	3,556		$	3,889
			2014			2013			2012
	Capital expenditures
	Oral, Personal and Home Care
	North America		$	136		$	54		$	43
	Latin America		205			235			237
	Europe/South Pacific		78			74			71
	Asia		147			123			88
	Africa/Eurasia		14			11			16
	Total Oral, Personal and Home Care		580			497			455
	Pet Nutrition		40			45			37
	Corporate		137			128			73
	Total Capital expenditures		$	757		$	670		$	565
			2014			2013			2012
	Depreciation and amortization
	Oral, Personal and Home Care
	North America		$	43		$	51		$	50
	Latin America		93			93			91
	Europe/South Pacific		84			85			85
	Asia		78			72			70
	Africa/Eurasia		10			11			11
	Total Oral, Personal and Home Care		308			312			307
	Pet Nutrition		52			51			50
	Corporate		82			76			68
	Total Depreciation and amortization		$	442		$	439		$	425
			2014			2013			2012
	Identifiable assets
	Oral, Personal and Home Care
	North America		$	2,326		$	2,301		$	2,157
	Latin America		3,693			4,202			4,288
	Europe/South Pacific		3,836			3,978			3,649
	Asia		1,903			1,794			1,608
	Africa/Eurasia		510			557			561
	Total Oral, Personal and Home Care		12,268			12,832			12,263
	Pet Nutrition		1,051			1,087			1,045
	Corporate(3)		140			66			86
	Total Identifiable assets(4)		$	13,459		$	13,985		$	13,394
	____________
(3)	In 2014, Corporate identifiable assets primarily consist of derivative instruments (62%) and investments in equity securities (22%).  In 2013, Corporate identifiable assets primarily consist of derivative instruments (32%) and investments in equity securities (41%).  In 2012, Corporate identifiable assets primarily consist of derivative instruments (67%) and investments in equity securities (28%).
(4)	Long-lived assets in the U.S., primarily property, plant and equipment and goodwill and other intangibles represented approximately one-third of total long-lived assets of $8,086, $8,248 and $8,066 in 2014, 2013 and 2012, respectively.

Supplemental_Income_Statement_1

Supplemental Income Statement Information (Tables)	12 Months Ended
	Dec. 31, 2014
Supplemental Income Statement Elements [Abstract]
Other (income) expense, net
	Other (income) expense, net	2014			2013			2012
	Amortization of intangible assets	$	32		$	32		$	31
	2012 Restructuring Program	195			202			81
	Venezuela remeasurement charges	327			172			—
	Charges for European competition law matters	41			23			—
	Costs related to the sale of land in Mexico	—			3			—
	Business realignment and other cost-saving initiatives	—			—			2
	Equity (income)	(7		)	(5		)	(7		)
	Other, net	(18		)	(5		)	6
	Total Other (income) expense, net	$	570		$	422		$	113
Interest expense, net
	Interest (income) expense, net	2014			2013			2012
	Interest incurred	$	134		$	119		$	81
	Interest capitalized	(4		)	(3		)	(1		)
	Interest income	(106		)	(125		)	(65		)
	Total Interest (income) expense, net	$	24		$	(9	)	$	15
Research and development and Advertising
		2014			2013			2012
	Research and development	$	277		$	267		$	259
	Advertising	$	1,784		$	1,891		$	1,792

Supplemental_Balance_Sheet_Inf1

Supplemental Balance Sheet Information (Tables)	12 Months Ended
	Dec. 31, 2014
Balance Sheet Related Disclosures [Abstract]
Schedule of Inventory, Current	Inventories by major class are as follows:
	Inventories	2014			2013
	Raw materials and supplies	$	349		$	340
	Work-in-process	55			60
	Finished goods	978			1,025
	Total Inventories	$	1,382		$	1,425
Property, Plant and Equipment
	Property, plant and equipment, net	2014			2013
	Land	$	250		$	254
	Buildings	1,660			1,625
	Manufacturing machinery and equipment	5,220			5,220
	Other equipment	1,255			1,231
		8,385			8,330
	Accumulated depreciation	(4,305		)	(4,247		)
	Total Property, plant and equipment, net	$	4,080		$	4,083
Other accruals
	Other accruals	2014			2013
	Accrued advertising and coupon redemption	$	550		$	676
	Accrued payroll and employee benefits	332			361
	Accrued taxes other than income taxes	122			131
	Restructuring accrual	114			142
	Pension and other retiree benefits	89			94
	Accrued interest	28			27
	Derivatives	5			11
	Other	677			647
	Total Other accruals	$	1,917		$	2,089
Other liabilities
	Other liabilities	2014			2013
	Pension and other retiree benefits	$	1,886		$	1,387
	Restructuring accrual	78			16
	Other	259			274
	Total Other liabilities	$	2,223		$	1,677

Supplemental_Comprehensive_Inc1

Supplemental Comprehensive Income (Loss) Information (Tables)	12 Months Ended
	Dec. 31, 2014
Other Comprehensive Income (Loss), Net of Tax [Abstract]
Schedule of Comprehensive Income (Loss)	Other Comprehensive Income (Loss) components attributable to Colgate-Palmolive Company before tax and net of tax during the years ended December 31 were as follows:
			2014						2013						2012
			Pre-tax			Net of Tax			Pre-tax			Net of Tax			Pre-tax			Net of Tax
	Cumulative translation adjustments		$	(663	)	$	(681	)	$	(188	)	$	(163	)	$	18		$	(20	)
	Pension and other benefits:
	Net actuarial gain (loss) and prior		(580		)	(374		)	295			189			(317		)	(207		)
	service costs arising during the
	period
	Amortization of net actuarial loss,		67			45			111			70			101			62
	transition and prior service costs(1)
	Curtailment loss - unamortized		—			—			91			59			—			—
	prior service costs(1)
	Retirement Plan and other retiree benefit		(513		)	(329		)	497			318			(216		)	(145		)
	adjustments
	Available-for-sale securities:
	Unrealized gains (losses) on available-		(341		)	(222		)	(113		)	(73		)	28			18
	for-sale securities(2)
	Reclassification of (gains) losses		267			174			133			86			—			—
	into net earnings on available-
	for-sale securities(3)
	Gains (losses) on available-for-sale		(74		)	(48		)	20			13			28			18
	securities
	Cash flow hedges:
	Unrealized gains (losses) on cash flow		9			6			20			13			13			8
	hedges
	Reclassification of (gains) losses		(5		)	(4		)	(17		)	(11		)	(11		)	(7		)
	into net earnings on cash flow
	hedges(4)
	Gains (losses) on cash flow hedges		4			2			3			2			2			1
	Total Other comprehensive income (loss)		$	(1,246	)	$	(1,056	)	$	332		$	170		$	(168	)	$	(146	)
	_________
	(1)	These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 10, Retirement Plans and Other Retiree Benefits for additional details.
	(2)	For the year ended December 31, 2014, these amounts included pretax net losses of $324 related to the remeasurement of the bolivar denominated fixed interest rate bonds and the devaluation-protected bonds in Venezuela.
	For the year ended December 31, 2013, these amounts included pretax losses of $133 related only to the remeasurement of the bolivar denominated fixed interest rate bonds in Venezuela as a result of the devaluation in the first quarter of 2013. No remeasurement charge was required on the devaluation-protected bonds in the first quarter of 2013 since the official exchange rate changed from 4.30 to 6.30 bolivares per dollar and the devaluation-protected bonds revalued to the official exchange rate. See Note 7, Fair Value Measurements and Financial Instruments for additional details.
	(3)	Represents reclassification of losses on the Venezuela bonds into Other (income) expense, net due to an impairment in the fair value of the bonds as a result of the effective devaluations in the first and third quarters of 2014 and the devaluation in 2013. See Note 7, Fair Value Measurements and Financial Instruments for additional details.
	(4)	These (gains) losses are reclassified into Cost of sales. See Note 7, Fair Value Measurements and Financial Instruments for additional details.

Quarterly_Financial_Data_Unaud1

Quarterly Financial Data (Unaudited) (Tables)	12 Months Ended
	Dec. 31, 2014
Quarterly Financial Data [Abstract]
Schedule of Quarterly Financial Information	Quarterly Financial Data (Unaudited)
		Total			First			Second			Third			Fourth
					Quarter			Quarter			Quarter			Quarter
	2014
	Net sales	$	17,277		$	4,325		$	4,352		$	4,379		$	4,221
	Gross profit	10,109		(1)	2,524		(3)	2,552		(5)	2,558		(7)	2,475		(9)
	Net income including noncontrolling interests	2,339		(2)	432		(4)	661		(6)	580		(8)	666		(10)
	Net income attributable to Colgate-Palmolive Company	2,180		(2)	388		(4)	622		(6)	542		(8)	628		(10)
	Earnings per common share:
	Basic	2.38		(2)	0.42		(4)	0.68		(6)	0.59		(8)	0.69		(10)
	Diluted	2.36		(2)	0.42		(4)	0.67		(6)	0.59		(8)	0.68		(10)
	2013
	Net sales	$	17,420		$	4,315		$	4,346		$	4,398		$	4,361
	Gross profit	10,201		(11)	2,515		(13)	2,534		(15)	2,585		(17)	2,567		(19)
	Net income including noncontrolling interests	2,410		(12)	506		(14)	604		(16)	699		(18)	601		(20)
	Net income attributable to Colgate-Palmolive Company	2,241		(12)	460		(14)	561		(16)	656		(18)	564		(20)
	Earnings per common share:
	Basic	2.41		(12)	0.49		(14)	0.6		(16)	0.71		(18)	0.61		(20)
	Diluted	2.38		(12)	0.48		(14)	0.6		(16)	0.7		(18)	0.6		(20)
	____________
	Note:	Basic and diluted earnings per share are computed independently for each quarter and the year-to-date period presented. Accordingly, the sum of the quarterly earnings per common share may not necessarily equal the earnings per share for the year-to-date period.
	(1)	Gross profit for the full year of 2014 includes $29 of charges related to the 2012 Restructuring Program and $4 of costs related to the sale of land in Mexico.
	(2)	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the full year of 2014 include $208 of aftertax charges related to the 2012 Restructuring Program, $214 of aftertax charges related to the 2014 Venezuela Remeasurements, $41 of charges for European competition law matters, $3 of aftertax costs related to the sale of land in Mexico and a $66 charge for a foreign tax matter.
	(3)	Gross profit for the first quarter of 2014 includes $10 of charges related to the 2012 Restructuring Program and $1 of costs related to the sale of land in Mexico.
	(4)	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the first quarter of 2014 include $73 of aftertax charges related to the 2012 Restructuring Program, a $174 aftertax charge related to the 2014 Venezuela Remeasurements and $1 of aftertax costs related to the sale of land in Mexico.
	(5)	Gross profit for the second quarter of 2014 includes $6 of charges related to the 2012 Restructuring Program and $2 of costs related to the sale of land in Mexico.
	(6)	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the second quarter of 2014 include $53 of aftertax charges related to the 2012 Restructuring Program and $1 of aftertax costs related to the sale of land in Mexico.
	(7)	Gross profit for the third quarter of 2014 includes $7 of charges related to the 2012 Restructuring Program and $1 of costs related to the sale of land in Mexico.
	(8)	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the third quarter of 2014 include $41 of aftertax charges related to the 2012 Restructuring Program, a $40 aftertax charge related to the 2014 Venezuela Remeasurements, an $11 charge for a European competition law matter, $1 of aftertax costs related to the sale of land in Mexico and a $66 charge for a foreign tax matter.
	(9)	Gross profit for the fourth quarter of 2014 includes $6 of charges related to the 2012 Restructuring Program.
	(10)	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the fourth quarter of 2014 include $41 of aftertax charges related to the 2012 Restructuring Program and a $30 charge for a European competition law matter.
	(11)	Gross profit for the full year of 2013 includes $32 of charges related to the 2012 Restructuring Program and $15 of costs related to the sale of land in Mexico.
	(12)	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the full year of 2013 include $278 of aftertax charges related to the 2012 Restructuring Program, a $111 aftertax charge related to the 2013 Venezuela Remeasurement, a $23 charge for a European competition law matter and $12 of aftertax costs related to the sale of land in Mexico.
	(13)	Gross profit for the first quarter of 2013 includes $8 of charges related to the 2012 Restructuring Program and $4 of costs related to the sale of land in Mexico.
	(14)	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the first quarter of 2013 include $52 of aftertax charges related to the 2012 Restructuring Program, a $111 aftertax charge related to the 2013 Venezuela Remeasurement and $3 of aftertax costs related to the sale of land in Mexico.
	(15)	Gross profit for the second quarter of 2013 includes $10 of charges related to the 2012 Restructuring Program and $4 of costs related to the sale of land in Mexico.
	(16)	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the second quarter of 2013 include $79 of aftertax charges related to the 2012 Restructuring Program, an $18 charge for a European competition law matter and $4 of aftertax costs related to the sale of land in Mexico.
	(17)	Gross profit for the third quarter of 2013 includes $8 of charges related to the 2012 Restructuring Program and $3 of costs related to the sale of land in Mexico.
	(18)	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the third quarter of 2013 include $22 of aftertax charges related to the 2012 Restructuring Program and $2 of aftertax costs related to the sale of land in Mexico.
	(19)	Gross profit for the fourth quarter of 2013 includes $6 of charges related to the 2012 Restructuring Program and $4 of costs related to the sale of land in Mexico.
	(20)	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the fourth quarter of 2013 include $125 of aftertax charges related to the 2012 Restructuring Program, a $5 charge for a European competition law matter and $3 of aftertax costs related to the sale of land in Mexico.

Nature_of_Operations_Details

Nature of Operations (Details)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
	business_segment
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of product segments	2
Entity-Wide Information, Revenue from External Customer [Line Items]
Percentage of worldwide sales	100.00%	100.00%	100.00%
Oral Care [Member]
Entity-Wide Information, Revenue from External Customer [Line Items]
Percentage of worldwide sales	46.00%	46.00%	44.00%
Personal Care [Member]
Entity-Wide Information, Revenue from External Customer [Line Items]
Percentage of worldwide sales	21.00%	21.00%	22.00%
Home Care [Member]
Entity-Wide Information, Revenue from External Customer [Line Items]
Percentage of worldwide sales	20.00%	20.00%	21.00%
Pet Nutrition [Member]
Entity-Wide Information, Revenue from External Customer [Line Items]
Percentage of worldwide sales	13.00%	13.00%	13.00%

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Principles of Consolidation [Abstract]
Investments accounted for using the equity method, minimum interest	20.00%
Investments accounted for using the equity method, maximum interest	50.00%
Equity method investments included in Other assets	$31	$27
Investments accounted for using the cost method, maximum interest	20.00%
Shipping and Handling Costs [Abstract]
Shipping and handling costs classified as Selling, general and administrative expenses	$1,326	$1,304	$1,262
Inventories [Abstract]
Approximate percentage of inventories determined using the first-in, first-out (FIFO) method	80.00%
Minimum [Member] | Machinery and equipment [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life	3 years
Maximum [Member] | Machinery and equipment [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life	15 years
Maximum [Member] | Buildings [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life	40 years

Summary_of_Significant_Account3

Summary of Significant Accounting Policies (Details 1) (Trademarks, local brands, and non-compete agreements [Member])	12 Months Ended
	Dec. 31, 2014
Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated useful life of finite-lived intangible assets	5 years
Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated useful life of finite-lived intangible assets	40 years

Acquisitions_and_Divestitures_

Acquisitions and Divestitures (Details) (USD $)

3 Months Ended

12 Months Ended

0 Months Ended

In Millions, unless otherwise specified

Sep. 30, 2014

Jun. 30, 2014

Mar. 31, 2014

Dec. 31, 2013

Sep. 30, 2013

Jun. 30, 2013

Mar. 31, 2013

Sep. 30, 2012

Sep. 30, 2011

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Oct. 03, 2014

MEXICO

Sale of Land in Mexico [Abstract]

First Installment received from the sale of land in Mexico

$24

Second Installment received from the sale of land in Mexico

36

Pretax costs related to sale of land in Mexico

4

18

24

Aftertax costs related to sale of land

1

1

1

3

2

4

3

3

12

18

Oral Care Member | MYANMAR

Business Acquisition [Line Items]

Cash consideration for acquisition of business

$62

Restructuring_and_Related_Impl2

Restructuring and Related Implementation Charges (Details) (Two Thousand Twelve Restructuring Program [Member], USD $)	3 Months Ended	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2012	Dec. 31, 2014
Restructuring Cost and Reserve [Line Items]
Duration Of Restructuring Program	4 years
Expected Percent of Total Charges Resulting In Cash Expenditure		75.00%
One-time Termination Benefits [Member]
Restructuring Cost and Reserve [Line Items]
Estimated Percent Of Total Cumulative Pretax Charges Of Implementing Restructuring Program By Category		50.00%
Incremental Depreciation And Asset Impairment [Member]
Restructuring Cost and Reserve [Line Items]
Estimated Percent Of Total Cumulative Pretax Charges Of Implementing Restructuring Program By Category		10.00%
Charges Resulting Directly From Exit Activities [Member]
Restructuring Cost and Reserve [Line Items]
Estimated Percent Of Total Cumulative Pretax Charges Of Implementing Restructuring Program By Category		20.00%
Implementation Of New Strategies [Member]
Restructuring Cost and Reserve [Line Items]
Estimated Percent Of Total Cumulative Pretax Charges Of Implementing Restructuring Program By Category		20.00%
Pet Nutrition [Member]
Restructuring Cost and Reserve [Line Items]
Expected Percent Of Total Restructuring Charges Related To Segment For The Duration Of The Program		10.00%
Corporate, Non-Segment [Member]
Restructuring Cost and Reserve [Line Items]
Expected Percent Of Total Restructuring Charges Related To Segment For The Duration Of The Program		40.00%
North America [Member]
Restructuring Cost and Reserve [Line Items]
Expected Percent Of Total Restructuring Charges Related To Segment For The Duration Of The Program		15.00%
Europe/South Pacific
Restructuring Cost and Reserve [Line Items]
Expected Percent Of Total Restructuring Charges Related To Segment For The Duration Of The Program		20.00%
Latin America [Member]
Restructuring Cost and Reserve [Line Items]
Expected Percent Of Total Restructuring Charges Related To Segment For The Duration Of The Program		5.00%
Asia [Member]
Restructuring Cost and Reserve [Line Items]
Expected Percent Of Total Restructuring Charges Related To Segment For The Duration Of The Program		5.00%
Africa/Eurasia [Member]
Restructuring Cost and Reserve [Line Items]
Expected Percent Of Total Restructuring Charges Related To Segment For The Duration Of The Program		5.00%
Expected Completion Date 2016 [Member] | Minimum [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Program Expected Cost Before Tax		$1,285
Restructuring Program Total Expected Cost After Tax		950
Restructuring and Related Cost, Positions Eliminated [Abstract]
Restructuring and Related Cost, Expected Number of Positions Eliminated		2,000
Expected Completion Date 2016 [Member] | Maximum [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Program Expected Cost Before Tax		1,435
Restructuring Program Total Expected Cost After Tax		1,050
Restructuring and Related Cost, Positions Eliminated [Abstract]
Restructuring and Related Cost, Expected Number of Positions Eliminated		2,500
Expected Completion Date 2015 [Member] | Minimum [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Program Expected Cost, Upcoming Fiscal Year, Before Tax		330
Restructuring Program Expected Cost, Upcoming Fiscal Year, After Tax		245
Expected Completion Date 2015 [Member] | Maximum [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Program Expected Cost, Upcoming Fiscal Year, Before Tax		385
Restructuring Program Expected Cost, Upcoming Fiscal Year, After Tax		$285

Restructuring_and_Related_Impl3

Restructuring and Related Implementation Charges (Details 1) (Two Thousand Twelve Restructuring Program [Member], USD $)	3 Months Ended								12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Restructuring Cost and Reserve [Line Items]
Pretax charges related to the 2012 Restructuring Program									$286	$371	$89
Aftertax charges related to the 2012 Restructuring Program	41	41	53	73	125	22	79	52	208	278	70
Cost of Sales [Member]
Restructuring Cost and Reserve [Line Items]
Pretax charges related to the 2012 Restructuring Program	6	7	6	10	6	8	10	8	29	32	2
Selling, General and Administrative Expenses [Member]
Restructuring Cost and Reserve [Line Items]
Pretax charges related to the 2012 Restructuring Program									62	137	6
Other (Income) Expense, Net [Member]
Restructuring Cost and Reserve [Line Items]
Pretax charges related to the 2012 Restructuring Program									$195	$202	$81

Restructuring_and_Related_Impl4

Restructuring and Related Implementation Charges (Details 2) (Two Thousand Twelve Restructuring Program [Member])	12 Months Ended			27 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2014
Pet Nutrition [Member]
Restructuring Cost and Reserve [Line Items]
Percent of Restructuring Charges Related to Segment for Period	10.00%	8.00%	3.00%
Percent Of Restructuring Charges Reportable Segment Program Charges Incurred To Date				8.00%
Corporate, Non-Segment [Member]
Restructuring Cost and Reserve [Line Items]
Percent of Restructuring Charges Related to Segment for Period	49.00%	42.00%	38.00%
Percent Of Restructuring Charges Reportable Segment Program Charges Incurred To Date				44.00%
North America [Member]
Restructuring Cost and Reserve [Line Items]
Percent of Restructuring Charges Related to Segment for Period	11.00%	11.00%	2.00%
Percent Of Restructuring Charges Reportable Segment Program Charges Incurred To Date				10.00%
Latin America [Member]
Restructuring Cost and Reserve [Line Items]
Percent of Restructuring Charges Related to Segment for Period	4.00%	4.00%	0.00%
Percent Of Restructuring Charges Reportable Segment Program Charges Incurred To Date				4.00%
Europe South Pacific [Member]
Restructuring Cost and Reserve [Line Items]
Percent of Restructuring Charges Related to Segment for Period	20.00%	28.00%	55.00%
Percent Of Restructuring Charges Reportable Segment Program Charges Incurred To Date				28.00%
Asia [Member]
Restructuring Cost and Reserve [Line Items]
Percent of Restructuring Charges Related to Segment for Period	3.00%	0.00%	0.00%
Percent Of Restructuring Charges Reportable Segment Program Charges Incurred To Date				1.00%
Africa/Eurasia [Member]
Restructuring Cost and Reserve [Line Items]
Percent of Restructuring Charges Related to Segment for Period	3.00%	7.00%	2.00%
Percent Of Restructuring Charges Reportable Segment Program Charges Incurred To Date				5.00%

Restructuring_and_Related_Impl5

Restructuring and Related Implementation Charges (Details 3) (Two Thousand Twelve Restructuring Program [Member], USD $)	Dec. 31, 2014
In Millions, unless otherwise specified
Restructuring Cost and Reserve [Line Items]
Pretax Charges Related to the Restructuring Program to Date	$746
After Tax Charges Related to the Restructuring Program to Date	556
One-time Termination Benefits [Member]
Restructuring Cost and Reserve [Line Items]
Pretax Charges Related to the Restructuring Program to Date	295
Incremental Depreciation [Member]
Restructuring Cost and Reserve [Line Items]
Pretax Charges Related to the Restructuring Program to Date	51
Asset Impairment [Member]
Restructuring Cost and Reserve [Line Items]
Pretax Charges Related to the Restructuring Program to Date	2
Other Restructuring [Member]
Restructuring Cost and Reserve [Line Items]
Pretax Charges Related to the Restructuring Program to Date	$398

Restructuring_and_Related_Impl6

Restructuring and Related Implementation Charges (Details 4) (Two Thousand Twelve Restructuring Program [Member], USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Restructuring Reserve [Roll Forward]
Beginning Balance	$158	$89	$0
Charges	286	371	89
Cash Payments	-212	-169	-5
Charges against assets	-31	-44	0
Foreign exchange	-9	2	5
Other	0	-91
Ending Balance	192	158	89
One-time Termination Benefits [Member]
Restructuring Reserve [Roll Forward]
Beginning Balance	116	84	0
Charges	73	144	78
Cash Payments	-95	-97	-1
Charges against assets	-5	-17	0
Foreign exchange	-4	2	7
Other	0	0
Ending Balance	85	116	84
Incremental Depreciation [Member]
Restructuring Reserve [Roll Forward]
Beginning Balance	0	0	0
Charges	25	26	0
Cash Payments	0	0	0
Charges against assets	-25	-26	0
Foreign exchange	0	0	0
Other	0	0
Ending Balance	0	0	0
Asset Impairment [Member]
Restructuring Reserve [Roll Forward]
Beginning Balance	0	0	0
Charges	1	1	0
Cash Payments	0	0	0
Charges against assets	-1	-1	0
Foreign exchange	0	0	0
Other	0	0
Ending Balance	0	0	0
Other Restructuring [Member]
Restructuring Reserve [Roll Forward]
Beginning Balance	42	5	0
Charges	187	200	11
Cash Payments	-117	-72	-4
Charges against assets	0	0	0
Foreign exchange	-5	0	-2
Other	0	-91
Ending Balance	107	42	5
Third party Incremental Cost [Member]
Restructuring Reserve [Roll Forward]
Charges	65	50	8
Contract Termination [Member]
Restructuring Reserve [Roll Forward]
Charges	40	34	3
Land and Building [Member]
Restructuring Reserve [Roll Forward]
Charges	$82	$25

Goodwill_and_Other_Intangible_2

Goodwill and Other Intangible Assets (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Millions, unless otherwise specified
Goodwill [Line Items]
Goodwill	$2,307	$2,474
Oral, Personal and Home Care [Member]
Goodwill [Line Items]
Goodwill	2,292	2,459
Pet Nutrition [Member]
Goodwill [Line Items]
Goodwill	15	15
North America | Oral, Personal and Home Care [Member]
Goodwill [Line Items]
Goodwill	352	362
Latin America | Oral, Personal and Home Care [Member]
Goodwill [Line Items]
Goodwill	320	353
Europe/South Pacific | Oral, Personal and Home Care [Member]
Goodwill [Line Items]
Goodwill	1,374	1,525
Asia | Oral, Personal and Home Care [Member]
Goodwill [Line Items]
Goodwill	160	126
Africa/Eurasia | Oral, Personal and Home Care [Member]
Goodwill [Line Items]
Goodwill	$86	$93

Goodwill_and_Other_Intangible_3

Goodwill and Other Intangible Assets (Details 1) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Finite and indefinite-lived intangible assets [Line Items]
Finite & Indefinite Life Intangibles, Gross	$1,752	$1,816
Finite-Lived Intangible Assets, Accumulated Amortization	-339	-320
Intangible Assets, Net (Excluding Goodwill)	1,413	1,496
Amortization of Intangible Assets	32	32	31
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Future amortization expense - 2015	30
Future amortization expense - 2016	30
Future amortization expense - 2017	30
Future amortization expense - 2018	30
Future amortization expense - 2019	30
Trademarks
Finite and indefinite-lived intangible assets [Line Items]
Finite-Lived Intangible Assets, Gross	552	551
Finite-Lived Intangible Assets, Accumulated Amortization	-285	-275
Finite-Lived Intangible Assets, Net	267	276
Other finite life intangible assets
Finite and indefinite-lived intangible assets [Line Items]
Finite-Lived Intangible Assets, Gross	213	219
Finite-Lived Intangible Assets, Accumulated Amortization	-54	-45
Finite-Lived Intangible Assets, Net	159	174
Indefinite life intangible assets
Finite and indefinite-lived intangible assets [Line Items]
Indefinite-Lived Intangible Assets (Excluding Goodwill)	987	1,046
Finite-Lived Intangible Assets, Accumulated Amortization	$0	$0

LongTerm_Debt_and_Credit_Facil2

Long-Term Debt and Credit Facilities (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Debt Instrument [Line Items]
Total Debt	$6,132	$5,644
Less: Current portion of long-term debt	-488	-895
Total Debt, Excluding Current Maturities	5,644	4,749
Short-term Bank Loans and Notes Payable	16	13
Weighted-average interest rate on short term borrowings	1.90%	2.20%
Scheduled maturities of long-term debt [Abstract]
2015	488
2016	263
2017	660
2018	697
2019	498
Thereafter	3,271
Notes
Debt Instrument [Line Items]
Weighted average interest rate	1.90%
Maturity date range, start	31-Dec-15
Maturity date range, end	31-Dec-78
Total Debt	5,877	5,644
Commercial paper
Debt Instrument [Line Items]
Weighted average interest rate	0.00%
Maturity date	2015
Total Debt	$255	$0

LongTerm_Debt_and_Credit_Facil3

Long-Term Debt and Credit Facilities (Details 1)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2014	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013
	Notes	Notes	Notes	Forty Year Notes at Variable Rate [Member]	Forty Year Notes at Variable Rate [Member]	Five Year Notes at 1 Point 75 Percent [Member]	Ten Year Note at 3 point 25 Percent [Member]	Five Year Notes at 1 Point 5 Percent [Member]	Five Year Notes at Point 9 Percent [Member]	Ten Year Notes at 2 Point 1 Percent [Member]
	USD ($)	EUR (€)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Schedule of U.S. dollar-denominated notes [Line Items]
Face amount				$134	$82	$500	$500	$300	$400	$400
Debt Instrument, Term				40 years	40 years	5 years	10 years	5 years	5 years	10 years
Fixed Interest rate						1.75%	3.25%	1.50%	0.90%	2.10%
Retirement of Notes - Portion Due in Current Year	$250	€ 250	$250

LongTerm_Debt_and_Credit_Facil4

Long-Term Debt and Credit Facilities (Details 2) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Line of credit facility [Line Items]
Unused borrowing capacity	$3,001
Amended Domestic Revolving Credit Facility 2370 Million Capacity [Member]
Line of credit facility [Line Items]
Maximum borrowing capacity	2,370
Line of Credit Facility, Expiration Date	30-Nov-19
Debt Instrument, Term	5 years
Domestic Revolving Credit Facility 165 Million Capacity [Member]
Line of credit facility [Line Items]
Maximum borrowing capacity	165
Line of Credit Facility, Expiration Date	30-Nov-15
Domestic Revolving Credit Facility 20 Million Capacity [Member]
Line of credit facility [Line Items]
Maximum borrowing capacity	20
Line of Credit Facility, Expiration Date	31-Dec-15
Domestic Revolving Credit Facility 1850 Million Capacity [Member]
Line of credit facility [Line Items]
Maximum borrowing capacity		$1,850
Line of Credit Facility, Expiration Date		30-Nov-18
Debt Instrument, Term		5 years

Fair_Value_Measurements_and_Fi2

Fair Value Measurements and Financial Instruments (Details)	12 Months Ended
	Dec. 31, 2014
	country_and_territory
Financial Instruments and Fair Value Measurements [Abstract]
Minimum Number Of Countries And Territories Serving Consumers	200

Fair_Value_Measurements_and_Fi3

Fair Value Measurements and Financial Instruments (Details 1) (USD $)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Designated Derivative Instruments [Abstract]
Derivative Assets	$94	$35
Derivative Liabilities	7	19
Derivative Instruments Not Designated as Hedging Instruments [Abstract]
Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value	8	0
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value	0	3
Total asset derivatives	102	35
Total liability derivatives	7	22
Financial Instruments, Owned, at Fair Value [Abstract]
Total other financial instruments	564	858
Fair Value, Inputs, Level 2 [Member] | Bonds Issued By Venezuelan Government [Member]
Financial Instruments, Owned, at Fair Value [Abstract]
Available-for-sale Securities, Fair Value Disclosure	399	685	642
Other Current Assets [Member]
Financial Instruments, Owned, at Fair Value [Abstract]
Marketable Securities	200	173
Notes Receivable, Fair Value Disclosure	42	0
Other Current Assets [Member] | Fair Value, Inputs, Level 2 [Member] | Bonds Issued By Venezuelan Government [Member]
Financial Instruments, Owned, at Fair Value [Abstract]
Available-for-sale Securities, Fair Value Disclosure	77
Interest Rate Swap Contracts [Member] | Other Current Assets [Member]
Designated Derivative Instruments [Abstract]
Derivative Assets	1	1
Interest Rate Swap Contracts [Member] | Other Accruals [Member]
Designated Derivative Instruments [Abstract]
Derivative Liabilities	0	0
Interest Rate Swap Contracts [Member] | Other Assets [Member]
Designated Derivative Instruments [Abstract]
Derivative Assets	12	20
Interest Rate Swap Contracts [Member] | Other Liabilities [Member]
Designated Derivative Instruments [Abstract]
Derivative Liabilities	2	1
Foreign Currency Contracts [Member] | Other Current Assets [Member]
Designated Derivative Instruments [Abstract]
Derivative Assets	21	14
Derivative Instruments Not Designated as Hedging Instruments [Abstract]
Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value	0	0
Foreign Currency Contracts [Member] | Other Accruals [Member]
Designated Derivative Instruments [Abstract]
Derivative Liabilities	4	8
Derivative Instruments Not Designated as Hedging Instruments [Abstract]
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value	0	3
Foreign Currency Contracts [Member] | Other Assets [Member]
Designated Derivative Instruments [Abstract]
Derivative Assets	60	0
Derivative Instruments Not Designated as Hedging Instruments [Abstract]
Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value	8	0
Foreign Currency Contracts [Member] | Other Liabilities [Member]
Designated Derivative Instruments [Abstract]
Derivative Liabilities	0	10
Derivative Instruments Not Designated as Hedging Instruments [Abstract]
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value	0	0
Commodity Contracts [Member] | Other Current Assets [Member]
Designated Derivative Instruments [Abstract]
Derivative Assets	0	0
Commodity Contracts [Member] | Other Accruals [Member]
Designated Derivative Instruments [Abstract]
Derivative Liabilities	1	0
Estimate of Fair Value Measurement [Member] | Other Assets [Member] | Fair Value, Inputs, Level 2 [Member] | Bonds Issued By Venezuelan Government [Member]
Financial Instruments, Owned, at Fair Value [Abstract]
Available-for-sale Securities, Fair Value Disclosure	$322	$685

Fair_Value_Measurements_and_Fi4

Fair Value Measurements and Financial Instruments (Details 2) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Millions, unless otherwise specified
Debt Instrument [Line Items]
Carrying value of long-term debt	$6,132	$5,644
Carrying Value [Member]
Debt Instrument [Line Items]
Carrying value of long-term debt	6,132	5,644
Fair Value, Inputs, Level 2 [Member]
Debt Instrument [Line Items]
Estimated fair value of long term-debt	$6,346	$5,690

Fair_Value_Measurements_and_Fi5

Fair Value Measurements and Financial Instruments (Details 3) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Not Designated as Hedging Instrument [Member] | Cross-Currency Swap (Member)
Derivative Instruments, Gain (Loss) [Line Items]
Notional Value of Derivative	$102	$96
Activity related to derivatives not designated as hedging instruments [Abstract]
Gain (loss) on instrument	5	-2
Gain (loss) on hedged item	-5	2
Fair Value Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Notional Value of Derivative	2,601	2,508
Activity related to fair value hedges [Abstract]
Gain (loss) on derivative	-5	2
Gain (loss) on hedged items	5	-2
Fair Value Hedging [Member] | Foreign Currency Contracts [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Notional Value of Derivative	1,163	1,320
Activity related to fair value hedges [Abstract]
Gain (loss) on derivative	3	24
Gain (loss) on hedged items	-3	-24
Fair Value Hedging [Member] | Interest Rate Swap Contracts [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Notional Value of Derivative	1,438	1,188
Activity related to fair value hedges [Abstract]
Gain (loss) on derivative	-8	-22
Gain (loss) on hedged items	8	22
Cash Flow Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Notional Value of Derivative	525	400
Activity related to cash flow hedges [Abstract]
Gain (loss) recognized in OCI	9	20
Cash Flow Hedging [Member] | Foreign Currency Contracts [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Notional Value of Derivative	511	386
Activity related to cash flow hedges [Abstract]
Gain (loss) recognized in OCI	9	20
Cash Flow Hedging [Member] | Commodity Contracts [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Notional Value of Derivative	14	14
Activity related to cash flow hedges [Abstract]
Gain (loss) recognized in OCI	0	0
Net Investment Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Notional Value of Derivative	864	785
Activity related to net investment hedges [Abstract]
Gain (loss) on instruments	84	-28
Gain (loss) on hedged items	-84	27
Net Investment Hedging [Member] | Foreign Currency Contracts [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Notional Value of Derivative	567	529
Activity related to net investment hedges [Abstract]
Gain (loss) on instruments	73	-24
Gain (loss) on hedged items	-73	23
Net Investment Hedging [Member] | Foreign Currency Denominated Debt [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Notional Value of Derivative	297	256
Activity related to net investment hedges [Abstract]
Gain (loss) on instruments	11	-4
Gain (loss) on hedged items	-11	4
Reclassification out of Accumulated Other Comprehensive Income [Member] | Cash Flow Hedging [Member]
Activity related to cash flow hedges [Abstract]
Gain (loss) reclassified into Cost of sales	5	17
Reclassification out of Accumulated Other Comprehensive Income [Member] | Cash Flow Hedging [Member] | Foreign Currency Contracts [Member]
Activity related to cash flow hedges [Abstract]
Gain (loss) reclassified into Cost of sales	5	16
Reclassification out of Accumulated Other Comprehensive Income [Member] | Cash Flow Hedging [Member] | Commodity Contracts [Member]
Activity related to cash flow hedges [Abstract]
Gain (loss) reclassified into Cost of sales	$0	$1

Fair_Value_Measurements_and_Fi6

Fair Value Measurements and Financial Instruments (Details 4)

12 Months Ended

In Millions, unless otherwise specified

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2014

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2014

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2014

Dec. 31, 2012

USD ($)

USD ($)

Other Current Assets [Member]

Other Current Assets [Member]

Fair Value, Inputs, Level 1 [Member]

Fair Value, Inputs, Level 2 [Member]

Fair Value, Inputs, Level 2 [Member]

Fair Value, Inputs, Level 2 [Member]

Fair Value, Inputs, Level 2 [Member]

Fair Value, Inputs, Level 2 [Member]

Fair Value, Inputs, Level 2 [Member]

VENEZUELA

VENEZUELA

USD ($)

USD ($)

Other Current Assets [Member]

Bonds Issued By Venezuelan Government [Member]

Bonds Issued By Venezuelan Government [Member]

Bonds Issued By Venezuelan Government [Member]

Other Current Assets [Member]

Estimate of Fair Value Measurement [Member]

Estimate of Fair Value Measurement [Member]

VEF

VEF

Deposits [Member]

USD ($)

USD ($)

USD ($)

Bonds Issued By Venezuelan Government [Member]

Other Assets [Member]

Other Assets [Member]

USD ($)

USD ($)

Bonds Issued By Venezuelan Government [Member]

Bonds Issued By Venezuelan Government [Member]

USD ($)

USD ($)

Financial Instruments and Fair Value Measurements [Abstract]

Loss (gain) related to the remeasurement of fixed interest rate and devaluation-protected bonds in Venezuela

$324

Schedule of Available for Sale Securities and Marketable Securities [Line Items]

Marketable Securities

200

173

123

Available-for-sale Securities

399

685

642

77

322

685

Fair Value of U.S. dollar-linked, devaluation-protected bonds

114

Fair Value of fixed interest rate bonds

285

Loss related to the remeasurement of fixed interest rate bonds in Venezuela

$133

Official Exchange Rate

6.3

4.3

Fair_Value_Measurements_and_Fi7

Fair Value Measurements and Financial Instruments (Details 5) (Fair Value, Inputs, Level 2 [Member], Bonds Issued By Venezuelan Government [Member], USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Fair Value, Inputs, Level 2 [Member] | Bonds Issued By Venezuelan Government [Member]
Venezuelan Investments [Roll Forward]
Beginning balance	$685	$642
Unrealized gain (loss) on investment	-341	-113
Purchases and sales during the period	55	156
Ending balance	$399	$685

Capital_Stock_and_StockBased_C2

Capital Stock and Stock-Based Compensation Plans (Details) (USD $)	12 Months Ended
In Millions, except Share data, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Feb. 19, 2015
Preference Stock [Abstract]
Shares authorized (in shares)	50,262,150
Stock Repurchases [Abstract]
Repurchased stock	$1,530	$1,521	$1,943
Increase of Common Stock, Percentage, Stock Splits		100.00%
Stockholders' Equity Note, Stock Split, Conversion Ratio		2
Summary of common stock activity [Roll Forward]
Common Stock Balance, January 1 (in shares)	919,946,575	935,728,676	960,036,150
Common stock acquired (in shares)	-23,131,081	-25,573,317	-38,730,602
Shares issued for stock options (in shares)	7,977,124	7,883,834	12,217,230
Shares issued for restricted stock and other (in shares)	1,919,527	1,907,382	2,205,898
Common Stock Balance, December 31 (in shares)	906,712,145	919,946,575	935,728,676
Summary Of Treasury Stock Activity [Roll Forward]
Treasury Stock Balance, January 1 (in shares)	545,759,785	529,977,684	505,670,210
Common stock acquired (in shares)	23,131,081	25,573,317	38,730,602
Shares issued for stock options (in shares)	-7,977,124	-7,883,834	-12,217,230
Shares issued for restricted stock and other (in shares)	-1,919,527	-1,907,382	-2,205,898
Treasury Stock Balance, December 31 (in shares)	558,994,215	545,759,785	529,977,684
Stock-based compensation [Abstract]
Allocated Share-based Compensation Expense	131	128	120
Total income tax benefit	42	39	37
Fair Value Assumptions [Abstract]
Weighted-average estimated fair value of stock options granted (in dollars per share)	$7.60	$7.41	$6.73
Expected term (in years)	4 years 6 months	4 years 6 months	4 years 6 months
Expected Volatility Rate (in hundredths)	17.10%	18.40%	20.80%
Risk-Free Rate (in hundredths)	1.60%	1.50%	0.60%
Expected Dividend Yield (in hundredths)	2.30%	2.30%	2.40%
Summary of restricted stock award activity [Roll Forward]
Restricted stock awards - beginning balance (in shares)	4,539,000
Granted (in shares)	1,092,000
Vested (in shares)	-1,867,000
Forfeited (in shares)	-70,000
Restricted stock awards - ending balance (in shares)	3,694,000	4,539,000
Weighted average grant date fair value per award [Roll Forward]
Weighted average grant date fair value of restricted stock awards - beginning of period (in dollars per share)	$48
Weighted average grant date fair value of restricted stock awards - shares granted (in dollars per share)	$64
Weighted average grant date fair value of restricted stock awards - shares vested (in dollars per share)	$42
Weighted average grant date fair value of restricted stock awards - shares forfeited (in dollars per share)	$52
Weighted average grant date fair value of restricted stock awards - end of period (in dollars per share)	$56	$48
Summary of stock option plan activity [Roll Forward]
Options - beginning balance (in shares)	42,832,000
Granted (in shares)	9,036,000
Shares issued for stock options (in shares)	-8,526,000
Forfeited or expired (in shares)	-440,000
Options - ending balance (in shares)	42,902,000	42,832,000
Options exercisable (in shares)	24,946,000
Additional disclosures pertaining to stock options [Abstract]
Weighted average exercise price of options - beginning of period (in dollars per share)	$47
Weighted average exercise price of options - shares granted (in dollars per share)	$64
Weighted average exercise price of options - shares exercised (in dollars per share)	$41
Weighted average exercise price of options - shares forfeited or expired (in dollars per share)	$57
Weighted average exercise price of options - end of period (in dollars per share)	$52	$47
Weighted average exercise price of options exercisable - end of period (in dollars per share)	$46
Weighted average remaining contractual life, options outstanding (in years)	4 years
Weighted average remaining contractual life, options exercisable (in years)	3 years
Value of unexercised in-the-money options, options outstanding	746
Value of unexercised in-the-money options, options exercisable	582
Stock-based compensation, additional disclosures [Abstract]
Employee Service Share-based Compensation, Tax Benefit Realized from Exercise of Stock Options	63	51	60
Proceeds from Stock Options Exercised	314	289	409
Program 2011 [Member]
Stock Repurchases [Abstract]
Treasury stock repurchase authorization (in shares)	50,000,000
Incentive Stock Plans [Member]
Additional disclosures pertaining to restricted stock awards [Abstract]
Number of shares available for grant (in shares)	12,414,000
Unrecognized compensation expense	63
Unrecognized compensation expense, weighted-average period of recognition in years	2 years 1 month 6 days
Total fair value of shares vested	71	69	63
Stock Option Plans [Member]
Additional disclosures pertaining to restricted stock awards [Abstract]
Number of shares available for grant (in shares)	46,062,000
Unrecognized compensation expense	46
Unrecognized compensation expense, weighted-average period of recognition in years	1 year 6 months
Stock-based compensation, additional disclosures [Abstract]
Contractual term (in years)	6 years
Vesting period (in years)	3 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Total Intrinsic Value	211	180	210
Program 2015 [Member] | Subsequent Event [Member]
Stock-based compensation, additional disclosures [Abstract]
Stock Repurchase Program, Authorized Amount				$5,000

Employee_Stock_Ownership_Plan_

Employee Stock Ownership Plan (Details) (USD $)	12 Months Ended
In Millions, except Share data, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 29, 2010	Dec. 31, 1989
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Long-term notes issued by ESOP					$410
Average interest rate on ESOP notes					8.70%
Preference stock purchased from the proceeds of the notes (in shares)					6,315,149
Common stock converted (in shares)				38,483,072
Employee Stock Ownership Plan (ESOP), Shares in ESOP	26,137,798	29,119,135
Outstanding Borrowings from the Company	20
Common shares released and allocated to participant accounts (in shares)	18,489,250
Common shares available for future allocation to participant accounts (in shares)	7,648,548
Annual ESOP expense	2	0	0
Dividends paid by the Company on shares held by the ESOP	40	41	40
Company contributions to the ESOP	$2	$0	$0

Retirement_Plans_and_Other_Ret2

Retirement Plans and Other Retiree Benefits (Details) (USD $)	12 Months Ended
In Millions, except Share data, unless otherwise specified	Dec. 31, 2014		Dec. 31, 2013		Dec. 31, 2012
Defined Benefit Plan Disclosure [Line Items]
Percentage Of Fixed Income Portfolio Invested In Us Treasury Or Agency Securities	50.00%		50.00%
Two Thousand Twelve Restructuring Program [Member]
Defined Benefit Plan Disclosure [Line Items]
Restructuring Reserve, Charges Against Assets	$31		$44		$0
Defined Benefit Plan, Curtailments	0		-91
Other Restructuring [Member] | Two Thousand Twelve Restructuring Program [Member]
Defined Benefit Plan Disclosure [Line Items]
Restructuring Reserve, Charges Against Assets	0		0		0
Defined Benefit Plan, Curtailments	0		-91
One-time Termination Benefits [Member] | Two Thousand Twelve Restructuring Program [Member]
Defined Benefit Plan Disclosure [Line Items]
Restructuring Reserve, Charges Against Assets	5		17		0
Defined Benefit Plan, Curtailments	0		0
United States Pension Plan of US Entity [Member]
Defined Benefit Plan, Assets, Target Allocations [Abstract]
Target asset allocation	100.00%
Allocation of plan assets and level of valuation input for each major asset category [Abstract]
Total investments at fair value	1,771		1,736		1,597
Dividends received by plans on the Company's common stock	2		3
Defined Benefit Plan Percentage Of Equity Securities Invested In Employer Securities	7.00%		6.00%
Defined Benefit Plan, Plan Assets, Common Shares Sold	0		1,540,215
United States Pension Plan of US Entity [Member] | Equity securities
Defined Benefit Plan, Assets, Target Allocations [Abstract]
Target asset allocation	27.00%
United States Pension Plan of US Entity [Member] | Cash & cash equivalents | Level 1 [Member]
Allocation of plan assets and level of valuation input for each major asset category [Abstract]
Total investments at fair value	48		97
United States Pension Plan of US Entity [Member] | U.S. common stocks | Level 1 [Member]
Allocation of plan assets and level of valuation input for each major asset category [Abstract]
Total investments at fair value	130		127
United States Pension Plan of US Entity [Member] | International common stocks | Level 1 [Member]
Allocation of plan assets and level of valuation input for each major asset category [Abstract]
Total investments at fair value	0		51
United States Pension Plan of US Entity [Member] | Fixed income securities
Defined Benefit Plan, Assets, Target Allocations [Abstract]
Target asset allocation	53.00%
United States Pension Plan of US Entity [Member] | Fixed income securities | Level 2 [Member]
Allocation of plan assets and level of valuation input for each major asset category [Abstract]
Total investments at fair value	625	[1]	433	[1]
United States Pension Plan of US Entity [Member] | Developed market equity index funds | Level 2 [Member]
Allocation of plan assets and level of valuation input for each major asset category [Abstract]
Total investments at fair value	352	[2]	359	[2]
United States Pension Plan of US Entity [Member] | Emerging market equity index funds | Level 2 [Member]
Allocation of plan assets and level of valuation input for each major asset category [Abstract]
Total investments at fair value	32	[2]	33	[2]
United States Pension Plan of US Entity [Member] | Other common stock funds | Level 2 [Member]
Allocation of plan assets and level of valuation input for each major asset category [Abstract]
Total investments at fair value	118	[2]	123	[2]
United States Pension Plan of US Entity [Member] | Fixed income funds: U.S. or foreign government and agency securities | Level 2 [Member]
Allocation of plan assets and level of valuation input for each major asset category [Abstract]
Total investments at fair value	115	[2]	149	[2]
United States Pension Plan of US Entity [Member] | Fixed income funds: investment grade corporate bonds | Level 2 [Member]
Allocation of plan assets and level of valuation input for each major asset category [Abstract]
Total investments at fair value	168	[2]	203	[2]
United States Pension Plan of US Entity [Member] | Fixed income funds: high yield corporate bonds and other | Level 2 [Member]
Allocation of plan assets and level of valuation input for each major asset category [Abstract]
Total investments at fair value	136	[2]	119	[2]
United States Pension Plan of US Entity [Member] | Guaranteed investment contracts | Level 2 [Member]
Allocation of plan assets and level of valuation input for each major asset category [Abstract]
Total investments at fair value	1	[3]	2	[3]
United States Pension Plan of US Entity [Member] | Real Estate [Member] | Level 3 [Member]
Allocation of plan assets and level of valuation input for each major asset category [Abstract]
Total investments at fair value	46	[4]	40	[4]
United States Pension Plan of US Entity [Member] | Real estate and other investments
Defined Benefit Plan, Assets, Target Allocations [Abstract]
Target asset allocation	20.00%
International Pension Benefits [Member]
Defined Benefit Plan, Assets, Target Allocations [Abstract]
Target asset allocation	100.00%
Allocation of plan assets and level of valuation input for each major asset category [Abstract]
Total investments at fair value	552		558		486
International Pension Benefits [Member] | Equity securities
Defined Benefit Plan, Assets, Target Allocations [Abstract]
Target asset allocation	39.00%
International Pension Benefits [Member] | Cash & cash equivalents | Level 1 [Member]
Allocation of plan assets and level of valuation input for each major asset category [Abstract]
Total investments at fair value	10		23
International Pension Benefits [Member] | U.S. common stocks | Level 1 [Member]
Allocation of plan assets and level of valuation input for each major asset category [Abstract]
Total investments at fair value	3		0
International Pension Benefits [Member] | International common stocks | Level 1 [Member]
Allocation of plan assets and level of valuation input for each major asset category [Abstract]
Total investments at fair value	2		0
International Pension Benefits [Member] | Fixed income securities
Defined Benefit Plan, Assets, Target Allocations [Abstract]
Target asset allocation	47.00%
International Pension Benefits [Member] | Fixed income securities | Level 2 [Member]
Allocation of plan assets and level of valuation input for each major asset category [Abstract]
Total investments at fair value	0	[1]	0	[1]
International Pension Benefits [Member] | Developed market equity index funds | Level 2 [Member]
Allocation of plan assets and level of valuation input for each major asset category [Abstract]
Total investments at fair value	193	[2]	229	[2]
International Pension Benefits [Member] | Emerging market equity index funds | Level 2 [Member]
Allocation of plan assets and level of valuation input for each major asset category [Abstract]
Total investments at fair value	8	[2]	9	[2]
International Pension Benefits [Member] | Other common stock funds | Level 2 [Member]
Allocation of plan assets and level of valuation input for each major asset category [Abstract]
Total investments at fair value	27	[2]	41	[2]
International Pension Benefits [Member] | Fixed income funds: U.S. or foreign government and agency securities | Level 2 [Member]
Allocation of plan assets and level of valuation input for each major asset category [Abstract]
Total investments at fair value	107	[2]	73	[2]
International Pension Benefits [Member] | Fixed income funds: investment grade corporate bonds | Level 2 [Member]
Allocation of plan assets and level of valuation input for each major asset category [Abstract]
Total investments at fair value	75	[2]	71	[2]
International Pension Benefits [Member] | Fixed income funds: high yield corporate bonds and other | Level 2 [Member]
Allocation of plan assets and level of valuation input for each major asset category [Abstract]
Total investments at fair value	54	[2]	35	[2]
International Pension Benefits [Member] | Guaranteed investment contracts | Level 2 [Member]
Allocation of plan assets and level of valuation input for each major asset category [Abstract]
Total investments at fair value	54	[3]	56	[3]
International Pension Benefits [Member] | Real Estate [Member] | Level 3 [Member]
Allocation of plan assets and level of valuation input for each major asset category [Abstract]
Total investments at fair value	19	[4]	21	[4]	20
Defined Benefit Plan, Actual Return on Plan Assets Sold During Period	0		0
Defined Benefit Plan, Actual Return on Plan Assets Still Held	-1		0
Defined Benefit Plan, Purchases, Sales, and Settlements	-1		1
International Pension Benefits [Member] | Real estate and other investments
Defined Benefit Plan, Assets, Target Allocations [Abstract]
Target asset allocation	14.00%
Other Retiree Benefits [Member]
Allocation of plan assets and level of valuation input for each major asset category [Abstract]
Total investments at fair value	41		41		37
Other Retiree Benefits [Member] | Cash & cash equivalents | Level 1 [Member]
Allocation of plan assets and level of valuation input for each major asset category [Abstract]
Total investments at fair value	1		3
Other Retiree Benefits [Member] | U.S. common stocks | Level 1 [Member]
Allocation of plan assets and level of valuation input for each major asset category [Abstract]
Total investments at fair value	3		3
Other Retiree Benefits [Member] | International common stocks | Level 1 [Member]
Allocation of plan assets and level of valuation input for each major asset category [Abstract]
Total investments at fair value	0		1
Other Retiree Benefits [Member] | Fixed income securities | Level 2 [Member]
Allocation of plan assets and level of valuation input for each major asset category [Abstract]
Total investments at fair value	13	[1]	8	[1]
Other Retiree Benefits [Member] | Developed market equity index funds | Level 2 [Member]
Allocation of plan assets and level of valuation input for each major asset category [Abstract]
Total investments at fair value	9	[2]	9	[2]
Other Retiree Benefits [Member] | Emerging market equity index funds | Level 2 [Member]
Allocation of plan assets and level of valuation input for each major asset category [Abstract]
Total investments at fair value	1	[2]	1	[2]
Other Retiree Benefits [Member] | Other common stock funds | Level 2 [Member]
Allocation of plan assets and level of valuation input for each major asset category [Abstract]
Total investments at fair value	3	[2]	3	[2]
Other Retiree Benefits [Member] | Fixed income funds: U.S. or foreign government and agency securities | Level 2 [Member]
Allocation of plan assets and level of valuation input for each major asset category [Abstract]
Total investments at fair value	3	[2]	3	[2]
Other Retiree Benefits [Member] | Fixed income funds: investment grade corporate bonds | Level 2 [Member]
Allocation of plan assets and level of valuation input for each major asset category [Abstract]
Total investments at fair value	4	[2]	5	[2]
Other Retiree Benefits [Member] | Fixed income funds: high yield corporate bonds and other | Level 2 [Member]
Allocation of plan assets and level of valuation input for each major asset category [Abstract]
Total investments at fair value	3	[2]	4	[2]
Other Retiree Benefits [Member] | Guaranteed investment contracts | Level 2 [Member]
Allocation of plan assets and level of valuation input for each major asset category [Abstract]
Total investments at fair value	0	[3]	0	[3]
Other Retiree Benefits [Member] | Real Estate [Member] | Level 3 [Member]
Allocation of plan assets and level of valuation input for each major asset category [Abstract]
Total investments at fair value	$1	[4]	$1	[4]
[1]	The fixed income securities are traded over the counter and certain of these securities lack daily pricing or liquidity and as such are classified as Level 2. As of December 31, 2014 and 2013, approximately 50% of the fixed income portfolio was invested in U.S. treasury or agency securities, with the remainder invested in other government bonds and corporate bonds.
[2]	Interests in common/collective trust funds are valued using the net asset value (“NAV”) per unit in each fund. The NAV is based on the value of the underlying investments owned by each trust, minus its liabilities, divided by the number of shares outstanding.
[3]	The guaranteed investment contracts (“GICs”) represent contracts with insurance companies measured at the cash surrender value of each contract. The Level 2 valuation reflects that the cash surrender value is based principally on a referenced pool of investment funds with active redemption.
[4]	Real estate is valued using the NAV per unit of funds that are invested in real estate property. The investment value of the real estate property is determined quarterly using independent market appraisals as determined by the investment manager. Since the appraisals include unobservable inputs, these investments are classified as Level 3. These unobservable inputs may include items such as annual gross rents, projected vacancy rates, collection losses and recovery rates, yield rates, growth assumptions and risk adjusted discount rates.

Retirement_Plans_and_Other_Ret3

Retirement Plans and Other Retiree Benefits Additional Disclosures (Details) (USD $)	12 Months Ended
In Millions, except Share data, unless otherwise specified	Dec. 31, 2014		Dec. 31, 2013		Dec. 31, 2012
Amounts Recognized in Balance Sheet
Current liabilities	($89)		($94)
Estimated amounts that will be amortized from accumulated other comprehensive income [Abstract]
Expected Benefit Payments From Company Assets	69
Total benefit payments [Abstract]
2015	244
2016	227
2017	238
2018	238
2019	250
2020-2024	1,614
United States Pension Plans of Us Entity And Other Post Retirement Plans [Member] | Real Estate [Member] | Level 3 [Member]
Change in Plan Assets
Fair value of plan assets at beginning of year	41		72
Earned income, net of management expenses	2		2
Unrealized gain on investment	4		9
Purchases, sales, issuances and settlements, net	0		-42
Fair value of plan assets at end of year	47		41
Funded Status
Fair value of plan assets at end of year	47		41
United States
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Benefit Obligation, Percentage Increase Due To Expected Mortality Update In The Current Year	6.00%
Defined Benefit Plan Percentage Of Equity Securities Invested In Employer Securities	7.00%		6.00%
Defined Benefit Plan, Plan Assets Sold	0		1,540,215
Change in Benefit Obligations
Benefit obligations at beginning of year	2,102		2,227
Service Cost	1		24
Interest cost	102		90		97
Participants' contributions	0		1
Acquisitions/plan amendments	0		40
Actuarial loss (gain)	362		-148
Foreign exchange impact	0		0
Termination benefits	5	[1]	11	[1]
Curtailments and settlements	0		-12
Benefit payments	-154		-131
Other	-12		0
Benefit obligations at end of year	2,406		2,102		2,227
Change in Plan Assets
Fair value of plan assets at beginning of year	1,736		1,597
Actual return on plan assets	178		148
Company's benefit plan contributions	23		121
Participants' contributions	0		1
Foreign exchange impact	0		0
Settlements	0		0
Benefit payments	-154		-131
Other	-12		0
Fair value of plan assets at end of year	1,771		1,736		1,597
Funded Status
Benefit obligations at end of year	2,406		2,102		2,227
Fair value of plan assets at end of year	1,771		1,736		1,597
Net amount recognized	-635		-366
Amounts Recognized in Balance Sheet
Noncurrent assets	0		16
Current liabilities	-20		-19
Noncurrent liabilities	-615		-363
Net amount recognized	-635		-366
Amounts recognized in Accumulated other comprehensive income consist of
Actuarial loss	933		674
Transition/prior service cost	2		3
Amounts recognized in accumulated other comprehensive income	935		677
Accumulated benefit obligation	2,283		1,995
Weighted-Average Assumptions Used to Determine Benefit Obligations
Discount Rate	4.24%		4.96%
Long-term rate of return on plan assets	6.80%		6.80%
Long-term rate of compensation increase	3.50%		3.50%
ESOP growth rate	0.00%		0.00%
Medical cost trend rate of increase	0.00%		0.00%
Long-term rate of return on plan assets [Abstract]
Average annual rates of return for the most recent 1-year period	11.00%
Average annual rates of return for the most recent 5-year period	10.00%
Average annual rates of return for the most recent 10-year period	7.00%
Average annual rates of return for the most recent 15-year period	5.00%
Average annual rates of return for the most recent 25-year period	8.00%
Components of Net Periodic Benefit Cost
Defined Benefit Plan, Service Cost	1		24		24
Interest cost	102		90		97
Annual ESOP allocation	0		0		0
Expected return on plan assets	-112		-118		-112
Amortization of transition and prior service costs (credits)	1		9		9
Amortization of actuarial loss	37		68		62
Net periodic benefit cost	29		73		80
Other postretirement charges	5		102		0
Total pension cost	34		175		80
Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost
Discount Rate	4.96%		4.14%		4.90%
Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Return on Assets	6.80%		7.30%		7.75%
Long-term rate of compensation increase	3.50%		3.50%		4.00%
ESOP growth rate	0.00%		0.00%		0.00%
Voluntary contributions to postretirement plans	2		101		101
Total benefit payments [Abstract]
2015	139
2016	139
2017	139
2018	139
2019	140
2020-2024	721
Defined Benefit Plan Dividends Received On Employer Securities	2		3
Defined Benefit Plan, Health Care Cost Trend Rate Assumed for Next Fiscal Year	0.00%		0.00%		0.00%
United States | Real Estate [Member] | Level 3 [Member]
Change in Plan Assets
Fair value of plan assets at end of year	46	[2]	40	[2]
Funded Status
Fair value of plan assets at end of year	46	[2]	40	[2]
International Pension Benefits [Member]
Change in Benefit Obligations
Benefit obligations at beginning of year	894		888
Service Cost	17		19
Interest cost	35		34		35
Participants' contributions	4		3
Acquisitions/plan amendments	0		2
Actuarial loss (gain)	123		-1
Foreign exchange impact	-88		12
Termination benefits	0	[1]	0	[1]
Curtailments and settlements	-28		-21
Benefit payments	-40		-41
Other	-1		-1
Benefit obligations at end of year	916		894		888
Change in Plan Assets
Fair value of plan assets at beginning of year	558		486
Actual return on plan assets	65		59
Company's benefit plan contributions	36		61
Participants' contributions	4		3
Foreign exchange impact	-43		2
Settlements	-27		-11
Benefit payments	-40		-41
Other	-1		-1
Fair value of plan assets at end of year	552		558		486
Funded Status
Benefit obligations at end of year	916		894		888
Fair value of plan assets at end of year	552		558		486
Net amount recognized	-364		-336
Amounts Recognized in Balance Sheet
Noncurrent assets	6		12
Current liabilities	-28		-36
Noncurrent liabilities	-342		-312
Net amount recognized	-364		-336
Amounts recognized in Accumulated other comprehensive income consist of
Actuarial loss	259		181
Transition/prior service cost	19		23
Amounts recognized in accumulated other comprehensive income	278		204
Accumulated benefit obligation	817		802
Weighted-Average Assumptions Used to Determine Benefit Obligations
Discount Rate	3.06%		3.99%
Long-term rate of return on plan assets	5.05%		5.50%
Long-term rate of compensation increase	2.83%		3.02%
ESOP growth rate	0.00%		0.00%
Medical cost trend rate of increase	0.00%		0.00%
Components of Net Periodic Benefit Cost
Defined Benefit Plan, Service Cost	17		19		12
Interest cost	35		34		35
Annual ESOP allocation	0		0		0
Expected return on plan assets	-29		-26		-26
Amortization of transition and prior service costs (credits)	4		2		2
Amortization of actuarial loss	6		10		9
Net periodic benefit cost	33		39		32
Other postretirement charges	-8		3		9
Total pension cost	25		42		41
Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost
Discount Rate	3.99%		3.57%		4.59%
Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Return on Assets	5.50%		5.39%		5.91%
Long-term rate of compensation increase	3.02%		2.80%		2.87%
ESOP growth rate	0.00%		0.00%		0.00%
Total benefit payments [Abstract]
2015	63
2016	45
2017	55
2018	54
2019	64
2020-2024	646
Defined Benefit Plan, Health Care Cost Trend Rate Assumed for Next Fiscal Year	0.00%		0.00%		0.00%
International Pension Benefits [Member] | Real Estate [Member] | Level 3 [Member]
Change in Plan Assets
Fair value of plan assets at beginning of year	21	[2]	20
Earned income, net of management expenses	0		0
Unrealized gain on investment	-1		0
Purchases, sales, issuances and settlements, net	-1		1
Fair value of plan assets at end of year	19	[2]	21	[2]
Funded Status
Fair value of plan assets at end of year	19	[2]	21	[2]
Pension Benefits [Member]
Benefit Obligation Exceeds Fair Value of Plan Assets
Projected benefit obligation	2,958		1,130
Fair value of plan assets	1,955		402
Accumulated benefit obligation	2,725		700
Fair value of plan assets	1,922		66
Estimated amounts that will be amortized from accumulated other comprehensive income [Abstract]
Net actuarial loss	48
Net transition & prior service cost	11
Other Retiree Benefits [Member]
Change in Benefit Obligations
Benefit obligations at beginning of year	792		875
Service Cost	10		11
Interest cost	42		38		40
Participants' contributions	0		0
Acquisitions/plan amendments	0		0
Actuarial loss (gain)	203		-101
Foreign exchange impact	-3		-5
Termination benefits	0	[1]	6	[1]
Curtailments and settlements	0		0
Benefit payments	-33		-32
Other	0		0
Benefit obligations at end of year	1,011		792		875
Change in Plan Assets
Fair value of plan assets at beginning of year	41		37
Actual return on plan assets	4		4
Company's benefit plan contributions	29		32
Participants' contributions	0		0
Foreign exchange impact	0		0
Settlements	0		0
Benefit payments	-33		-32
Other	0		0
Fair value of plan assets at end of year	41		41		37
Funded Status
Benefit obligations at end of year	1,011		792		875
Fair value of plan assets at end of year	41		41		37
Net amount recognized	-970		-751
Amounts Recognized in Balance Sheet
Noncurrent assets	0		0
Current liabilities	-41		-39
Noncurrent liabilities	-929		-712
Net amount recognized	-970		-751
Amounts recognized in Accumulated other comprehensive income consist of
Actuarial loss	481		296
Transition/prior service cost	-3		1
Amounts recognized in accumulated other comprehensive income	478		297
Accumulated benefit obligation	0		0
Weighted-Average Assumptions Used to Determine Benefit Obligations
Discount Rate	4.36%		5.24%
Long-term rate of return on plan assets	6.80%		6.80%
Long-term rate of compensation increase	0.00%		0.00%
ESOP growth rate	10.00%		10.00%
Medical cost trend rate of increase	7.00%		7.00%
Assumed medical cost trend rates [Abstract]
Ultimate medical cost trend rate	5.00%
Year which ultimate medical cost trend rate is reached	2021
Effect of a 1% change in the assumed medical cost trend rate [Abstract]
Effect of one percentage point increase on accumulated postretirement benefit obligation	150
Effect of one percentage point decrease on accumulated postretirement benefit obligation	-119
Effect of one percentage point increase on service and interest cost	11
Effect of one percentage point decrease on service and interest cost	-9
Components of Net Periodic Benefit Cost
Defined Benefit Plan, Service Cost	11		13		11
Interest cost	42		38		40
Annual ESOP allocation	-1		-2		-2
Expected return on plan assets	-3		-3		-3
Amortization of transition and prior service costs (credits)	3		1		3
Amortization of actuarial loss	16		21		18
Net periodic benefit cost	68		68		67
Other postretirement charges	0		6		1
Total pension cost	68		74		68
Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost
Discount Rate	5.24%		4.32%		5.26%
Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Return on Assets	6.80%		7.30%		7.75%
Long-term rate of compensation increase	0.00%		0.00%		0.00%
ESOP growth rate	10.00%		10.00%		10.00%
Estimated amounts that will be amortized from accumulated other comprehensive income [Abstract]
Net actuarial loss	27
Net transition & prior service cost	3
Total benefit payments [Abstract]
2015	42
2016	43
2017	44
2018	45
2019	46
2020-2024	247
Other Post-Retirement Plan, Benefit Obligation, Percentage Increase Due To Expected Mortality Update In The Current Year	9.00%
Defined Benefit Plan, Health Care Cost Trend Rate Assumed for Next Fiscal Year	7.00%		7.50%		8.00%
Other Retiree Benefits [Member] | Real Estate [Member] | Level 3 [Member]
Change in Plan Assets
Fair value of plan assets at end of year	1	[2]	1	[2]
Funded Status
Fair value of plan assets at end of year	1	[2]	1	[2]
Two Thousand Twelve Restructuring Program [Member]
Defined Benefit Plan Disclosure [Line Items]
Restructuring Reserve, Charges Against Assets	31		44		0
Two Thousand Twelve Restructuring Program [Member] | Other Restructuring [Member]
Defined Benefit Plan Disclosure [Line Items]
Restructuring Reserve, Charges Against Assets	$0		$0		$0
[1]	Represents pension and other retiree benefit enhancements incurred in 2014 and 2013 pursuant to the 2012 Restructuring Program.
[2]	Real estate is valued using the NAV per unit of funds that are invested in real estate property. The investment value of the real estate property is determined quarterly using independent market appraisals as determined by the investment manager. Since the appraisals include unobservable inputs, these investments are classified as Level 3. These unobservable inputs may include items such as annual gross rents, projected vacancy rates, collection losses and recovery rates, yield rates, growth assumptions and risk adjusted discount rates.

Income_Taxes_Details

Income Taxes (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014		Dec. 31, 2013		Dec. 31, 2012
	country_and_territory
Components of income before income taxes [Abstract]
United States	$1,094		$1,018		$1,155
International	2,439		2,547		2,719
Total Income before income taxes	3,533		3,565		3,874
Provision for income taxes [Abstract]
United States	348		314		395
International	846		841		848
Total Provision for income taxes	1,194		1,155		1,243
Income tax provision reconciliation [Abstract]
Goodwill and intangible assets	-40		-14		-7
Property, plant and equipment	-13		0		-13
Pension and other retiree benefits	19		85		-14
Stock-based compensation	11		10		5
Tax loss and tax credit carryforwards	5		-30		-39
Other, net	-19		-33		32
Total deferred tax provision	-37		18		-36
Effective Tax Rate Reconciliation [Abstract]
Tax at United States statutory rate	35.00%		35.00%		35.00%
State income taxes, net of federal benefit	0.70%		0.40%		0.70%
Earnings taxed at other than United States statutory rate	-2.30%		-1.40%		-2.60%
Charge for a foreign tax matter	1.90%	[1]	0.00%	[1]	0.00%
Other, net	-1.50%		-1.60%		-1.00%
Effective tax rate	33.80%		32.40%		32.10%
Deferred tax liabilities:
Goodwill and intangible assets	-497		-475
Property, plant and equipment	-380		-375
Other	-266		-237
Deferred tax liabilities, total	-1,143		-1,087
Deferred tax assets:
Pension and other retiree benefits	638		448
Tax loss and tax credit carryforwards	33		28
Accrued liabilities	276		317
Stock-based compensation	119		116
Other	148		95
Deferred tax assets, total	1,214		1,004
Net deferred income taxes	71		-83
Deferred taxes included within:
Other current assets	256		284
Deferred tax assets, noncurrent	76		77
Deferred tax liabilities, noncurrent	-261		-444
Net deferred income taxes	71		-83
Undistributed earnings of foreign subsidiaries	4,900
Minimum Number Of Countries And Territories Serving Consumers	200
Income Tax Effects Allocated Directly to Equity	251		116		80
Unrecognized tax benefits:
Balance, January 1	199		212		176
Increases as a result of tax positions taken during the current year	23		23		34
Decreases of tax positions taken during prior years	-11		-52		-6
Increases of tax positions taken during prior years	32		37		10
Decreases as a result of settlements with taxing authorities and the expiration of statutes of limitations	-10		-22		-3
Effect of foreign currency rate movements	-15		1		1
Balance, December 31	218		199		212
Unrecognized tax benefits that would impact effective tax rate	195
Interest (income) expense recognized related to unrecognized tax benefits	4		5		5
Accrued interest related to unrecognized tax benefits	24		24		19
Income Taxes [Line Items]
Accrual for Taxes Other than Income Taxes, Current	$122		$131
Minimum [Member]
Income Taxes [Line Items]
Statue Of Limitations Of Certain Foreign Entities	3 years
Maximum [Member]
Income Taxes [Line Items]
Statue Of Limitations Of Certain Foreign Entities	6 years
[1]	The charge for a foreign tax matter relates to a notice of an adverse decision in a foreign court regarding a tax position taken in prior years received by the Company in the second quarter of 2014.

Earnings_Per_Share_Details

Earnings Per Share (Details) (USD $)

3 Months Ended

12 Months Ended

In Millions, except Share data, unless otherwise specified

Dec. 31, 2014

Sep. 30, 2014

Jun. 30, 2014

Mar. 31, 2014

Dec. 31, 2013

Sep. 30, 2013

Jun. 30, 2013

Mar. 31, 2013

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Income [Abstract]

Basic EPS

$2,180

$2,241

$2,472

Diluted EPS

$2,180

$2,241

$2,472

Shares [Abstract]

Basic EPS (in shares)

915,100,000

930,800,000

952,100,000

Stock options and restricted stock (in shares)

9,200,000

9,100,000

8,100,000

Diluted EPS (in shares)

924,300,000

939,900,000

960,200,000

Earnings Per Share, Basic [Abstract]

Basic EPS (in dollars per share)

$0.69

[1]

$0.59

[2]

$0.68

[3]

$0.42

[4]

$0.61

[5]

$0.71

[6]

$0.60

[7]

$0.49

[8]

$2.38

[9]

$2.41

[10]

$2.60

Earnings Per Share, Diluted [Abstract]

Diluted EPS (in dollars per share)

$0.68

[1]

$0.59

[2]

$0.67

[3]

$0.42

[4]

$0.60

[5]

$0.70

[6]

$0.60

[7]

$0.48

[8]

$2.36

[9]

$2.38

[10]

$2.57

Employee Stock Option [Member]

Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]

Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

1,729,511

1,785,032

3,504,608

Restricted Stock Units (RSUs) [Member]

Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]

Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

2,311

3,709

2,252

[1]

Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the fourth quarter of 2014 include $41 of aftertax charges related to the 2012 Restructuring Program and a $30 charge for a European competition law matter.

[2]

Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the third quarter of 2014 include $41 of aftertax charges related to the 2012 Restructuring Program, a $40 aftertax charge related to the 2014 Venezuela Remeasurements, an $11 charge for a European competition law matter, $1 of aftertax costs related to the sale of land in Mexico and a $66 charge for a foreign tax matter.

[3]

Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the second quarter of 2014 include $53 of aftertax charges related to the 2012 Restructuring Program and $1 of aftertax costs related to the sale of land in Mexico.

[4]

Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the first quarter of 2014 include $73 of aftertax charges related to the 2012 Restructuring Program, a $174 aftertax charge related to the 2014 Venezuela Remeasurements and $1 of aftertax costs related to the sale of land in Mexico.

[5]

Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the fourth quarter of 2013 include $125 of aftertax charges related to the 2012 Restructuring Program, a $5 charge for a European competition law matter and $3 of aftertax costs related to the sale of land in Mexico.

[6]

Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the third quarter of 2013 include $22 of aftertax charges related to the 2012 Restructuring Program and $2 of aftertax costs related to the sale of land in Mexico.

[7]

Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the second quarter of 2013 include $79 of aftertax charges related to the 2012 Restructuring Program, an $18 charge for a European competition law matter and $4 of aftertax costs related to the sale of land in Mexico.

[8]

Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the first quarter of 2013 include $52 of aftertax charges related to the 2012 Restructuring Program, a $111 aftertax charge related to the 2013 Venezuela Remeasurement and $3 of aftertax costs related to the sale of land in Mexico.

[9]

Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the full year of 2014 include $208 of aftertax charges related to the 2012 Restructuring Program, $214 of aftertax charges related to the 2014 Venezuela Remeasurements, $41 of charges for European competition law matters, $3 of aftertax costs related to the sale of land in Mexico and a $66 charge for a foreign tax matter.

[10]

Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the full year of 2013 include $278 of aftertax charges related to the 2012 Restructuring Program, a $111 aftertax charge related to the 2013 Venezuela Remeasurement, a $23 charge for a European competition law matter and $12 of aftertax costs related to the sale of land in Mexico.

Commitments_and_Contingencies_

Commitments and Contingencies (Details) (USD $)	3 Months Ended	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
		country_and_territory
Operating leases,minimum rental commitments[Abstract]
Minimum rental commitments under noncancellable operating leases due within one year of the balance sheet date		$201
Minimum rental commitments under noncancellable operating leases due in two years of the balance sheet date		170
Minimum rental commitments under noncancellable operating leases due in three years of the balance sheet date		148
Minimum rental commitments under noncancellable operating leases due in four years of the balance sheet date		138
Minimum rental commitments under noncancellable operating leases due in five years of the balance sheet date		126
Minimum rental commitments under noncancellable operating leases due after five years of the balance sheet date		280
Operating leases, rental expense [Abstract]
Rental expense		234	232	228
Contractual commitments (Abstract)
Contractual commitments, amount		774
Contingencies [Abstract]
Minimum Number Of Countries And Territories Serving Consumers		200
Loss Contingency, Range of Possible Loss, Minimum		0
Loss Contingency, Range of Possible Loss, Maximum		200
Brazilian internal revenue authority, matter 1		107
Brazilian internal revenue authority, matter 2		66
European competition matters - Swiss competition law authority		6
European competition matters - Spanish competition law authority		3
European competition matters - Italian competition law authority		3
European competition matters - Hill's France Subsidiary		7
Fine Imposed French Competition Authority		57
Fine Imposed French Competition Authority - As a result of Sanex Acquisition		25
ERISA Matter	$40

Venezuela_Details

Venezuela (Details)

12 Months Ended

3 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

In Millions, except Per Share data, unless otherwise specified

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Sep. 30, 2014

Mar. 31, 2014

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2014

Mar. 31, 2013

Dec. 31, 2013

Dec. 31, 2014

Dec. 31, 2012

USD ($)

USD ($)

USD ($)

CP Venezuela [Member]

CP Venezuela [Member]

CP Venezuela [Member]

CP Venezuela [Member]

CP Venezuela [Member]

VENEZUELA

VENEZUELA

VENEZUELA

VENEZUELA

USD ($)

USD ($)

USD ($)

USD ($)

Sales Revenue, Net [Member]

USD ($)

USD ($)

VEF

VEF

Foreign Currency [Line Items]

Official Exchange Rate

6.3

4.3

SICAD Exchange Rate

12

Venezuela remeasurement charges

$327

$172

$0

$327

$172

Venezuela Remeasurement Charges Aftertax

40

174

214

111

111

111

Impact of Aftertax Remeasurement Charge Per Common Share, Diluted

$0.23

$0.12

Percentage Of Consolidated Net sales Represented By CP Venezuela

3.00%

Bolivar Denominated Monetary Net Asset Position

549

Bolivar Denominated Non Monetary Asset Position

310

Bolivar Denominated Non Monetary Fixed Asset Position

235

Total Investment in CP Venezuela Including Intercompany Payables

$955

Segment_Information_Details

Segment Information (Details) (USD $)	3 Months Ended						12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014		Sep. 30, 2014	Dec. 31, 2013		Jun. 30, 2013	Dec. 31, 2014		Dec. 31, 2013		Dec. 31, 2012
							business_segment
Segment Reporting Information [Line Items]
Number of Product Segments							2
Venezuela remeasurement charges							$327		$172		$0
Charges for European Competition Law Matters	30		11	5		18	41		23
Business realignment and other cost-saving initiatives											21
Total Net sales							17,277		17,420		17,085
Total Operating profit							3,557		3,556		3,889
Total Capital expenditures							757		670		565
Total Depreciation and amortization							442		439		425
Total Identifiable assets	13,459	[1]		13,985	[1]		13,459	[1]	13,985	[1]	13,394	[1]
Percentage Of Corporate Identifiable Assets Consisting Of Derivative Instruments	62.00%			32.00%			62.00%		32.00%		67.00%
Percentage Of Corporate Identifiable Assets Consisting Of Investments In Equity Securities	22.00%			41.00%			22.00%		41.00%		28.00%
Total Long Lived Assets	8,086			8,248			8,086		8,248		8,066
MEXICO
Segment Reporting Information [Line Items]
Pretax costs related to sale of land in Mexico							4		18		24
UNITED STATES | Oral, Personal and Home Care [Member]
Segment Reporting Information [Line Items]
Total Net sales							2,835		2,771		2,669
UNITED STATES | Pet Nutrition [Member]
Segment Reporting Information [Line Items]
Total Net sales							1,149		1,116		1,052
CP Venezuela [Member]
Segment Reporting Information [Line Items]
Venezuela remeasurement charges							327		172
Operating Segments [Member] | Oral, Personal and Home Care [Member]
Segment Reporting Information [Line Items]
Total Net sales							15,022		15,209		14,925
Total Operating profit							4,053		4,083		3,897
Total Capital expenditures							580		497		455
Total Depreciation and amortization							308		312		307
Total Identifiable assets	12,268			12,832			12,268		12,832		12,263
Operating Segments [Member] | Pet Nutrition [Member]
Segment Reporting Information [Line Items]
Total Net sales							2,255	[2]	2,211	[2]	2,160	[2]
Total Operating profit							592		563		589
Total Capital expenditures							40		45		37
Total Depreciation and amortization							52		51		50
Total Identifiable assets	1,051			1,087			1,051		1,087		1,045
Operating Segments [Member] | North America [Member] | Oral, Personal and Home Care [Member]
Segment Reporting Information [Line Items]
Total Net sales							3,124	[3]	3,072	[3]	2,971	[3]
Total Operating profit							926		927		810
Total Capital expenditures							136		54		43
Total Depreciation and amortization							43		51		50
Total Identifiable assets	2,326			2,301			2,326		2,301		2,157
Operating Segments [Member] | Latin America [Member] | Oral, Personal and Home Care [Member]
Segment Reporting Information [Line Items]
Total Net sales							4,769		5,012		5,032
Total Operating profit							1,279		1,385		1,454
Total Capital expenditures							205		235		237
Total Depreciation and amortization							93		93		91
Total Identifiable assets	3,693			4,202			3,693		4,202		4,288
Operating Segments [Member] | Europe/South Pacific | Oral, Personal and Home Care [Member]
Segment Reporting Information [Line Items]
Total Net sales							3,406		3,396		3,417
Total Operating profit							877		805		747
Total Capital expenditures							78		74		71
Total Depreciation and amortization							84		85		85
Total Identifiable assets	3,836			3,978			3,836		3,978		3,649
Operating Segments [Member] | Asia [Member] | Oral, Personal and Home Care [Member]
Segment Reporting Information [Line Items]
Total Net sales							2,515		2,472		2,264
Total Operating profit							736		698		619
Total Capital expenditures							147		123		88
Total Depreciation and amortization							78		72		70
Total Identifiable assets	1,903			1,794			1,903		1,794		1,608
Operating Segments [Member] | Africa/Eurasia [Member] | Oral, Personal and Home Care [Member]
Segment Reporting Information [Line Items]
Total Net sales							1,208		1,257		1,241
Total Operating profit							235		268		267
Total Capital expenditures							14		11		16
Total Depreciation and amortization							10		11		11
Total Identifiable assets	510			557			510		557		561
Corporate, Non-Segment [Member]
Segment Reporting Information [Line Items]
Total Operating profit							-1,088		-1,090		-597
Total Capital expenditures							137		128		73
Total Depreciation and amortization							82		76		68
Total Identifiable assets	140	[4]		66	[4]		140	[4]	66	[4]	86	[4]
Two Thousand Twelve Restructuring Program [Member]
Segment Reporting Information [Line Items]
Pretax charges related to the 2012 Restructuring Program							$286		$371		$89
Sales Revenue, Net [Member]
Segment Reporting Information [Line Items]
Percentage of Consolidated Net Sales represented by Sales outside US	80.00%						80.00%
Percentage of Consolidated Net Sales coming from Emerging Markets	50.00%						50.00%
[1]	Long-lived assets in the U.S., primarily property, plant and equipment and goodwill and other intangibles represented approximately one-third of total long-lived assets of $8,086, $8,248 and $8,066 in 2014, 2013 and 2012, respectively.
[2]	Net sales in the U.S. for Pet Nutrition were $1,149, $1,116 and $1,052 in 2014, 2013 and 2012, respectively.
[3]	Net sales in the U.S. for Oral, Personal and Home Care were $2,835, $2,771 and $2,669 in 2014, 2013 and 2012, respectively.
[4]	In 2014, Corporate identifiable assets primarily consist of derivative instruments (62%) and investments in equity securities (22%). In 2013, Corporate identifiable assets primarily consist of derivative instruments (32%) and investments in equity securities (41%). In 2012, Corporate identifiable assets primarily consist of derivative instruments (67%) and investments in equity securities (28%).

Supplemental_Income_Statement_2

Supplemental Income Statement Information (Details) (USD $)	3 Months Ended				12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Sep. 30, 2014	Dec. 31, 2013	Jun. 30, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Other (income) expense, net
Amortization of intangible assets					$32	$32	$31
Charges for European Competition Law Matters	30	11	5	18	41	23
Other (income) expense, net					570	422	113
Interest (income) expense, net
Interest incurred					134	119	81
Interest Capitalized					-4	-3	-1
Interest income					-106	-125	-65
Total Interest (income) expense, net					24	-9	15
Research and development					277	267	259
Advertising					1,784	1,891	1,792
Other (income) expense, net
Other (income) expense, net
Amortization of intangible assets					32	32	31
Pretax charges related to the 2012 Restructuring Program					195	202	81
Venezuela Remeasurement Charges					327	172	0
Charges for European Competition Law Matters					41	23	0
Pretax costs related to sale of land in Mexico					0	3	0
Business realignment and other cost-saving initiatives					0	0	2
Equity (income)					-7	-5	-7
Total Other (income) expense, net					-18	-5	6
Other (income) expense, net					$570	$422	$113

Supplemental_Balance_Sheet_Inf2

Supplemental Balance Sheet Information (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Millions, unless otherwise specified
Inventory, Net [Abstract]
Raw materials and supplies	$349	$340
Work-in-process	55	60
Finished goods	978	1,025
Total Inventories	1,382	1,425
LIFO Inventory Amount	287	289
Excess of Replacement or Current Costs over Stated LIFO Value	18	37
Property, Plant and Equipment [Abstract]
Land	250	254
Buildings	1,660	1,625
Manufacturing machinery and equipment	5,220	5,220
Other equipment	1,255	1,231
Property, plant and equipment, gross	8,385	8,330
Accumulated depreciation	-4,305	-4,247
Total Property, plant and equipment, net	4,080	4,083
Other liabilities
Pension and other retiree benefits	1,886	1,387
Restructuring Reserve, Noncurrent	78	16
Other	259	274
Total Other liabilities	$2,223	$1,677

Supplemental_Balance_Sheet_Inf3

Supplemental Balance Sheet Information Supplemental Other Accruals (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Millions, unless otherwise specified
Balance Sheet Related Disclosures [Abstract]
Accrued advertising and coupon redemption	$550	$676
Accrued payroll and employee benefits	332	361
Accrual for Taxes Other than Income Taxes, Current	122	131
Restructuring Reserve, Current	114	142
Pension and other retiree benefits	89	94
Accrued interest	28	27
Derivative Liability, Current	5	11
Other	677	647
Total Other accruals	$1,917	$2,089

Supplemental_Comprehensive_Inc2

Supplemental Comprehensive Income (Loss) Information (Details)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014		Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2014	Dec. 31, 2012
	USD ($)		USD ($)		USD ($)		VENEZUELA	VENEZUELA
							VEF	VEF
Other Comprehensive Income (Loss), Net of Tax [Abstract]
Cumulative translation adjustments, before-tax	($663)		($188)		$18
Cumulative translation adjustment, net-of-tax	-681		-163		-20
Pension and other benefits:
Net actuarial loss & prior service costs arising during the period, before-tax	-580		295		-317
Net actuarial loss & prior service costs arising during the period, net-of-tax	-374		189		-207
Amortization of net actuarial loss, transition & prior service costs, before-tax	67	[1]	111	[1]	101	[1]
Amortization of net actuarial loss, transition & prior service costs, net-of-tax	45	[1]	70	[1]	62	[1]
Curtailment Loss Unamortized Prior Service Costs, before tax	0	[1]	91	[1]	0	[1]
Curtailment Loss Unamortized Prior Service Costs, net-of-tax	0	[1]	59	[1]	0	[1]
Retirement Plan and other retiree benefit adjustments, before-tax	-513		497		-216
Retirement Plan and other retiree benefit adjustments, net-of-tax	-329		318		-145
Available-for-sale securities:
Unrealized gains (losses) on available-for-sale securities, before-tax	-341	[2]	-113	[2]	28	[2]
Unrealized gains (losses) on available-for-sale securities, net-of-tax	-222	[2]	-73	[2]	18	[2]
Reclassification of (gains) losses into net earnings on available-for-sale securities, before-tax	267	[3]	133	[3]	0	[3]
Reclassification of (gains) losses into net earnings on available-for-sale securities, net-of-tax	174	[3]	86	[3]	0	[3]
Gains (losses) on available-for-sale securities, before-tax	-74		20		28
Gains (losses) on available-for-sale securities, net-of-tax	-48		13		18
Cash flow hedges:
Unrealized gains (losses) on cash flow hedges, before-tax	9		20		13
Unrealized gains (losses) on cash flow hedges, net-of-tax	6		13		8
Reclassification of (gains) losses into net earnings on cash flow hedges, before-tax	-5	[4]	-17	[4]	-11	[4]
Reclassification of (gains) losses into net earnings on cash flow hedges, net of tax	-4	[4]	-11	[4]	-7	[4]
Gains (losses) on cash flow hedges, before-tax	4		3		2
Gains (losses) on cash flow hedges, net-of-tax	2		2		1
Total Other comprehensive income (loss), before-tax	-1,246		332		-168
Total Other comprehensive income (loss), net-of-tax	-1,056		170		-146
Remeasurement Due To Change in Foreign Exchange Rates [Abstract]
Loss (gain) related to the remeasurement of fixed interest rate and devaluation-protected bonds in Venezuela	324
Loss related to the remeasurement of fixed interest rate bonds in Venezuela			$133
Foreign Currency [Line Items]
Official Exchange Rate							6.3	4.3
[1]	These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 10, Retirement Plans and Other Retiree Benefits for additional details.
[2]	For the year ended December 31, 2014, these amounts included pretax net losses of $324 related to the remeasurement of the bolivar denominated fixed interest rate bonds and the devaluation-protected bonds in Venezuela. For the year ended December 31, 2013, these amounts included pretax losses of $133 related only to the remeasurement of the bolivar denominated fixed interest rate bonds in Venezuela as a result of the devaluation in the first quarter of 2013. No remeasurement charge was required on the devaluation-protected bonds in the first quarter of 2013 since the official exchange rate changed from 4.30 to 6.30 bolivares per dollar and the devaluation-protected bonds revalued to the official exchange rate. See Note 7, Fair Value Measurements and Financial Instruments for additional details.
[3]	Represents reclassification of losses on the Venezuela bonds into Other (income) expense, net due to an impairment in the fair value of the bonds as a result of the effective devaluations in the first and third quarters of 2014 and the devaluation in 2013. See Note 7, Fair Value Measurements and Financial Instruments for additional details.
[4]	These (gains) losses are reclassified into Cost of sales. See Note 7, Fair Value Measurements and Financial Instruments for additional details.

Supplemental_Comprehensive_Inc3

Supplemental Comprehensive Income (Loss) Information (Details 1) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Millions, unless otherwise specified
Other Comprehensive Income (Loss), Net of Tax [Abstract]
Unrecognized pension and other retiree benefit costs, aftertax	$1,064	$735
Foreign currency translation adjustments	$2,453	$1,772

Quarterly_Financial_Data_Unaud2

Quarterly Financial Data (Unaudited) (Details) (USD $)	3 Months Ended																12 Months Ended
In Millions, except Per Share data, unless otherwise specified	Dec. 31, 2014		Sep. 30, 2014		Jun. 30, 2014		Mar. 31, 2014		Dec. 31, 2013		Sep. 30, 2013		Jun. 30, 2013		Mar. 31, 2013		Dec. 31, 2014		Dec. 31, 2013		Dec. 31, 2012
Quarterly financial data (Unaudited) [Abstract]
Charge for a foreign tax matter			$66														$66
Charges for European Competition Law Matters	30		11						5				18				41		23
Net sales	4,221		4,379		4,352		4,325		4,361		4,398		4,346		4,315		17,277		17,420		17,085
Gross profit	2,475	[1]	2,558	[2]	2,552	[3]	2,524	[4]	2,567	[5]	2,585	[6]	2,534	[7]	2,515	[8]	10,109	[9]	10,201	[10]	9,932
Net income including noncontrolling interests	666	[11]	580	[12]	661	[13]	432	[14]	601	[15]	699	[16]	604	[17]	506	[18]	2,339	[19]	2,410	[20]	2,631
Net income attributable to Colgate-Palmolive Company	628	[11]	542	[12]	622	[13]	388	[14]	564	[15]	656	[16]	561	[17]	460	[18]	2,180	[19]	2,241	[20]	2,472
Earnings per common share:
Basic EPS (in dollars per share)	$0.69	[11]	$0.59	[12]	$0.68	[13]	$0.42	[14]	$0.61	[15]	$0.71	[16]	$0.60	[17]	$0.49	[18]	$2.38	[19]	$2.41	[20]	$2.60
Diluted EPS (in dollars per share)	$0.68	[11]	$0.59	[12]	$0.67	[13]	$0.42	[14]	$0.60	[15]	$0.70	[16]	$0.60	[17]	$0.48	[18]	$2.36	[19]	$2.38	[20]	$2.57
MEXICO
Quarterly financial data (Unaudited) [Abstract]
Pretax costs related to sale of land in Mexico																	4		18		24
Aftertax costs related to sale of land			1		1		1		3		2		4		3		3		12		18
CP Venezuela [Member]
Quarterly financial data (Unaudited) [Abstract]
Venezuela Remeasurement Charges Aftertax			40				174										214		111
Two Thousand Twelve Restructuring Program [Member]
Quarterly financial data (Unaudited) [Abstract]
Pretax charges related to the 2012 Restructuring Program																	286		371		89
Aftertax charges related to the 2012 Restructuring Program	41		41		53		73		125		22		79		52		208		278		70
Gross Profit [Member] | Two Thousand Twelve Restructuring Program [Member]
Quarterly financial data (Unaudited) [Abstract]
Pretax charges related to the 2012 Restructuring Program	6		7		6		10		6		8		10		8		29		32		2
Cost of Sales [Member] | MEXICO
Quarterly financial data (Unaudited) [Abstract]
Pretax costs related to sale of land in Mexico			$1		$2		$1		$4		$3		$4		$4		$4		$15
[1]	Gross profit for the fourth quarter of 2014 includes $6 of charges related to the 2012 Restructuring Program.
[2]	Gross profit for the third quarter of 2014 includes $7 of charges related to the 2012 Restructuring Program and $1 of costs related to the sale of land in Mexico.
[3]	Gross profit for the second quarter of 2014 includes $6 of charges related to the 2012 Restructuring Program and $2 of costs related to the sale of land in Mexico.
[4]	Gross profit for the first quarter of 2014 includes $10 of charges related to the 2012 Restructuring Program and $1 of costs related to the sale of land in Mexico.
[5]	Gross profit for the fourth quarter of 2013 includes $6 of charges related to the 2012 Restructuring Program and $4 of costs related to the sale of land in Mexico.
[6]	Gross profit for the third quarter of 2013 includes $8 of charges related to the 2012 Restructuring Program and $3 of costs related to the sale of land in Mexico.
[7]	Gross profit for the second quarter of 2013 includes $10 of charges related to the 2012 Restructuring Program and $4 of costs related to the sale of land in Mexico.
[8]	Gross profit for the first quarter of 2013 includes $8 of charges related to the 2012 Restructuring Program and $4 of costs related to the sale of land in Mexico.
[9]	Gross profit for the full year of 2014 includes $29 of charges related to the 2012 Restructuring Program and $4 of costs related to the sale of land in Mexico.
[10]	Gross profit for the full year of 2013 includes $32 of charges related to the 2012 Restructuring Program and $15 of costs related to the sale of land in Mexico.
[11]	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the fourth quarter of 2014 include $41 of aftertax charges related to the 2012 Restructuring Program and a $30 charge for a European competition law matter.
[12]	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the third quarter of 2014 include $41 of aftertax charges related to the 2012 Restructuring Program, a $40 aftertax charge related to the 2014 Venezuela Remeasurements, an $11 charge for a European competition law matter, $1 of aftertax costs related to the sale of land in Mexico and a $66 charge for a foreign tax matter.
[13]	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the second quarter of 2014 include $53 of aftertax charges related to the 2012 Restructuring Program and $1 of aftertax costs related to the sale of land in Mexico.
[14]	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the first quarter of 2014 include $73 of aftertax charges related to the 2012 Restructuring Program, a $174 aftertax charge related to the 2014 Venezuela Remeasurements and $1 of aftertax costs related to the sale of land in Mexico.
[15]	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the fourth quarter of 2013 include $125 of aftertax charges related to the 2012 Restructuring Program, a $5 charge for a European competition law matter and $3 of aftertax costs related to the sale of land in Mexico.
[16]	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the third quarter of 2013 include $22 of aftertax charges related to the 2012 Restructuring Program and $2 of aftertax costs related to the sale of land in Mexico.
[17]	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the second quarter of 2013 include $79 of aftertax charges related to the 2012 Restructuring Program, an $18 charge for a European competition law matter and $4 of aftertax costs related to the sale of land in Mexico.
[18]	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the first quarter of 2013 include $52 of aftertax charges related to the 2012 Restructuring Program, a $111 aftertax charge related to the 2013 Venezuela Remeasurement and $3 of aftertax costs related to the sale of land in Mexico.
[19]	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the full year of 2014 include $208 of aftertax charges related to the 2012 Restructuring Program, $214 of aftertax charges related to the 2014 Venezuela Remeasurements, $41 of charges for European competition law matters, $3 of aftertax costs related to the sale of land in Mexico and a $66 charge for a foreign tax matter.
[20]	Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and earnings per common share for the full year of 2013 include $278 of aftertax charges related to the 2012 Restructuring Program, a $111 aftertax charge related to the 2013 Venezuela Remeasurement, a $23 charge for a European competition law matter and $12 of aftertax costs related to the sale of land in Mexico.

Schedule_II_Valuation_and_Qual1

Schedule II - Valuation and Qualifying Accounts (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Allowance for doubtful accounts and estimated returns
Movement in Valuation Allowances and Reserves [Roll Forward]
Valuation Allowances and Reserves, Beginning Balance	$67	$61	$49
Valuation Allowances and Reserves, Charged to Cost and Expense	0	15	18
Valuation Allowances and Reserves, Charged to Other Accounts	0	0	0
Valuation Allowances and Reserves, Deductions	13	9	6
Valuation Allowances and Reserves, Ending Balance	54	67	61
Valuation allowance for deferred tax assets
Movement in Valuation Allowances and Reserves [Roll Forward]
Valuation Allowances and Reserves, Beginning Balance	6	1	1
Valuation Allowances and Reserves, Charged to Cost and Expense	0	6	0
Valuation Allowances and Reserves, Charged to Other Accounts	0	0	0
Valuation Allowances and Reserves, Deductions	6	1	0
Valuation Allowances and Reserves, Ending Balance	$0	$6	$1